Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3002173	ab-hb	g/l (g/l)	27821	297045	0.00%
3002173	ab-thb	g/l (g/l)	10215	48573	0.00%
3002173	ab-hemoglobiini	g/l (g/l)	2530	10296	0.00%
3002173	ab-hb	— (—)	2091	9281	100.00%	Distribution not available
3002173	ab-hb	g/l_______ (g/l)	586	1226	0.00%
3002173	ab-chb	g/L (g/l)	536	1200	0.00%
3002173	ab-hb	g/L (g/l)	481	1059	0.00%
3002173	ab-hb	G/L (g/l)	414	1435	0.00%
3002173	hemoglobiini(totaali),valtimoveri	g/l (g/l)	414	787	0.00%
3002173	ab-hb-vt	g/l (g/l)	144	225	0.00%
3002173	ab-hemoglobiini	g/l_______ (g/l)	122	173	0.00%
3002173	ab-thb	g/L (g/l)	58	61	0.00%
3002173	hemoglobiini(totaali),valtimoveri	g/l_______ (g/l)	29	30	0.00%
3002173	ab-chb	— (—)	25	28	100.00%	Distribution not available
3002173	ab-hblask	g/l (g/l)	16	36	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Care involving dialysis

1014

2934

4.50

320.44

18.7

8.4

103.21

123.59

g/l

177.06

996

2876

Other nutritional deficiencies

5188

27355

1.84

319.66

10.7

8.8

123.80

121.37

g/l

13.02

5108

26709

Symptoms and signs involving the digestive system and abdomen

7574

23440

1.70

319.42

9.5

8.8

121.82

122.17

g/l

0.67

7418

22864

ILD medications: immunosuppressive drugs

4952

25533

1.87

319.10

12.8

8.5

116.30

122.33

g/l

76.67

4867

24945

Non-allergic asthma (mode), excluding more controls

1533

5446

3.10

319.03

8.3

6.4

124.83

121.18

g/l

9.04

1503

5308

Mood disorders, excluding more controls

7009

25247

1.71

316.45

9.5

8.7

122.44

121.49

g/l

3.11

6886

24651

Hernia

7246

30006

1.69

315.50

9.3

8.6

120.89

121.68

g/l

2.41

7118

29286

Osteopathies and chondropathies

4749

24610

1.90

315.14

9.0

8.4

117.38

121.27

g/l

33.06

4652

24060

Abdominal and pelvic pain

7524

23436

1.69

311.87

9.2

8.8

122.49

122.17

g/l

0.61

7370

22860

Pain, not elsewhere classified

2329

10332

2.47

311.70

9.2

8.1

121.15

121.83

g/l

0.86

2296

10078

Cardiomyopathy

1631

6187

3.02

311.56

15.5

7.4

123.15

123.04

g/l

0.07

1614

6026

Kidney transplant status

748

1797

5.90

310.52

16.5

11.0

104.75

124.42

g/l

112.53

738

1760

Epilepsy

2734

12969

2.31

310.06

9.4

8.6

122.37

120.38

g/l

5.60

2680

12666

Nutritional anaemias

4373

23263

1.94

309.65

10.5

7.6

111.27

121.32

g/l

192.23

4293

22729

Diverticular disease of intestine

5917

21870

1.79

309.49

8.8

8.4

120.08

122.21

g/l

11.79

5828

21372

Certain infectious and parasitic diseases

7416

20185

1.95

307.65

10.3

7.6

119.80

123.52

g/l

38.71

7253

19685

Atherosclerosis, excluding cerebral and coronary sclerosis

4192

16470

2.24

307.65

10.3

7.4

115.79

121.32

g/l

55.02

4112

16074

Myocardial infarction

4933

14715

2.66

307.65

10.8

7.8

119.95

121.74

g/l

6.65

4831

14403

Angina pectoris

5400

16123

2.49

307.65

9.4

7.8

121.26

121.56

g/l

0.44

5264

15775

Other CVD (FINNGEN)

1225

1757

6.48

307.65

10.3

6.7

117.28

122.58

g/l

11.79

1208

1707

Abnormal findings on diagnostic imaging of lung

4617

23670

2.03

307.65

9.6

8.2

121.86

120.51

g/l

4.30

4512

23158

Renal failure

5939

20867

2.85

307.65

15.2

7.4

111.71

122.27

g/l

253.18

5833

20393

Asthma-related infections

5850

26010

2.42

307.65

9.5

8.4

123.39

120.56

g/l

20.03

5712

25422

STROKE

5368

12689

3.22

307.65

11.4

7.1

121.06

122.99

g/l

8.13

5261

12401

Anaemias

2078

1198

12.88

307.65

13.6

5.3

111.70

127.34

g/l

85.36

2045

1163

Dyspnoea

9748

29805

2.65

307.65

9.0

8.6

123.46

120.66

g/l

29.41

9592

29090

Sequelae of external causes of morbidity and mortality

2766

11599

2.77

307.65

11.7

8.3

115.64

121.29

g/l

38.61

2715

11337

Condition for Implicit Sepsis (Organ dysfunction codes)

9514

25109

2.98

307.65

13.3

7.1

119.66

123.02

g/l

37.89

9331

24521

Bacterial Sepsis

6556

17923

3.67

307.65

14.5

6.9

116.07

122.47

g/l

97.95

6422

17510

Heart failure,strict

6676

16021

3.50

307.65

12.5

7.6

119.03

122.52

g/l

28.01

6583

15645

Abnormalities of breathing

8366

19933

2.63

307.65

9.1

9.0

124.33

120.65

g/l

39.34

8212

19455

Hypertensive diseases

6615

15572

2.61

307.65

11.0

8.3

121.82

123.21

g/l

5.07

6495

15182

Presence of cardiac and vascular implants and grafts

5032

16878

2.51

307.65

12.0

7.7

117.60

122.03

g/l

39.53

4910

16512

General symptoms and signs

9035

22243

2.18

307.65

9.6

8.4

121.38

122.70

g/l

6.22

8845

21706

Erysipelas

5626

22534

2.39

307.65

10.0

7.6

119.18

123.51

g/l

42.83

5534

22024

Hypothyroidism and >3 levothyroxin purchases

1352

1234

6.59

307.65

10.9

5.5

125.34

127.55

g/l

2.03

1325

1196

Septicaemia

5540

17708

3.42

307.65

14.0

7.3

113.43

122.64

g/l

178.65

5432

17311

Poisoning by drugs, medicaments and biological substances

2283

7916

3.31

307.65

9.7

9.3

124.54

122.89

g/l

3.20

2242

7733

Metabolic disorders

9314

24300

2.54

307.65

10.6

8.1

120.56

122.46

g/l

12.94

9127

23699

Other respiratory disorders and diseases

2367

9439

2.98

307.65

14.7

7.7

125.39

119.97

g/l

25.27

2322

9215

Examination and observation for other reasons

5168

13805

2.28

307.65

10.0

8.6

119.82

122.43

g/l

13.86

5131

13444

Other chronic obstructive pulmonary disease

4622

17641

2.43

307.65

10.1

8.3

124.25

119.90

g/l

33.51

4537

17249

Malignant neoplasm, including Hilmo

7515

21207

2.23

307.65

9.1

9.2

119.82

123.84

g/l

48.54

7348

20742

Care involving use of rehabilitation procedures

6142

25154

2.42

307.65

9.9

8.2

120.86

122.78

g/l

9.94

5922

24622

Explicit Sepsis, including avohilmo

5789

17819

3.51

307.65

14.0

6.8

113.56

122.41

g/l

172.74

5680

17399

Colorectal adenocarcinoma

2177

8929

2.80

307.65

8.2

8.1

115.83

122.17

g/l

43.92

2138

8737

Colorectal cancer

2563

10334

2.75

307.65

8.3

8.2

115.50

122.13

g/l

56.06

2515

10105

Viral Sepsis

2689

8454

3.90

307.65

13.5

6.8

119.34

122.15

g/l

8.57

2625

8245

Implicit viral Sepsis, including avohilmo

3631

12707

3.38

307.65

12.8

6.7

119.65

122.03

g/l

8.67

3558

12403

Asthma, hospital admissions 3, pneumonia

4315

16616

3.02

307.65

10.4

7.9

122.09

119.89

g/l

9.32

4218

16224

Any event in cancer register

7716

22163

2.19

307.65

9.1

119.80

123.61

g/l

45.81

7545

21674

Excluding asthma or asthma-COPD overlap

5968

14518

2.19

307.65

10.2

7.3

122.04

121.59

g/l

0.78

5825

14190

Malignant neoplasm of digestive organs, including Hilmo

4732

14584

2.74

307.65

9.7

8.7

115.46

122.84

g/l

111.99

4640

14279

Type 2 diabetes

8027

25482

1.94

307.65

11.0

7.8

121.78

121.79

g/l

0.01

7878

24875

Asthma, hospital admissions , main diagnosis only

6427

33588

1.76

307.65

8.0

8.8

123.93

120.99

g/l

24.13

6279

32834

First line medication for Crohn's disease

9335

26546

2.02

307.65

9.9

8.4

120.67

122.52

g/l

12.46

9137

25925

Suicide or other Intentional self-harm

2145

8623

2.80

307.65

10.1

9.3

124.39

122.75

g/l

3.05

2100

8427

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4144

20765

2.18

307.65

11.6

9.3

121.74

123.31

g/l

4.50

4080

20279

Ischaemic heart disease, wide definition

7467

21606

2.36

307.65

10.6

8.4

121.06

121.72

g/l

1.70

7327

21149

Other medical care

5333

19157

2.66

307.65

8.2

7.8

116.38

121.81

g/l

64.40

5210

18752

Ischemic heart diseases

8306

20559

2.69

307.65

11.9

7.9

121.01

122.13

g/l

4.36

8142

20106

Cerebrovascular diseases (FINNGEN)

3391

4555

6.22

307.65

13.1

6.6

121.70

124.59

g/l

9.42

3327

4437

Asthma, hospital admission 2, infections

5850

26010

2.42

307.65

9.5

8.4

123.39

120.56

g/l

20.03

5712

25422

Other and unspecified anaemias

4245

20757

2.12

307.65

10.1

7.8

107.73

122.04

g/l

307.65

4175

20276

Hypertensive Heart Disease

2402

6933

3.01

307.65

9.5

7.5

119.68

121.36

g/l

3.03

2375

6770

Bleeding

8333

28279

2.28

307.65

11.4

8.1

117.91

122.40

g/l

63.13

8172

27636

Non-rheumatic valve diseases

4956

13077

3.11

307.65

11.4

7.5

115.58

122.35

g/l

86.49

4865

12755

Any reimbursement code in KELA

3803

6362

3.20

307.65

10.6

7.6

123.39

125.00

g/l

3.78

3726

6198

Disorders of gallbladder, biliary tract and pancreas

7951

30692

1.70

307.65

10.0

8.4

120.04

121.69

g/l

9.59

7799

29991

Solid cancers

7240

20734

2.22

307.65

8.8

9.2

119.64

123.70

g/l

49.51

7078

20287

Diabetes mellitus

8361

26079

1.97

307.65

11.1

7.9

121.57

121.86

g/l

0.56

8205

25456

Mental and behavioural disorders due to alcohol

4680

22872

2.13

307.65

11.3

9.0

121.95

123.00

g/l

2.54

4605

22322

Heart failure, not strict

9349

21178

3.54

307.65

13.1

7.6

118.54

122.90

g/l

59.82

9190

20692

Neoplasms

5178

14332

1.99

307.65

9.8

9.6

122.52

124.73

g/l

9.94

5061

13999

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1935

7843

2.88

307.65

8.2

8.5

115.45

122.39

g/l

44.05

1883

7675

3854

18228

2.29

307.65

8.9

8.7

124.46

120.79

g/l

22.30

3773

17809

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6455

27747

2.57

307.65

11.2

7.9

116.37

121.95

g/l

86.92

6311

27133

Implicit Sepsis, including avohilmo

9472

25257

3.06

307.65

13.3

7.1

119.41

122.96

g/l

42.39

9292

24669

Asthma-related pneumonia or sepsis

4315

16616

3.02

307.65

10.4

7.9

122.09

119.89

g/l

9.32

4218

16224

COPD, hospital admissions

4600

19688

2.21

307.65

10.1

8.2

124.27

120.20

g/l

29.85

4514

19249

Sequelae with surgical and medical care as external cause

2207

9083

2.85

307.65

11.7

8.4

115.08

121.05

g/l

35.77

2171

8878

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

8634

28003

2.10

307.65

12.4

7.8

117.74

122.98

g/l

92.89

8453

27372

COPD-related respiratory insufficiency

1486

5280

3.53

307.65

13.8

7.8

125.98

119.85

g/l

20.49

1460

5156

Asthma

6670

14405

2.59

307.65

8.9

7.4

124.34

121.58

g/l

18.19

6519

14080

COPD related to multimorbidity

4117

17374

2.26

307.65

10.3

8.0

123.69

120.03

g/l

21.92

4039

16984

COPD/asthma related infections

8035

21203

2.02

307.65

10.2

7.5

120.65

121.69

g/l

3.86

7843

20723

5552

25118

2.09

307.65

11.7

8.8

121.53

122.88

g/l

4.43

5464

24523

Asthma (only as main-diagnosis)

5970

14405

2.51

307.65

8.2

7.4

124.30

121.58

g/l

16.46

5834

14080

Complications of medical and surgical care

8016

30696

2.65

307.65

11.0

8.0

116.84

122.14

g/l

95.18

7843

30018

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3039

5766

3.62

307.65

10.6

6.6

121.23

124.45

g/l

11.21

2971

5607

Malignant neoplasm

7333

20984

2.22

307.65

9.0

9.2

119.43

123.76

g/l

55.39

7166

20528

All influenza

2627

10087

2.97

307.65

9.2

7.6

121.65

122.38

g/l

0.96

2550

9880

ILD differential diagnosis

5906

14548

2.16

307.65

10.1

7.4

122.06

121.58

g/l

0.87

5765

14220

COPD (mode)

3638

9440

3.57

307.65

10.4

7.2

124.20

120.81

g/l

15.13

3571

9243

Persons encountering health services for specific procedures and health care

10390

27327

2.46

307.65

10.9

8.2

119.14

123.07

g/l

58.83

10117

26748

COPD differential diagnosis

5911

14552

2.16

307.65

10.1

7.4

122.06

121.59

g/l

0.85

5770

14224

9602

21203

2.97

307.65

12.0

7.5

119.77

121.69

g/l

13.26

9375

20723

Pulmonary embolism

3159

13855

2.63

307.65

10.3

8.1

121.62

120.23

g/l

3.14

3093

13540

Any death

6555

22472

2.30

307.65

12.3

8.0

115.51

122.93

g/l

133.60

6399

22003

Venous thromboembolism

5037

26039

2.04

307.65

9.6

8.1

121.00

120.65

g/l

0.55

4926

25460

Cerebrovascular diseases

7254

26010

2.13

307.65

10.4

8.3

120.47

121.23

g/l

2.32

7108

25443

Paroxysmal tachycardia

1693

3701

4.24

307.65

12.6

6.5

123.31

124.00

g/l

0.60

1666

3605

Implicit bacterial Sepsis

5909

16455

3.79

307.65

14.9

6.8

116.06

122.26

g/l

83.34

5789

16075

Fall on same level

8690

28756

1.69

307.65

9.8

8.7

120.25

122.70

g/l

20.92

8511

28083

Chronic kidney disease

3580

15329

2.59

307.65

13.1

7.2

109.82

121.95

g/l

221.34

3509

14960

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6312

29333

2.04

307.65

9.5

8.3

121.57

120.84

g/l

1.94

6175

28700

COPD, hospital admissions 3, with asthma pneumonia sepsis

2952

11781

2.46

307.65

10.5

7.8

123.74

119.89

g/l

17.55

2893

11496

Respiratory insufficiency

1111

2684

5.36

307.65

13.9

6.9

130.91

119.81

g/l

44.22

1093

2624

Hypertensive heart and/or renal disease

2662

7336

3.04

307.65

9.7

7.6

118.63

121.54

g/l

8.61

2631

7163

Other diseases of the digestive system

3236

15895

2.28

307.65

10.9

7.9

113.25

121.73

g/l

88.21

3190

15515

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1538

5073

3.51

307.65

10.2

9.6

125.05

123.23

g/l

2.64

1509

4956

Provisional assignment of new diseases of uncertain etiology

5653

23811

2.66

307.65

12.0

7.9

120.47

121.19

g/l

1.76

5577

23237

COPD, hospital admission 2, with asthma infections

3421

14041

2.39

307.65

10.5

7.9

124.30

120.16

g/l

22.87

3354

13705

Diseases of arteries, arterioles and capillaries

7081

24640

2.37

307.65

11.4

7.9

116.81

121.99

g/l

76.30

6952

24080

Codes for special purposes

5658

23827

2.66

307.65

12.0

7.9

120.47

121.19

g/l

1.75

5582

23251

Transplanted organ and tissue status

1315

3411

5.12

307.65

27.2

8.5

107.17

124.55

g/l

147.00

1297

3326

Antihypertensive medication - note that there are other indications

3753

7710

2.70

307.65

11.0

7.4

123.41

123.91

g/l

0.63

3674

7495

Later onset COPD, excluding more controls

2306

6553

3.16

307.65

8.8

6.5

122.73

119.20

g/l

11.38

2263

6406

Dialysis, with operation codes

1726

5120

4.44

307.65

22.8

8.0

105.45

123.85

g/l

225.91

1700

5008

Aplastic and other anaemias

4612

21840

2.14

307.65

10.2

7.8

107.86

122.10

g/l

307.65

4528

21340

Diabetes medication

8318

28249

1.82

307.65

10.4

8.2

121.41

121.79

g/l

0.83

8156

27580

Acute tubulo-interstitial nephritis

5872

23610

2.30

307.65

9.3

7.4

116.65

122.39

g/l

83.95

5769

23046

Dipeptidyl peptidase 4 (DPP-4) inhibitors

5002

22110

1.93

307.65

9.7

8.1

119.53

120.94

g/l

4.60

4894

21613

All chronic kidney diseases

5907

20120

2.65

307.65

11.9

7.5

112.71

123.23

g/l

256.63

5802

19646

Diabetes, varying definitions

8321

26102

1.97

307.65

11.2

7.9

121.57

121.86

g/l

0.55

8166

25477

Early onset COPD, excluding more controls

2159

7124

3.56

307.65

11.8

7.5

126.25

122.00

g/l

14.59

2123

6966

Viral pneumonia

1536

4609

4.07

307.65

15.2

7.6

121.17

122.48

g/l

1.43

1488

4515

Poisoning by medicine

2088

7047

3.42

307.65

9.9

9.4

124.57

122.88

g/l

3.09

2051

6878

Other diseases of the respiratory system

2367

9439

2.98

307.65

14.7

7.7

125.39

119.97

g/l

25.27

2322

9215

Other heart diseases, wide

8370

20477

2.72

307.65

11.9

7.8

121.35

123.10

g/l

9.48

8193

19973

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2354

9672

2.69

307.65

9.7

9.1

124.12

122.49

g/l

3.28

2297

9450

Other anaemias

4271

20887

2.12

307.65

10.1

7.8

107.74

122.05

g/l

307.65

4201

20403

Asthma/COPD (KELA code 203)

7678

29905

1.81

307.65

8.1

8.8

124.35

120.80

g/l

39.35

7496

29235

Type 2 diabetes, definitions combined, including avohilmo

7401

24864

1.82

307.65

10.5

7.9

122.70

121.65

g/l

3.76

7268

24269

Other (not insulin) diabetes medications

7608

27323

1.72

307.65

9.6

8.1

122.25

121.69

g/l

1.38

7460

26674

Endocrine, nutritional and metabolic diseases

5576

13804

2.15

307.65

10.8

7.5

122.91

122.78

g/l

0.15

5464

13434

Stroke, including SAH

5867

23220

1.98

307.65

10.6

8.3

120.35

120.97

g/l

1.40

5748

22706

Stroke, excluding SAH

5449

22436

1.90

307.65

10.1

8.3

120.28

120.83

g/l

1.11

5337

21935

Unstable angina pectoris

3449

12521

2.42

307.65

8.9

7.5

121.94

121.12

g/l

1.38

3357

12236

Coronary revascularization (ANGIO or CABG)

8315

20127

2.84

307.65

11.8

7.9

120.81

122.10

g/l

5.60

8144

19693

5357

24672

2.12

307.65

11.7

8.8

121.39

122.96

g/l

5.57

5272

24087

Other arrhythmias

4766

17949

2.12

307.65

8.9

7.6

123.10

122.54

g/l

1.01

4649

17508

Myocardial infarction, strict

4500

13995

2.57

307.65

10.3

7.8

120.00

121.73

g/l

5.89

4405

13698

Intracranial trauma

4648

14017

2.41

307.65

9.5

8.4

121.78

120.49

g/l

3.50

4566

13682

Any gastric operation

5982

12132

2.65

307.65

10.6

6.5

120.35

126.03

g/l

65.15

5853

11826

Fever of other and unknown origin

5631

19877

2.73

307.65

10.4

8.4

116.61

122.27

g/l

72.04

5525

19411

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

10733

27945

2.87

307.65

11.9

7.8

119.82

122.56

g/l

29.91

10486

27325

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2354

8128

3.19

307.65

9.7

8.8

124.12

122.39

g/l

3.53

2297

7939

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

7816

25215

1.96

307.65

10.5

7.9

121.34

121.86

g/l

1.23

7664

24607

Asthma, unspecified (mode), excluding more controls

4964

12046

3.29

307.65

9.1

6.9

123.47

121.74

g/l

6.06

4852

11759

Malignant neoplasm of digestive organs

4218

13907

2.65

307.65

9.5

8.7

115.14

122.74

g/l

108.99

4131

13619

Paralytic ileus and intestinal obstruction

2887

11568

2.89

307.65

10.9

7.9

117.41

121.38

g/l

20.14

2824

11290

Substance abuse, excluding more controls

5370

20475

2.41

307.65

11.3

9.0

122.27

122.33

g/l

0.07

5287

19972

Pulmonary heart disease

3159

13939

2.61

307.65

10.3

8.2

121.62

120.27

g/l

2.98

3093

13624

Mental and behavioural disorders due to psychoactive substance use

5489

25606

2.14

307.65

11.2

8.9

122.25

122.74

g/l

0.88

5404

25001

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5854

27095

2.41

307.65

11.2

8.0

116.37

121.60

g/l

71.04

5722

26489

Hypertension

6605

15570

2.61

307.65

11.0

8.3

121.83

123.22

g/l

5.02

6485

15180

Coronary atherosclerosis

6539

17447

2.67

307.65

10.5

7.9

119.89

121.78

g/l

9.37

6417

17072

Type 2 diabetes, definitions combined

7506

24997

1.85

307.65

10.5

7.8

122.65

121.73

g/l

2.98

7369

24400

Personality disorders, excluding more controls

1935

7439

2.85

307.65

9.3

9.2

124.35

123.02

g/l

1.99

1902

7257

Covid-19 confirmed case

4851

17318

3.38

307.65

12.6

7.8

119.94

120.78

g/l

1.90

4791

16881

Other intervertebral disc disorders

6679

22853

1.85

307.65

7.9

9.2

123.01

121.18

g/l

9.43

6484

22336

COPD, early/later onset

4650

19833

2.21

307.65

10.1

8.2

124.25

120.21

g/l

29.81

4565

19388

Implicit Sepsis

9149

24476

3.19

307.65

13.4

7.1

118.90

122.95

g/l

53.07

8970

23916

Complications of procedures, not elsewhere classified

8396

29794

2.53

307.65

11.1

7.9

117.02

122.76

g/l

112.97

8229

29100

Injuries to the head

8630

32622

1.64

307.65

9.4

8.6

121.08

121.73

g/l

1.98

8488

31838

GASTRO-related operations

5982

12132

2.65

307.65

10.6

6.5

120.35

126.03

g/l

65.15

5853

11826

COPD

4825

18198

2.45

307.65

10.1

8.3

124.32

119.92

g/l

35.51

4734

17796

Hypertensive diseases (excluding secondary)

4320

6210

4.52

307.65

12.0

6.8

122.47

125.10

g/l

9.36

4247

6041

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9306

30780

2.22

307.65

10.8

8.2

113.68

124.00

g/l

307.65

9109

30076

Implicit bacterial Sepsis, including avohilmo

6386

17540

3.69

307.65

14.5

6.9

116.53

122.30

g/l

77.28

6257

17137

Type 2 diabetes, strict (exclude DM1)

7538

25196

1.84

307.65

10.5

7.9

122.65

121.67

g/l

3.35

7401

24596

Asthma (mode)

6251

14548

2.43

307.65

8.6

7.4

123.84

121.58

g/l

12.09

6109

14220

Major coronary heart disease event excluding revascularizations

6052

17550

2.56

307.65

10.5

7.8

121.00

121.69

g/l

1.54

5925

17170

Pulmonary heart disease, diseases of pulmonary circulation

3502

15268

2.65

307.65

10.5

8.0

121.84

120.25

g/l

4.28

3432

14921

Insulin, intermediate and long-acting

5271

26317

2.13

307.65

11.2

8.3

118.94

122.10

g/l

21.48

5173

25705

Myocardial infarction, without ST-elevation

4162

19224

2.19

307.65

10.0

8.0

118.81

120.90

g/l

8.36

4073

18786

Hypothyroidism (congenital or acquired)

1374

1235

6.69

307.65

11.1

5.5

125.12

127.56

g/l

2.40

1347

1197

Implicit viral Sepsis

2686

8442

3.91

307.65

13.5

6.8

119.34

122.15

g/l

8.54

2622

8233

Disorders of lipoprotein metabolism and other lipidaemias

7746

22672

2.27

307.65

9.5

8.1

121.21

122.39

g/l

4.80

7602

22121

Hypo-osmolality and hyponatraemia

2001

7169

3.29

307.65

12.4

7.4

116.47

120.06

g/l

11.86

1966

6982

Pneumonias (Asthma/COPD co-morbidities)

10946

27608

2.91

307.65

12.2

7.6

119.93

122.63

g/l

29.25

10695

26990

Solid cancers, including Hilmo

7406

21037

2.22

307.65

8.9

9.2

120.00

123.76

g/l

43.02

7242

20582

Syncope and collapse

3820

16295

2.11

307.65

8.2

8.3

121.68

121.78

g/l

0.10

3742

15920

Complications of surgical and medical care, not elsewhere classified

10430

30531

2.53

307.65

10.9

7.9

117.07

122.90

g/l

138.98

10228

29817

Explicit Sepsis

5660

17586

3.49

307.65

14.1

6.9

113.47

122.32

g/l

169.35

5553

17174

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

9511

24989

2.88

307.65

13.2

7.1

119.97

123.25

g/l

35.99

9321

24398

Conduction disorders

2598

9034

2.55

307.65

10.1

7.2

120.42

121.79

g/l

2.54

2547

8801

Calcific aortic valvular stenosis

3335

14767

2.52

307.65

9.3

7.5

114.78

120.55

g/l

51.12

3273

14399

Pain in throat and chest

7286

19716

2.36

307.65

8.4

8.9

124.01

120.65

g/l

31.05

7111

19242

Hypothyroidism, levothyroxine purchases

1352

1234

6.59

307.65

10.9

5.5

125.34

127.55

g/l

2.03

1325

1196

Emergency coronary revascularization (for ACS)

9045

22813

2.70

307.65

11.4

7.9

120.65

121.82

g/l

5.16

8855

22318

Type 2 diabetes, wide definition

7512

22994

2.26

307.65

10.4

7.9

120.46

121.58

g/l

4.09

7367

22455

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2311

4249

2.89

307.65

9.4

8.9

124.21

123.13

g/l

1.30

2264

4130

Infections, IBD-co-morbidities

1544

2514

4.99

307.65

13.5

8.1

115.23

120.66

g/l

14.43

1511

2448

Cardiovascular diseases

4155

6498

3.66

307.65

11.6

6.8

123.41

124.82

g/l

3.14

4073

6315

All-cause Heart Failure

7125

19602

2.99

307.65

11.8

7.8

118.90

121.37

g/l

16.15

7012

19145

Asthma, including avohilmo

9164

32095

1.65

307.65

8.4

8.9

124.08

120.89

g/l

37.03

8960

31374

Insulin, combination of fast acting with intermediate-acting or long-acting

5716

27812

2.03

307.65

11.4

8.3

118.80

122.03

g/l

24.25

5605

27174

Headache

4869

20096

1.98

307.65

8.1

8.4

123.76

122.47

g/l

4.29

4776

19618

Calcific aortic valvular stenosis, diagnosis (helper)

3329

14760

2.51

307.65

9.3

7.5

114.79

120.55

g/l

50.90

3267

14392

DVT of lower extremities and pulmonary embolism

4100

20592

2.21

307.65

9.7

8.0

121.22

120.45

g/l

1.51

4011

20117

Inflammatory bowel disease treatment related agents

9291

29999

1.82

307.65

9.4

8.6

121.73

g/l

0.00

9097

29308

Heart failure and antihypertensive medication

3277

4120

6.55

307.65

15.5

7.4

119.48

123.15

g/l

12.50

3231

4009

Operations 2 for CAVS

3329

14760

2.51

307.65

9.3

7.5

114.79

120.55

g/l

50.90

3267

14392

Calcific aortic valvular stenosis, including rheumatic fever

3331

14803

2.50

307.65

9.3

7.5

114.80

120.54

g/l

50.65

3269

14435

ILD medications: prednisolone, methylprednisolone, prednisone

9178

28078

1.93

307.65

10.0

8.3

120.97

122.14

g/l

5.30

8994

27409

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1208

1929

5.31

307.65

13.2

8.2

123.09

120.38

g/l

3.17

1184

1877

Calcific aortic valvular stenosis, operated

3335

14767

2.52

307.65

9.3

7.5

114.78

120.55

g/l

51.12

3273

14399

Pneumonia, organism unspecified

9743

26123

2.87

307.65

11.6

7.7

119.74

122.51

g/l

28.20

9544

25551

Valvular operations

1873

5045

4.75

307.65

15.8

7.3

111.27

122.68

g/l

100.39

1835

4920

Bacterial infection, other or unspecified, including avohilmo

6633

21854

2.84

307.65

11.8

7.4

114.65

123.01

g/l

187.08

6484

21357

GI-bleeding

3241

15912

2.28

307.65

10.9

7.9

113.33

121.78

g/l

87.51

3195

15535

Symptoms and signs involving the circulatory and respiratory systems

7679

19963

2.04

307.65

8.9

9.0

123.58

120.68

g/l

23.88

7521

19484

Dental caries

2724

10085

2.92

307.65

14.0

8.9

115.05

122.59

g/l

59.65

2668

9850

Insulin, fast-acting

3261

15999

2.25

307.65

11.7

8.4

117.43

122.38

g/l

32.45

3191

15628

Asthma (diagnoses ohter than nonallergic)

7594

33516

1.96

307.65

8.6

8.7

123.46

120.93

g/l

20.76

7430

32764

Insulin medication

5707

23315

2.23

307.65

11.4

8.2

118.81

121.84

g/l

20.91

5597

22770

Atrial fibrillation and flutter

3150

4298

5.54

307.65

13.9

6.7

122.19

125.07

g/l

8.02

3082

4192

Caries of dentine

2427

9054

2.98

307.65

14.2

8.9

115.13

122.54

g/l

51.23

2372

8835

Diarrhoea and gastroenteritis of presumed infectious origin

5646

29236

1.83

307.65

10.2

8.4

120.60

121.95

g/l

4.97

5536

28543

ILD medications

9215

28330

1.86

307.65

10.2

8.3

120.82

122.19

g/l

7.03

9026

27657

Bacterial pneumonia, not elsewhere classified

4777

14450

3.43

307.65

12.1

7.3

119.41

121.82

g/l

11.64

4628

14144

Erysipelas, including avohilmo

7202

24561

2.40

307.65

9.8

7.6

119.51

123.65

g/l

48.42

7076

23985

Haemorrhage from respiratory passages

3263

13138

2.43

307.65

10.6

8.5

119.80

119.88

g/l

0.07

3194

12821

Symptoms and signs involving cognition, perception, emotional state and behaviour

8061

31024

1.85

307.65

8.4

8.9

122.10

121.46

g/l

1.91

7899

30316

Other chronic obstructive pulmonary disease, including avohilmo

5377

23068

2.12

307.65

10.0

8.3

124.15

120.40

g/l

30.24

5274

22564

Coronary artery bypass grafting

2735

8123

2.91

307.65

12.6

7.5

114.51

121.50

g/l

54.04

2674

7938

Other or unspecified ileus, impaction or obstruction

2006

7989

2.91

307.65

10.1

8.0

117.08

121.51

g/l

17.52

1966

7788

Nausea and vomiting

2517

10707

2.54

307.65

10.1

7.8

118.08

120.17

g/l

5.14

2471

10451

Diseases of arteries, arterioles and capillaries (FINNGEN)

2913

3512

7.09

307.65

13.0

6.8

116.72

124.87

g/l

55.36

2864

3426

Intestinal stricture

3374

14792

2.63

307.65

11.5

8.0

116.80

120.98

g/l

26.63

3310

14455

Percutaneous Coronary Intervention

8337

20121

2.86

307.65

11.8

7.9

120.84

122.11

g/l

5.37

8165

19687

Major coronary heart disease event

8618

21680

2.67

307.65

11.7

7.9

120.87

122.02

g/l

4.69

8441

21206

L04AD Calcineurin inhibitors

1359

3877

4.52

307.65

23.3

9.6

108.16

124.06

g/l

127.75

1340

3795

Diabetes, insulin treatment (Kela reimbursement)

8337

28764

1.83

307.65

10.5

8.2

121.21

121.81

g/l

1.62

8173

28086

Atrial fibrillation and flutter with reimbursement

2730

3501

5.87

307.65

12.8

6.8

123.48

124.44

g/l

1.11

2684

3416

Oxycodone

4400

14711

2.94

307.65

9.1

8.2

115.75

122.24

g/l

74.16

4304

14361

Peripheral arterial reconstruction

2065

8277

3.03

307.65

11.6

7.7

113.39

120.45

g/l

47.42

2026

8091

AV-block

1806

5753

3.07

307.65

10.5

6.9

119.25

121.63

g/l

4.78

1764

5598

Alcohol use disorder, ICD-based

3815

19390

2.17

307.65

11.7

9.3

121.81

123.32

g/l

3.95

3758

18939

Asthma-related pneumonia

4307

16588

3.02

307.65

10.4

7.9

122.06

119.87

g/l

9.16

4210

16197

Asthma, unspecified (mode)

5157

13848

2.98

307.65

9.0

7.2

123.22

121.29

g/l

7.82

5039

13541

Obesity related asthma

3054

14818

2.27

307.65

9.7

8.8

125.85

120.97

g/l

29.13

3003

14482

Alcohol use disorder, Swedish definition

5123

23876

2.14

307.65

11.9

8.9

121.29

123.04

g/l

6.54

5044

23309

Concussion

3745

13943

2.22

307.65

8.4

123.06

120.49

g/l

10.41

3678

13610

Hernia of abdominal wall, postoperative

1999

5766

4.05

307.65

11.3

6.8

119.65

125.76

g/l

28.89

1964

5621

Other septicaemia

4934

16325

3.42

307.65

14.3

7.3

113.06

122.52

g/l

168.58

4838

15957

Heart failure, strict

7249

19892

2.99

307.65

12.0

7.8

118.92

121.43

g/l

16.89

7138

19432

Secondary hypertension

718

1394

6.03

307.65

13.1

7.2

112.07

124.48

g/l

38.37

701

1354

Hypertension, essential

6686

15357

2.70

307.65

10.3

8.2

121.98

123.22

g/l

4.17

6566

14968

Any mental disorder

8225

25816

1.67

307.65

9.2

8.6

121.94

121.43

g/l

1.27

8061

25204

Substance abuse

5370

25213

2.16

307.65

11.3

9.0

122.27

122.77

g/l

0.90

5287

24614

Colorectal cancer, including Hilmo

2878

11256

2.75

307.65

8.4

8.3

115.60

122.19

g/l

61.25

2828

11016

Malignant neoplasm

7364

21009

2.22

307.65

9.0

9.2

119.44

123.77

g/l

55.63

7197

20552

Parasetamol

5472

11898

2.48

307.65

9.5

9.2

122.69

123.36

g/l

1.25

5356

11584

Spinal stenosis

4736

18641

2.04

307.65

7.4

8.8

120.66

120.50

g/l

0.20

4634

18242

Acute renal failure

3106

10626

3.68

307.65

19.5

7.3

111.99

122.34

g/l

122.60

3056

10378

Tramadol

7893

18925

2.78

307.65

10.0

8.4

120.76

122.90

g/l

14.17

7782

18444

Non-invasive ventilation

5658

4009

19.42

307.65

9.7

6.0

120.77

122.13

g/l

3.01

5322

3942

Heart failure and coronary heart disease

5275

13055

3.41

307.65

12.3

7.6

118.54

121.06

g/l

12.35

5188

12769

Codeine

7626

19738

2.24

307.65

8.8

8.3

121.91

122.99

g/l

3.89

7461

19234

Depression medications

1592

1293

6.64

307.65

9.8

5.2

125.78

128.14

g/l

2.46

1558

1252

Hypothyroidism, drug reimbursement

771

778

7.53

307.65

10.3

5.3

123.26

126.81

g/l

3.09

748

755

Spondylopathies

6493

21946

1.86

307.65

7.6

9.2

121.84

121.11

g/l

1.95

6355

21455

Other septicaemia, including avohilmo

5055

16624

3.42

307.65

14.2

7.3

113.16

122.53

g/l

169.68

4958

16252

Oral corticosteroids

9168

29531

1.94

307.65

9.2

8.6

122.05

121.64

g/l

1.01

8974

28851

Intestinal infectious diseases

7488

34271

1.71

307.65

10.1

8.5

120.12

121.87

g/l

10.01

7343

33479

Diseases of the digestive system

4311

22428

2.09

307.65

10.8

8.0

114.35

121.70

g/l

91.15

4240

21891

Peripheral artery disease

4486

17483

2.28

307.65

10.5

7.5

115.75

121.44

g/l

61.84

4404

17073

Asthma, excluding more controls

6341

12542

2.83

307.65

9.0

6.9

124.55

122.04

g/l

14.08

6199

12239

Cardiac arrest

760

1110

7.25

307.65

17.7

7.1

119.03

124.26

g/l

7.18

747

1076

Asthma (only as main-diagnosis), excluding more controls

5711

12542

2.73

307.65

8.3

6.9

124.58

122.04

g/l

13.44

5579

12239

Cardiovascular diseases (excluding rheumatic etc)

4896

7533

4.08

307.65

11.7

6.7

122.86

124.97

g/l

7.36

4801

7324

Diseases of oesophagus, stomach and duodenum

8420

30452

1.72

307.65

10.2

8.4

119.68

122.39

g/l

24.60

8239

29754

Bacterial infection, other or unspecified

6123

20872

2.84

307.65

12.0

7.4

114.23

122.86

g/l

186.32

5984

20400

Oedema, not elsewhere classified

2959

13434

2.37

307.65

9.7

8.0

118.95

121.32

g/l

7.86

2908

13114

Chronic lower respiratory diseases

9772

29929

1.82

307.65

9.1

8.8

124.13

120.81

g/l

40.48

9553

29259

Malignant neoplasm, wide definition

7530

21252

2.23

307.65

9.1

9.2

119.82

123.82

g/l

48.10

7363

20789

Convulsions, not elsewhere classified

2190

8066

3.01

307.65

10.2

8.8

121.81

123.10

g/l

1.98

2157

7864

Influenza and pneumonia

11145

26888

2.86

307.65

12.0

7.6

120.21

122.55

g/l

22.52

10882

26296

Other diseases of intestines

8165

26439

1.81

307.65

9.6

8.7

120.68

122.80

g/l

14.78

8006

25798

Other bacterial diseases

10601

27599

2.88

307.65

12.0

7.8

116.86

123.64

g/l

175.40

10379

26956

COPD/asthma/ILD related infections

8035

21203

2.02

307.65

10.2

7.5

120.65

121.69

g/l

3.86

7843

20723

Hard cardiovascular diseases

8548

19484

2.93

307.65

12.2

7.7

121.15

122.39

g/l

5.24

8371

19051

Cardiac arrhythmias

4811

9911

3.42

307.65

11.7

6.8

123.16

122.75

g/l

0.57

4696

9650

Other heart diseases

4580

6307

5.42

307.65

14.1

6.8

121.32

125.14

g/l

19.25

4489

6131

Renal tubulo-interstitial diseases

9319

28502

2.69

307.65

12.6

7.6

115.06

123.18

g/l

233.60

9156

27842

Heart failure and bmi 25plus

3947

10644

2.91

307.65

11.8

7.7

119.66

122.98

g/l

15.51

3882

10346

Other soft tissue disorders, not elsewhere classified

7467

24390

1.84

307.65

8.8

9.0

121.52

121.49

g/l

0.04

7321

23846

Other bacterial diseases, including avohilmo

10667

26948

2.76

307.65

11.7

7.7

117.57

123.77

g/l

146.35

10441

26310

Other neurological diseases

6378

28523

1.86

307.65

8.3

8.5

121.14

120.88

g/l

0.44

6230

27910

Nephropathy related operations

1703

5082

4.48

307.65

22.7

8.8

105.41

122.91

g/l

206.91

1676

4974

Other pulmonary diagnosis

5959

14518

2.19

307.65

10.1

7.3

122.01

121.59

g/l

0.70

5818

14190

Bacterial pneumoniae

4975

15197

3.39

307.65

12.1

7.4

119.41

121.90

g/l

12.81

4820

14876

Bacterial pneumonia (organism specified)

5217

18777

2.91

307.65

12.0

7.7

119.25

121.24

g/l

9.08

5058

18365

Opioids

7841

19887

2.17

307.65

9.7

8.3

121.05

123.01

g/l

11.72

7683

19380

Lower back pain or/and sciatica

8583

33094

1.70

307.65

7.8

8.9

122.65

121.29

g/l

7.40

8412

32330

Polyarthropathies

5411

19334

1.91

307.65

9.7

9.3

118.60

121.89

g/l

23.47

5298

18898

Other diseases of pleura

4875

20181

2.38

307.65

12.5

7.9

121.76

120.56

g/l

3.32

4786

19725

Low back pain

6239

23472

1.91

307.65

8.1

9.2

122.50

121.21

g/l

4.99

6117

22943

Dorsalgia

7441

23820

1.74

307.65

8.0

9.2

123.16

121.29

g/l

10.80

7281

23284

Valvular heart disease excluding rheumatic fever

5010

13131

3.13

307.65

11.8

7.5

115.51

122.38

g/l

89.69

4919

12808

Non-ischemic cardiomyopathy

3362

9836

3.17

307.65

11.7

7.5

119.46

121.04

g/l

3.64

3316

9589

Pain in limb

6903

24087

1.94

307.65

8.8

9.0

121.08

121.40

g/l

0.59

6781

23550

Malaise and fatigue

5292

17367

2.67

307.65

9.0

8.3

119.51

121.72

g/l

11.04

5201

16966

All pneumoniae

11001

27587

2.91

307.65

12.2

7.6

119.95

122.59

g/l

28.30

10744

26975

Pure hypercholesterolaemia

7372

21861

2.36

307.65

9.2

8.0

121.10

122.23

g/l

4.35

7232

21347

All kidney diseases

9750

28784

2.50

307.65

12.2

7.7

116.50

123.58

g/l

181.85

9572

28097

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

9602

21203

2.97

307.65

12.0

7.5

119.77

121.69

g/l

13.26

9375

20723

Pacemaker

3840

17711

2.28

307.65

11.9

7.6

118.88

120.30

g/l

3.97

3747

17304

Other disorders of fluid, electrolyte and acid-base balance

3857

12929

3.35

307.65

12.2

7.5

116.60

120.89

g/l

29.23

3789

12605

Codeine or tramadol medication

9342

28871

1.87

307.65

8.6

8.7

121.74

121.59

g/l

0.28

9145

28195

Other dorsopathies, not elsewhere classified

7385

23834

1.68

306.02

8.2

9.2

123.16

121.29

g/l

10.71

7210

23298

Neurological diseases, wide definition

1816

3262

2.97

305.72

10.5

8.8

124.69

121.00

g/l

8.50

1778

3167

Use of hypnotics and sedatives

8199

30114

1.63

304.27

9.1

8.8

120.95

122.01

g/l

4.43

8020

29423

Insulin, fast-acting or short human

3275

16807

2.14

303.96

11.8

8.7

117.41

122.20

g/l

30.76

3205

16415

Malignant neoplasm of urinary organs, including Hilmo

1347

4760

3.47

303.39

8.1

8.4

119.86

122.87

g/l

6.45

1325

4659

Ulcer of lower limb, not elsewhere classified

1711

6859

3.00

302.40

12.6

8.2

112.09

120.92

g/l

57.07

1696

6695

Other antidepressants

7864

25431

1.65

301.51

9.0

8.7

122.22

121.58

g/l

1.76

7705

24819

Iron deficiency anaemia

3812

20222

2.01

300.71

10.9

7.7

110.70

121.28

g/l

186.54

3745

19745

Abnormal findings on examination of blood, without diagnosis

4312

21911

1.94

299.82

9.2

8.9

120.09

121.98

g/l

7.12

4206

21456

Biguanides

7383

28130

1.66

299.54

9.5

8.4

122.25

121.34

g/l

2.99

7229

27469

Obesity

4851

26396

1.84

299.16

10.6

8.8

124.20

121.38

g/l

16.41

4778

25779

Sciatica+with lumbago

4183

20481

1.93

297.60

7.4

9.3

123.28

121.09

g/l

9.43

4105

20023

Obesity and other hyperalimentation

4866

26509

1.83

297.19

10.6

8.8

124.20

121.38

g/l

16.40

4793

25890

Statin medication

4398

13448

1.93

295.76

10.6

8.1

122.78

122.46

g/l

0.42

4306

13089

Nerve, nerve root and plexus disorders

8250

32198

1.61

294.52

8.3

8.8

122.25

121.36

g/l

3.32

8048

31487

Alcohol abuse, main dg, excluding more controls

1439

5295

3.13

291.85

10.7

9.2

124.24

123.78

g/l

0.33

1420

5172

8472

27867

1.61

291.70

9.0

8.2

122.14

120.76

g/l

7.13

8301

27228

L04AA Selective immunosuppressants

2013

8721

2.61

290.97

17.2

9.0

112.42

122.35

g/l

85.37

1985

8513

Diseases of the respiratory system

4450

12134

1.93

289.52

9.6

7.3

121.47

120.81

g/l

1.17

4350

11872

Symptoms and signs involving the urinary system

6241

29148

1.71

288.14

8.9

8.6

119.91

121.59

g/l

8.39

6120

28502

Colectomy operation

1814

7655

2.80

285.55

11.8

8.2

114.19

120.92

g/l

39.52

1788

7470

Malignant neoplasm of urinary organs

1175

3988

3.66

285.14

8.2

8.5

119.72

122.61

g/l

5.27

1154

3905

Early onset COPD

2159

9779

2.53

284.94

11.8

9.0

126.25

121.39

g/l

19.76

2123

9557

Other disorders of urethra and urinary system

5434

22586

1.77

281.33

8.4

8.2

119.09

121.07

g/l

10.37

5326

22040

COPD, hospital admissions 1, only main diagnosis

3349

15244

2.10

281.32

10.0

7.9

125.89

119.98

g/l

45.22

3299

14883

malignant neoplasm of female genital organs, including Hilmo

1543

5690

2.96

280.81

5.8

7.0

115.90

119.42

g/l

11.49

1508

5546

Other functional intestinal disorders

3743

18523

1.97

280.80

8.0

120.25

121.42

g/l

2.93

3652

18086

Other special examinations and investigations of persons without complaint or reported diagnosis

4851

13921

1.86

279.41

9.1

8.6

122.24

122.38

g/l

0.17

4723

13553

Lumbar disc prolapse

5005

21786

1.80

279.21

8.2

9.4

123.24

121.30

g/l

8.38

4869

21296

ILD, hospital admission 2, with pulmonary infections

1128

3774

3.65

278.22

13.1

7.1

121.81

120.55

g/l

1.12

1105

3686

Dizziness and giddiness

5888

28187

1.72

278.15

8.0

8.8

121.95

120.98

g/l

3.07

5772

27554

Substance use, excluding alcohol

1692

6891

2.75

277.08

11.1

9.4

124.40

123.71

g/l

0.64

1671

6730

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1176

4059

3.58

276.68

8.0

8.6

120.47

122.77

g/l

3.48

1158

3979

Vocal cord dysfunction

969

2478

3.79

275.53

11.8

6.0

121.85

122.19

g/l

0.19

937

2407

Hypokalaemia

1264

4508

3.31

274.80

12.0

7.6

118.28

120.64

g/l

3.40

1237

4402

Other disorders of skin and subcutaneous tissue

5906

30959

1.71

274.62

9.5

8.4

117.47

121.49

g/l

42.84

5796

30257

Infections of the skin and subcutaneous tissue

4643

26830

1.81

272.95

10.9

8.9

119.76

122.58

g/l

15.77

4568

26197

Benign neoplasm of colon, rectum, anus and anal canal

5504

28612

1.74

270.19

8.6

8.5

119.23

121.10

g/l

9.50

5413

27975

Episodal and paroxysmal disorders

7844

25809

1.60

269.59

9.0

8.7

123.67

120.33

g/l

34.32

7676

25189

Gout

2753

11853

2.22

269.00

10.8

8.8

117.32

121.67

g/l

20.32

2705

11600

Non-allergic asthma (mode)

1533

5957

2.82

268.39

8.3

6.9

124.83

120.62

g/l

11.90

1503

5818

Ischaemic Stroke, excluding all haemorrhages

4943

21698

1.81

267.50

9.6

8.3

120.11

120.73

g/l

1.27

4841

21220

Other acute lower respiratory infections

4373

24205

1.83

266.03

9.8

8.4

123.23

121.15

g/l

8.69

4294

23635

Malignant neoplasm of kidney, except renal pelvis

1075

3619

3.71

265.05

8.0

8.5

120.30

122.61

g/l

3.30

1057

3545

Lung cancer and mesothelioma

1778

6340

2.68

264.91

8.5

7.0

120.89

120.20

g/l

0.73

1739

6206

Schizophrenia or delusion, excluding more controls

2278

10542

2.31

264.80

8.7

8.8

123.51

122.45

g/l

1.56

2224

10286

General examination and investigation of persons without complaint and reported diagnosis

4680

13888

1.84

263.57

9.4

8.6

122.46

122.39

g/l

0.07

4612

13522

Bronchitis

8193

32678

1.57

261.89

9.2

8.4

122.83

121.05

g/l

11.31

8043

31908

Neurological diseases

5751

17468

1.72

260.59

9.4

8.9

123.22

120.41

g/l

17.84

5627

17059

Gastrointestinal diseases

3713

9846

1.98

260.52

9.7

7.6

121.91

124.58

g/l

10.28

3626

9601

Misadventures to patients during surgical and medical care

1433

5644

2.95

257.12

13.2

7.9

115.05

121.76

g/l

29.46

1407

5522

Autoimmune diseases excluding thyroid diseases

7800

27911

1.58

252.26

9.9

8.6

119.72

122.60

g/l

26.12

7632

27272

Other symptoms and signs involving cognitive functions and awareness

4106

21131

1.85

251.48

7.6

8.5

120.99

120.53

g/l

0.74

4012

20655

Falls/tendency to fall

7507

24534

1.59

250.44

9.6

8.6

120.81

122.60

g/l

10.02

7346

23961

ILD, hospital admissions 3, with pneumonia sepsis

1000

3330

3.72

250.12

13.1

7.1

121.55

120.12

g/l

1.24

979

3266

Other and unspecified iron deficiency

2968

15751

2.05

247.80

10.7

7.6

110.90

121.18

g/l

145.40

2925

15365

Implicit fungal Sepsis, including avohilmo

837

2514

4.17

247.16

15.3

6.9

116.33

121.48

g/l

9.35

825

2451

Intestinal infectious diseases, including avohilmo, including avohilmo

8589

32424

1.53

246.56

9.8

8.5

120.53

121.79

g/l

6.14

8420

31673

Certain infectious and parasitic diseases, including avohilmo

5043

14989

1.76

245.98

9.5

7.7

120.71

123.37

g/l

14.21

4936

14604

Constipation

6926

30737

1.60

245.10

8.6

8.7

119.78

121.54

g/l

10.30

6775

30061

malignant neoplasm of female genital organs

1355

5174

2.93

244.02

5.6

6.9

115.89

119.14

g/l

8.79

1322

5048

Explicit bacterial Sepsis, including avohilmo

1130

4060

3.27

242.21

14.0

6.9

114.76

122.76

g/l

29.95

1112

3965

Autoimmune diseases excluding thyroid diseases, strict definition

7523

27046

1.58

242.06

9.8

8.6

119.71

122.57

g/l

24.95

7364

26427

Volume depletion

1050

3633

3.44

241.83

10.8

7.4

116.52

120.29

g/l

6.36

1034

3546

Alcohol dependence

2386

11953

2.21

239.00

10.8

9.3

122.38

123.24

g/l

1.07

2357

11686

Viral hepatitis, IBD co-morbidity

477

932

5.97

238.87

12.7

8.3

121.22

123.04

g/l

0.88

471

902

Malignant neoplasm of colon, including Hilmo

1794

8042

2.53

238.86

8.4

8.0

114.66

122.03

g/l

47.38

1763

7863

Obesity due to excess calories

3534

19968

1.89

238.70

10.5

8.8

124.14

121.54

g/l

10.67

3483

19502

Exposure to unspecified factor

7579

34572

1.55

238.49

10.6

8.4

119.56

122.04

g/l

20.50

7432

33776

Anxiety disorders, excluding more controls

5733

23058

1.66

235.71

9.4

8.7

122.87

121.57

g/l

4.63

5629

22511

Abnormalities of heart beat

2648

13263

2.07

234.57

8.3

122.79

119.37

g/l

13.77

2593

12931

Psychiatric diseases

7032

23033

1.59

233.16

9.2

8.7

121.98

121.36

g/l

1.51

6879

22474

Benzodiazepine use

7498

34053

1.55

231.89

8.8

8.7

121.65

121.54

g/l

0.16

7365

33254

Personality disorders

1935

8977

2.34

231.54

9.3

9.5

124.35

123.07

g/l

1.90

1902

8769

Intracranial injury

4624

26336

1.73

231.52

9.2

8.5

121.20

121.56

g/l

0.54

4548

25709

Type 1 diabetes

1920

8894

2.35

230.50

12.2

8.1

116.20

122.89

g/l

33.15

1873

8668

Explicit bacterial Sepsis

1095

3976

3.23

230.09

13.5

7.0

114.89

122.72

g/l

28.31

1077

3885

Disorders of adult personality and behaviour

2001

9428

2.29

229.73

9.2

9.5

124.37

123.21

g/l

1.70

1966

9205

Other postsurgical states

764

2282

4.22

227.91

9.9

8.1

119.49

122.60

g/l

3.61

758

2224

Focal epilepsy

1887

8829

2.39

226.36

9.1

8.7

122.98

121.35

g/l

2.93

1850

8622

Problems related to lifestyle

1008

3528

3.30

224.35

10.7

9.1

124.12

124.53

g/l

0.22

989

3431

Streptococcal septicaemia, including avohilmo

1013

3605

3.38

223.60

13.8

7.5

114.56

122.92

g/l

29.48

997

3522

Other diseases of urinary system

7209

27028

1.56

222.88

8.8

120.03

122.03

g/l

12.88

7068

26407

Artificial opening status

712

2086

4.52

222.59

16.9

8.3

113.82

121.86

g/l

22.25

702

2030

Peripheral artery operations in Hilmo

1338

5482

2.84

222.11

12.9

7.6

111.62

121.34

g/l

55.71

1320

5350

Injuries to the abdomen, lower back, lumbar spine and pelvis

3384

19054

1.88

221.86

9.5

8.2

118.22

121.15

g/l

13.97

3318

18611

Malignant neoplasm of rectum, including Hilmo

1250

4980

2.96

220.99

8.5

8.6

117.38

122.85

g/l

20.22

1229

4871

Mood disorders

7394

31983

1.54

220.21

9.6

8.7

122.60

121.49

g/l

4.41

7263

31236

Mood [affective] disorders

7375

31960

1.54

219.60

9.6

8.7

122.59

121.50

g/l

4.28

7246

31211

Unspecified mental disorder

2946

16167

1.95

219.01

8.6

9.2

123.49

122.33

g/l

2.27

2881

15796

Injuries to the hip and thigh

4110

22214

1.77

218.58

8.5

8.1

116.31

121.37

g/l

47.33

4036

21702

Alcohol abuse, main dg

1439

6119

2.67

217.76

10.7

10.0

124.24

123.68

g/l

0.42

1420

5988

Aneurysms, operations, SAH

1536

6752

2.59

216.59

11.2

8.1

121.65

120.37

g/l

1.71

1498

6579

Pain (limb, back, neck, head abdominally)

5066

15613

1.69

215.90

8.9

9.1

122.47

121.66

g/l

1.75

4951

15207

Type 1 diabetes, wide definition, subgroup 1

1559

6858

2.48

212.38

11.9

8.0

116.15

123.29

g/l

30.60

1522

6671

Other respiratory diseases principally affecting the interstitium

1808

8605

2.40

212.37

13.0

8.1

121.78

120.08

g/l

2.65

1773

8410

Benign neoplasm: Colon

4622

27247

1.70

212.23

8.7

8.4

119.15

120.94

g/l

7.53

4547

26641

Specific personality disorders

1666

7540

2.40

211.97

9.2

9.5

124.31

122.99

g/l

1.80

1638

7363

Streptococcal septicaemia

979

3520

3.34

211.95

13.3

7.4

114.66

122.90

g/l

28.14

963

3437

Liquid cancers, including Hilmo

2858

13823

1.97

210.99

9.3

8.6

113.93

122.76

g/l

85.29

2786

13528

Dorsopathies

7058

23895

1.55

210.68

8.5

9.3

122.80

121.30

g/l

6.87

6895

23359

Injuries to the thorax

3871

23318

1.77

209.94

10.2

8.6

120.87

121.64

g/l

1.46

3799

22770

External causes of morbidity and mortality

4222

12500

1.76

208.16

9.5

8.0

121.04

123.05

g/l

7.24

4134

12207

Chronic pancreatitis

1287

5371

2.82

207.17

14.8

9.0

115.47

122.68

g/l

27.65

1266

5241

Depression

6759

30442

1.54

207.06

9.6

8.8

122.79

121.59

g/l

4.73

6637

29725

Focal epilepsy, strict definition

1754

8282

2.37

206.11

9.2

8.7

123.02

121.33

g/l

2.92

1722

8086

Complications of internal orthopaedic prosthetic devices, implants and grafts

2023

10104

2.23

205.54

8.5

7.3

115.33

121.12

g/l

32.95

1985

9859

Glomerular diseases

1664

7755

2.43

204.16

13.5

8.8

110.22

122.30

g/l

95.73

1642

7579

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

641

1802

4.19

203.74

10.7

10.5

125.06

126.11

g/l

0.55

635

1767

Clear cell adenocarcinoma of kidney

631

1822

4.72

203.53

7.9

9.1

120.77

122.87

g/l

1.76

620

1788

Other reaction to severe stress, and adjustment disorders

2393

12524

2.03

203.31

10.3

8.9

122.18

122.07

g/l

0.09

2357

12205

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1045

3999

3.13

201.80

11.3

9.0

116.10

121.32

g/l

12.19

1021

3912

Spondylosis

4234

20360

1.72

201.74

7.5

9.1

121.91

120.93

g/l

2.35

4160

19918

Fracture of femur

2519

12217

2.03

200.89

8.3

7.4

112.54

120.23

g/l

70.94

2479

11918

Finngen Rheumatological endpoints

6590

25051

1.55

200.23

8.6

9.1

121.35

122.42

g/l

3.69

6422

24480

Obesity, other/unspecified

2424

12908

2.01

198.10

10.7

8.7

123.88

121.36

g/l

7.12

2392

12599

Hyperlipidaemia, other/unspecified

3132

16209

1.87

197.58

9.0

7.7

120.36

121.52

g/l

2.37

3077

15822

Focal epilepsy, mode (most common among epilepsy diagnosis)

1655

7766

2.38

197.50

9.2

8.7

123.41

121.35

g/l

3.97

1626

7584

Diseases of liver

2866

16223

1.91

196.28

13.2

8.7

116.37

122.16

g/l

36.51

2808

15876

Malignant neoplasm of colon

1473

6636

2.53

196.24

8.2

8.0

114.08

122.03

g/l

45.65

1446

6488

Disorders of thyroid, IBD co-morbidities

1075

2666

2.95

196.22

10.6

7.6

122.88

120.08

g/l

3.57

1048

2593

Acute alcohol intoxication

2157

11151

2.11

196.15

10.2

9.0

123.66

122.86

g/l

0.93

2126

10896

Kela-code for severe mental illness

2649

14572

1.95

196.08

8.3

9.3

123.56

122.43

g/l

2.01

2587

14236

Emotionally unstable personality disorder

886

3082

3.20

195.46

8.3

9.5

124.56

123.29

g/l

1.02

870

3011

Cutaneous abscess, furuncle and carbuncle

2091

10687

2.13

195.27

12.2

9.1

118.11

122.83

g/l

19.19

2056

10437

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1066

4182

3.02

195.20

8.5

8.7

117.36

122.75

g/l

16.94

1045

4094

Intestinal adhesions without obstruction

929

3398

3.28

194.99

10.9

7.8

119.08

121.27

g/l

2.45

914

3305

Hernia of abdominal wall

3721

22682

1.76

194.01

10.3

8.8

121.74

121.75

g/l

0.01

3650

22182

Ventral hernia

2081

10697

2.14

193.87

10.9

8.3

120.12

121.06

g/l

1.28

2042

10439

Osteoporosis

2320

11335

2.07

193.09

8.4

7.4

116.05

118.91

g/l

10.13

2271

11077

Deforming dorsopathies

2148

11116

2.09

192.23

7.6

8.7

119.74

120.45

g/l

0.94

2098

10874

Hyperkalaemia

689

2147

3.99

192.04

12.8

7.6

111.88

120.38

g/l

21.32

682

2095

Gout, FINNGEN

2753

15497

1.94

191.02

10.8

8.2

117.32

121.80

g/l

22.46

2705

15137

Retention of urine

3084

14414

1.87

190.74

8.6

119.37

121.80

g/l

8.69

3029

14076

Unspecified kidney failure

1131

4620

2.89

190.65

12.8

7.1

110.44

121.42

g/l

57.22

1115

4517

Persons encountering health services in other circumstances, wide

8272

29980

1.47

189.87

10.2

8.2

120.48

122.20

g/l

10.65

8154

29200

Cardiomyopathies, Primary/intrinsic

1067

4201

2.90

189.79

17.7

7.7

123.00

g/l

0.00

1053

4095

Extracorporeal dialysis

737

2446

3.89

188.92

20.4

9.7

103.51

122.75

g/l

118.18

721

2394

Transient ischemic attack

4277

21453

1.69

188.71

7.8

8.1

120.68

120.53

g/l

0.19

4180

20966

Fungal Sepsis

537

1448

4.88

188.37

19.2

7.1

113.90

121.87

g/l

13.20

529

1410

Adenocarcinoma and papilloma adenocarcinoma of rectum

1022

3999

3.03

188.09

8.4

8.6

117.70

122.70

g/l

14.04

1004

3914

Amputation

1090

4408

2.93

187.93

13.6

8.2

110.07

120.91

g/l

54.99

1075

4309

Acute alcohol intoxication, ICD10

1718

8330

2.28

187.58

10.6

9.7

123.98

123.59

g/l

0.30

1694

8157

Factors influencing health status and contact with health services

2045

4933

2.19

187.53

9.9

7.7

123.41

125.60

g/l

3.89

2005

4800

Glomerular disorders in diseases classified elsewhere

1167

4872

2.81

187.42

15.0

9.1

107.48

122.36

g/l

105.25

1153

4760

Acute bronchitis

3199

18483

1.81

186.61

9.4

8.1

123.57

120.59

g/l

12.90

3143

18048

Invasive ventilation

812

2849

3.50

185.71

20.9

9.0

115.38

121.70

g/l

13.27

788

2780

Type 1 diabetes, wide definition

1597

7492

2.31

185.62

11.9

8.0

116.26

122.96

g/l

28.03

1559

7294

Unspecified acute lower respiratory infection

1399

6291

2.50

185.51

11.6

8.8

122.24

122.28

g/l

0.02

1368

6159

Allergic asthma (mode), excluding more controls

1343

5671

2.45

185.17

8.1

6.9

124.33

121.95

g/l

3.80

1312

5520

Aortic aneurysm

2140

11084

2.10

184.75

12.6

7.9

118.61

122.44

g/l

13.82

2102

10822

Benign neoplasms

6802

25335

1.51

184.14

8.9

9.1

122.15

122.27

g/l

0.17

6660

24743

Cardiomyopathy (excluding other)

1097

4443

2.81

183.99

17.6

7.6

123.13

123.23

g/l

0.05

1083

4332

Schizophrenia or delusion

2278

12194

2.00

183.82

8.7

9.4

123.51

122.60

g/l

1.24

2224

11931

Unspecified fall

3999

24600

1.69

183.38

10.0

8.4

119.72

121.23

g/l

4.74

3928

24045

Diaphragmatic hernia

2921

16961

1.86

183.17

9.2

8.0

118.38

120.45

g/l

6.67

2873

16553

Gastroduodenal ulcer

2325

12616

2.01

182.00

10.6

7.7

114.35

121.20

g/l

42.91

2278

12332

Soft tissue disorders

6964

24515

1.50

181.81

8.6

9.1

122.10

121.52

g/l

1.36

6806

23968

Schizophrenia, schizotypal and delusional disorders

2280

12288

1.99

180.12

8.7

9.4

123.52

122.57

g/l

1.34

2225

12024

Other CVD

1937

10014

2.16

179.97

9.3

7.5

117.19

119.78

g/l

6.94

1902

9785

Shoulder lesions

5600

22346

1.57

179.10

7.5

9.0

122.66

121.33

g/l

4.79

5468

21856

1113

4564

2.70

178.97

13.3

8.4

117.94

122.28

g/l

10.03

1093

4440

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

653

2036

3.82

178.56

9.0

9.7

124.78

122.51

g/l

2.02

647

1992

Other headache syndromes

2862

16469

1.83

177.87

8.0

8.4

123.83

119.63

g/l

23.60

2807

16086

Other external causes of accidental injury

5365

17590

1.58

176.13

9.2

8.4

120.88

122.34

g/l

5.17

5252

17157

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

848

3105

3.18

175.17

9.8

8.1

120.89

122.23

g/l

1.05

833

3032

Implicit fungal Sepsis

496

1333

4.92

175.00

18.1

7.1

114.00

121.97

g/l

12.03

488

1296

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2021

10325

2.08

174.03

7.0

8.7

114.69

122.63

g/l

59.08

1978

10103

Malignant neoplasm of rectum

999

4022

2.92

172.94

8.3

8.7

117.30

122.69

g/l

15.99

980

3933

Undetermined asthma, excluding more controls

949

3648

2.86

172.61

8.4

6.5

123.23

121.36

g/l

1.89

932

3552

Dialysis

497

1360

4.87

171.62

15.8

9.1

102.92

124.06

g/l

87.03

492

1333

Any operation in hilmo

197

27.37

171.33

12.9

6.8

125.22

139.08

g/l

2.68

189

Anxiety (asthma-related co-morbidities)

3762

17672

1.69

171.23

10.0

8.9

123.28

122.37

g/l

1.81

3696

17251

Unspecified haematuria

3547

17843

1.73

170.07

9.4

8.7

118.92

121.92

g/l

14.62

3475

17443

Gout, idiopatic and unspecified

2348

13186

1.97

169.44

11.0

8.4

117.81

121.68

g/l

14.54

2314

12878

Traumatic subdural haemorrhage

1277

5345

2.51

169.39

10.4

7.5

118.07

119.25

g/l

1.22

1256

5206

Other bacterial intestinal infections

1572

7671

2.27

169.03

11.5

8.0

115.58

120.87

g/l

18.96

1537

7481

Sequelae of cerebrovascular disease

3076

15726

1.80

168.88

10.0

7.7

120.07

120.33

g/l

0.29

3015

15348

Other interstitial pulmonary diseases

1509

7330

2.35

168.68

11.8

8.1

123.25

120.13

g/l

6.55

1481

7169

ILD, hospital admissions

1490

7212

2.37

168.31

11.8

8.1

123.29

120.11

g/l

6.70

1462

7052

Interstitial lung disease endpoints

1509

7337

2.35

168.26

11.8

8.0

123.25

120.07

g/l

6.79

1481

7175

Interstitial lung disease

1509

7337

2.35

168.26

11.8

8.0

123.25

120.07

g/l

6.79

1481

7175

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

7185

32625

1.46

168.20

9.8

8.5

121.09

121.79

g/l

2.00

7048

31867

Missing teeth due to accident, extraction or parodontitis

4892

29184

1.58

168.04

8.7

8.6

120.67

121.11

g/l

0.81

4775

28574

Cholelithiasis, broad definition with cholecystitis

6238

28727

1.50

167.75

8.7

8.2

120.83

121.24

g/l

0.81

6112

28071

Accidents

5318

17590

1.57

167.69

9.1

8.4

120.99

122.34

g/l

4.49

5203

17157

Used for control exclusion in common control thyroid runs

7306

25983

1.46

166.13

9.6

8.6

121.23

122.55

g/l

5.63

7155

25380

Pain in joint

3922

15050

1.67

164.81

8.6

9.3

122.22

121.77

g/l

0.65

3854

14656

Diseases of the skin and subcutaneous tissue

6840

23948

1.48

164.62

9.4

8.4

120.69

122.42

g/l

8.69

6692

23374

Disorders of lens

5024

20723

1.58

164.23

10.3

9.0

118.99

122.32

g/l

23.24

4923

20279

Other complications of surgical and medical care, not elsewhere classified

866

3316

2.99

163.12

11.8

7.8

119.43

122.54

g/l

4.49

857

3230

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7813

29854

1.44

161.47

10.7

8.2

119.65

122.23

g/l

22.16

7718

29083

Myocarditis

361

780

5.33

160.65

15.8

7.5

124.91

126.91

g/l

0.84

350

759

Symptoms and signs involving the nervous and musculoskeletal systems

4321

28429

1.60

160.28

8.6

8.5

122.69

120.76

g/l

8.17

4234

27786

Colon adenocarcinoma

1178

5278

2.55

159.76

8.0

114.15

121.93

g/l

35.19

1157

5164

Vascular disorders of the intestines

772

2853

3.27

159.76

13.8

7.5

112.01

120.63

g/l

24.91

754

2772

Medical observation and evaluation for suspected diseases and conditions

4279

13918

1.63

159.40

9.9

8.6

122.02

122.38

g/l

0.49

4203

13550

Adjustment and management of implanted device

1654

8448

2.18

158.35

14.2

7.3

119.67

121.20

g/l

2.28

1637

8249

Allergic asthma (mode)

1343

6058

2.29

158.34

8.1

7.3

124.33

121.61

g/l

4.81

1312

5910

Postprocedural musculoskeletal disorders, not elsewhere classified

790

2988

3.25

158.18

8.3

8.7

116.45

120.75

g/l

7.37

762

2919

Other/unspecified dorsalgia

2668

15437

1.81

157.83

8.1

8.8

121.45

120.54

g/l

1.47

2611

15094

Fracture of rib(s), sternum and thoracic spine

2618

15389

1.84

157.77

10.5

8.6

120.51

121.51

g/l

1.65

2577

15049

Enterocolitis due to Clostridium difficile

1055

4550

2.67

156.54

12.3

7.9

113.02

120.30

g/l

24.34

1032

4444

Injury, poisoning and certain other consequences of external causes

3309

9909

1.74

156.49

9.1

7.8

121.49

122.82

g/l

2.88

3243

9653

ILD, hospital admissions 1, main diag only

1338

6401

2.41

156.25

11.7

8.1

123.62

120.05

g/l

7.43

1313

6258

Congenital malformations, deformations and chromosomal abnormalities

3752

22703

1.63

155.50

10.4

8.9

121.24

122.40

g/l

2.80

3661

22188

Other diseases of intestine

1391

6708

2.32

155.31

14.4

8.6

115.72

121.88

g/l

23.22

1370

6539

Anxiety disorders

6009

28735

1.49

154.93

9.5

8.9

122.87

121.65

g/l

4.40

5900

28046

Emphysema

796

3038

3.14

154.65

10.0

8.5

128.17

119.82

g/l

20.44

778

2971

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1398

6815

2.34

154.41

14.1

9.4

112.12

122.61

g/l

54.25

1378

6665

Autoimmune diseases

7655

28004

1.43

154.13

9.7

8.6

120.48

122.59

g/l

14.23

7498

27358

Persons encountering health services for examination and investigation

4321

13921

1.61

153.99

9.3

8.6

122.17

122.38

g/l

0.25

4226

13553

Neurotic, stress-related and somatoform disorders

5931

28446

1.49

153.96

9.5

8.9

122.87

121.68

g/l

4.20

5823

27764

Cough

2724

15030

1.78

153.47

8.2

8.7

122.35

119.69

g/l

9.40

2675

14671

Other and unspecified nonorganic psychotic disorders

1319

6190

2.30

153.47

9.6

9.9

123.90

123.75

g/l

0.09

1283

6047

Cardiodefibrillation

3050

18815

1.75

153.27

11.8

8.2

122.49

120.90

g/l

3.79

2997

18387

Other diseases of pericardium

482

1378

4.34

152.72

15.8

8.3

114.62

122.29

g/l

11.68

476

1345

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1998

8922

2.01

152.50

8.9

8.4

120.47

122.36

g/l

3.97

1950

8735

Viral pneumonia (unknown virus, not influenza)

683

2417

3.36

151.63

21.6

9.3

121.25

123.19

g/l

1.40

670

2367

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1251

5632

2.38

150.96

14.7

9.4

116.72

123.02

g/l

21.85

1226

5504

Other and unspecified drugs and medicaments

814

3164

3.01

150.83

9.7

8.8

120.96

121.37

g/l

0.22

800

3092

Status post-ami

2025

8348

2.00

150.81

8.7

7.4

120.51

121.35

g/l

0.99

1984

8152

Disorders of other endocrine glands

3103

18889

1.70

149.54

9.6

8.4

120.92

120.72

g/l

0.20

3039

18452

Visual disturbances

3592

23077

1.64

148.92

9.0

8.4

121.71

120.81

g/l

1.93

3499

22569

Gastric ulcer

1593

8197

2.15

148.81

10.8

7.8

114.02

120.86

g/l

30.13

1565

8009

Delirium, not induced by alcohol and other psychoactive substances

1245

5871

2.41

148.57

12.7

7.7

117.62

119.51

g/l

2.53

1234

5735

Nontraumatic intracranial haemmorrhage

1731

9159

2.08

148.24

12.4

7.6

120.66

119.90

g/l

0.84

1700

8932

Abnormal serum enzyme levels

2645

15337

1.81

147.84

8.5

9.4

121.57

122.61

g/l

1.71

2564

15027

Ascites

768

2938

3.10

147.73

12.6

8.3

109.49

121.11

g/l

44.51

752

2866

Genitourinary diseases

3856

12224

1.65

147.56

11.0

8.8

122.50

125.30

g/l

11.20

3773

11945

Other bacterial intestinal infections, including avohilmo

1858

10035

2.00

147.51

11.2

8.2

116.32

121.22

g/l

19.71

1819

9800

Depression or dysthymia

4576

16530

1.57

147.08

9.1

9.0

122.79

121.41

g/l

4.04

4493

16115

Endocarditis

412

1094

4.80

146.15

21.7

8.1

110.71

122.89

g/l

22.11

407

1066

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6867

31275

1.44

145.81

9.1

8.7

120.34

121.81

g/l

6.78

6723

30566

Hypotension

1657

8743

2.11

145.18

9.0

7.5

117.59

119.57

g/l

3.76

1632

8539

Other disorders of the musculoskeletal system and connective tissue

1304

6312

2.32

145.17

8.8

8.6

119.08

120.95

g/l

2.60

1269

6163

Other arthrosis

3954

17238

1.61

144.68

8.2

9.4

121.93

121.80

g/l

0.15

3859

16860

Cerebral aneurysm, nonruptured

812

3219

2.95

144.66

9.1

8.4

122.65

121.22

g/l

1.23

793

3137

Cholelithiasis

5873

28251

1.47

143.57

8.5

8.2

120.91

121.17

g/l

0.43

5756

27604

Endovascular or surgical operations to intracerebral aneurysms

634

2235

3.45

143.34

10.2

8.6

122.36

121.39

g/l

0.60

625

2174

Undetermined asthma

949

3994

2.60

142.97

8.4

6.9

123.23

120.86

g/l

2.82

932

3902

Other anxiety disorders

2830

14577

1.72

142.55

10.3

8.9

122.90

122.34

g/l

0.73

2788

14219

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1301

6089

2.27

142.55

14.7

9.5

116.86

122.76

g/l

20.24

1275

5947

Malignant neoplasm of ovary, including Hilmo

563

1844

3.62

142.32

6.7

7.7

112.94

119.46

g/l

15.31

550

1791

Rotator cuff syndrome

4586

21304

1.55

142.17

7.6

9.0

122.78

121.25

g/l

5.32

4483

20845

Fracture of lumbar spine and pelvis

1925

10675

1.96

141.05

9.2

7.7

115.61

120.15

g/l

20.04

1888

10426

Injuries to the shoulder and upper arm

6183

34173

1.45

140.58

8.6

8.8

120.93

121.72

g/l

2.27

6057

33397

Diabetic nephropathy, excluding more controls

1411

5749

2.27

140.50

13.4

10.3

110.97

123.68

g/l

87.15

1389

5621

Bacterial intestinal infections, IBD co-morbidities

1548

8054

2.11

139.32

11.5

8.1

115.24

120.64

g/l

19.90

1513

7870

Mental and behavioural disorders due to opioids

365

908

4.87

138.81

12.3

10.5

123.43

125.61

g/l

1.00

360

887

Periodontitis

7029

32686

1.42

138.75

9.9

8.5

121.16

121.72

g/l

1.36

6878

31939

Visual disturbances and blindness

3819

25234

1.59

138.42

9.0

8.3

121.51

120.69

g/l

1.76

3722

24680

Chronic periodontitis, including avohilmo

7018

32685

1.42

138.23

9.9

8.5

121.18

121.71

g/l

1.28

6867

31938

ILD-related respiratory insufficiency

463

1420

4.52

138.00

15.3

8.6

124.02

120.23

g/l

2.92

449

1389

Later onset COPD

2516

12146

1.81

136.86

8.5

7.1

122.51

119.05

g/l

13.11

2465

11854

Gout, strict definition

1722

9423

2.04

136.20

10.9

8.5

117.09

121.58

g/l

14.43

1703

9203

Gout, unspecified

1884

10607

1.97

135.06

11.1

8.4

117.60

121.69

g/l

13.42

1858

10369

Amiodarone users

1011

4626

2.57

133.53

18.5

8.4

122.78

120.98

g/l

1.84

995

4523

Senile cataract

4618

19154

1.54

133.37

10.1

9.0

119.04

122.01

g/l

17.59

4518

18735

All anxiety disorders

3808

19455

1.57

132.60

10.0

9.1

123.27

122.32

g/l

2.00

3742

18994

All influenza (not pneumonia)

1082

5000

2.36

131.81

10.2

8.1

121.80

123.44

g/l

1.70

1050

4902

Acute pancreatitis

1606

8632

2.03

130.86

13.1

8.6

118.81

122.01

g/l

7.14

1580

8429

Other cataract

3358

16137

1.63

129.80

9.2

8.8

118.83

121.68

g/l

12.25

3298

15767

Open wound of head

4068

25900

1.54

129.21

9.3

8.7

120.47

122.07

g/l

5.22

3998

25279

Cystitis

5621

23702

1.46

128.86

8.5

8.4

119.30

121.29

g/l

10.81

5519

23140

Malignant neoplasm of brain

389

1085

4.52

128.56

9.4

9.3

127.99

124.11

g/l

3.26

378

1062

Other specific joint derangements/joint disorders

4707

20147

1.51

128.48

8.4

9.5

122.54

122.17

g/l

0.58

4612

19688

Viral and other specified intestinal infections

1300

6298

2.14

128.11

9.9

8.6

121.89

123.12

g/l

1.20

1272

6152

Malignant neoplasm of brain, including Hilmo

495

1606

3.71

128.01

9.4

9.3

127.06

123.24

g/l

4.05

482

1573

Left ventricular outflow tract obstruction (LVOTO), broad definition

880

3828

2.63

127.70

16.4

10.7

115.88

124.46

g/l

26.55

867

3746

Non-small cell lung cancer, including Hilmo

1312

6216

2.19

127.60

8.7

8.0

120.97

122.30

g/l

1.66

1284

6086

Coxarthrosis

3804

16276

1.58

127.04

7.6

9.2

119.76

121.37

g/l

5.08

3717

15927

Superficial injury of head

1847

10408

1.90

126.68

8.4

8.3

120.49

121.22

g/l

0.78

1825

10140

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

4040

24932

1.53

126.18

10.4

8.9

121.24

122.33

g/l

2.68

3945

24368

Decubitus ulcer and pressure area

678

2653

3.06

125.91

14.2

8.1

112.28

120.48

g/l

19.65

668

2588

Coxarthrosis [arthrosis of hip](FG)

4149

19361

1.54

125.81

7.5

8.8

119.61

121.63

g/l

8.44

4059

18941

Viral and other specified intestinal infections, including avohilmo

1699

8937

1.92

125.21

9.6

8.6

122.21

122.94

g/l

0.70

1661

8720

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2227

13295

1.79

125.12

9.5

9.2

126.69

122.28

g/l

18.30

2197

12986

Glucagon-like peptide-1 (GLP-1) analogues

2227

13295

1.79

125.12

9.5

9.2

126.69

122.28

g/l

18.30

2197

12986

Sub-endpoint used in defining T1D endpoints

2059

11798

1.82

125.07

11.8

8.6

116.09

122.21

g/l

31.07

2007

11524

Malignant neoplasm of bronchus and lung, including Hilmo

1743

8058

1.96

124.78

8.4

8.2

120.83

122.25

g/l

2.24

1703

7889

Brain meningioma, including Hilmo

496

1637

3.65

124.75

7.3

8.1

122.16

120.69

g/l

1.04

491

1597

Brain meningioma

484

1576

3.71

124.60

7.4

8.2

121.91

120.67

g/l

0.79

479

1537

Diagnoses used for exclusion with ILD

2026

11839

1.85

124.51

12.4

8.4

121.05

120.98

g/l

0.05

1962

11573

Gonarthrosis [arthrosis of knee](FG)

5342

21751

1.47

124.11

7.3

9.0

122.31

122.05

g/l

0.39

5201

21269

Liquid cancers

2161

12118

1.80

123.82

10.0

8.5

113.10

122.49

g/l

71.63

2110

11860

Bipolar affective disorders

1187

5799

2.19

123.81

8.7

9.2

123.33

122.52

g/l

0.67

1166

5650

Autoimmune diseases related-to ILD

5731

34646

1.43

123.15

9.2

8.6

120.34

121.71

g/l

5.62

5616

33853

Cellulitis

1710

9540

1.93

122.55

10.6

8.9

118.60

122.39

g/l

10.84

1684

9319

Mental and behavioural disorders due to sedatives or hypnotics

590

2163

3.15

121.27

11.4

9.7

124.78

124.31

g/l

0.20

580

2120

Pleural effusion

1360

7134

2.12

120.92

11.5

7.7

116.16

120.11

g/l

10.86

1339

6971

Urinary track infection

3167

10019

1.64

120.63

8.7

7.4

117.61

119.87

g/l

8.49

3107

9750

Fracture of lower leg, including ankle

3870

25874

1.53

120.52

10.2

8.5

119.91

121.47

g/l

4.80

3788

25283

Mycoses

2090

12427

1.80

119.59

10.8

8.7

119.81

121.34

g/l

2.64

2049

12141

Disorders of choroid and retina

5910

30195

1.42

119.30

9.3

8.6

118.57

121.68

g/l

25.50

5798

29518

Nonischemic cardiomyopathy

841

3687

2.57

118.72

16.1

8.1

122.50

121.93

g/l

0.30

827

3601

Congenital malformations of the circulatory system

1050

4868

2.30

118.14

16.5

9.5

119.21

122.96

g/l

7.05

1034

4759

Malignant neoplasm of eye, brain and central nervous system

447

1435

3.78

117.98

8.9

9.3

127.33

123.59

g/l

3.56

436

1404

Spondylolisthesis/Spondylolysis

1381

7296

2.05

117.65

7.1

8.8

120.51

120.48

g/l

0.02

1352

7136

ILD medications: azathioprine

1031

4890

2.29

117.56

14.2

8.8

116.53

122.80

g/l

18.80

1018

4764

Acute peritonitis

641

2521

3.02

117.40

16.0

9.4

109.20

121.45

g/l

38.47

632

2460

Cervicobrachial syndrome

1535

8384

1.96

116.45

6.1

9.1

124.64

120.62

g/l

12.12

1510

8200

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

620

2385

3.00

116.41

9.3

125.93

122.78

g/l

3.62

603

2335

Cholecystectomy

4933

29933

1.45

116.10

8.8

8.2

120.87

120.51

g/l

0.61

4833

29259

Other gastritis (incl. Duodenitis)

1761

10107

1.88

115.32

10.0

8.0

118.07

121.41

g/l

8.92

1733

9882

Gonarthrosis

4515

17735

1.49

115.05

7.1

9.2

122.61

121.69

g/l

2.15

4388

17347

Aortic valve malfunction, age under 60 years

818

3614

2.59

114.82

15.9

10.6

115.86

124.53

g/l

25.31

806

3534

Acute upper respiratory infections of multiple and unspecified sites

5088

26548

1.44

114.79

9.5

8.6

123.12

121.24

g/l

8.31

5001

25911

Injuries to the knee and lower leg

8017

33009

1.35

114.62

9.3

8.6

121.55

121.53

g/l

0.03

7855

32251

Selective serotonin reuptake inhibitors

6626

25479

1.39

114.39

8.9

8.7

122.52

121.57

g/l

2.98

6490

24867

Idiopathic pulmonary fibrosis

791

3484

2.68

114.22

11.4

7.9

126.01

119.68

g/l

13.27

776

3404

Transport accidents

2962

15922

1.61

114.09

9.5

8.5

122.13

122.58

g/l

0.54

2884

15522

Abnormal findings on diagnostic imaging of other body structures

1168

5927

2.18

113.33

8.1

8.3

120.10

120.43

g/l

0.21

1146

5795

Other retinal disorders

4812

26096

1.46

113.06

9.3

8.3

117.68

121.27

g/l

28.29

4719

25498

Vascular diseases of the intestine

446

1481

3.76

112.89

16.6

7.5

113.94

120.40

g/l

8.87

437

1447

Malignant neoplasm of respiratory system and intrathoracic organs

1710

8052

1.90

112.85

8.8

8.3

120.34

122.33

g/l

3.92

1670

7883

Assault

912

4184

2.37

112.83

11.4

10.2

124.24

125.72

g/l

1.19

898

4090

Diseases of peritoneum

879

4035

2.47

112.23

13.5

8.6

112.18

121.29

g/l

30.85

860

3942

Malignant neoplasm of corpus uteri, including Hilmo

732

3107

2.67

111.47

4.9

6.7

118.49

118.94

g/l

0.27

717

3026

Nonorganic sleeping disorders, excluding more controls

1245

6420

2.06

111.05

9.3

8.6

122.99

122.00

g/l

0.94

1224

6260

Dysphagia

1889

11152

1.81

110.72

9.9

8.0

119.89

120.86

g/l

1.29

1852

10882

Diseases of the musculoskeletal system and connective tissue

3189

10320

1.60

110.65

9.0

9.9

122.61

122.20

g/l

0.47

3116

10079

Candidiasis, including avohilmo

2044

12306

1.76

110.28

10.6

8.2

119.65

120.51

g/l

1.15

2005

12030

Azathioprine

1031

5013

2.23

110.26

14.2

9.1

116.53

122.42

g/l

16.79

1018

4892

Acute pancreatitis (for exclusion)

1606

9121

1.91

109.74

13.1

8.8

118.81

121.92

g/l

6.82

1580

8915

Arthrosis

4807

18651

1.46

109.56

8.0

9.3

122.23

121.96

g/l

0.38

4671

18232

Diabetic maculopathy, excluding more controls

862

3943

2.43

109.41

11.8

7.5

112.79

122.28

g/l

30.44

843

3848

Post-traumatic stress disorder

507

1776

3.10

109.40

9.2

8.7

124.21

122.15

g/l

1.38

496

1736

Other metabolic disorders

882

4048

2.36

108.92

10.6

7.8

120.57

121.04

g/l

0.27

862

3949

Colon adenocarcinoma, helper endpoint

1178

6133

2.16

108.47

8.0

7.9

114.15

120.06

g/l

21.78

1157

5996

Disorders of mineral metabolism

705

2976

2.68

108.37

9.9

8.3

116.08

121.42

g/l

8.26

690

2904

Symptoms and signs involving the skin and subcutaneous tissue

4925

33669

1.43

108.35

8.3

8.7

121.50

121.20

g/l

0.48

4820

32922

Fibrosis and cirrhosis of liver

740

3234

2.67

107.80

12.8

8.9

111.71

121.66

g/l

27.02

723

3170

severe traumatic brain injury, does not include concussion

1851

11003

1.82

107.61

11.1

8.2

118.40

120.96

g/l

6.02

1820

10744

Abdominal aortic aneurysm (AAA)

901

4209

2.38

107.07

12.0

6.9

118.01

120.97

g/l

3.98

883

4111

Amputation of toe

724

3155

2.71

107.01

12.2

8.7

111.25

121.22

g/l

30.53

714

3085

Non-selective monoamine reuptake inhibitors

2570

15798

1.64

106.97

8.3

8.2

120.52

120.32

g/l

0.19

2519

15429

Diseases of the eye and adnexa

4789

16973

1.45

106.29

9.6

9.1

122.72

123.29

g/l

0.99

4690

16576

Iron deficiency anaemia secondary to blood loss (chronic)

1314

7093

2.03

105.98

12.1

7.5

108.18

121.08

g/l

84.56

1282

6922

Suppurative and necrotic conditions of lower respiratory tract

581

2309

3.02

104.95

16.3

9.2

115.23

122.26

g/l

13.02

570

2251

Chronic viral hepatitis

429

1425

3.48

104.94

12.2

11.0

122.04

125.70

g/l

2.66

423

1397

Chronic ulcer of skin, not elsewhere classified

670

2838

2.76

104.50

10.8

8.6

113.72

121.26

g/l

16.83

658

2768

Elevated blood glucose level

735

3226

2.59

104.30

11.9

9.1

121.03

122.34

g/l

0.87

726

3152

Other disorders of kidney and ureter

1117

5776

2.16

104.08

12.4

8.7

114.83

121.30

g/l

20.64

1093

5642

Congenital malformations of heart and great arteries

914

4236

2.30

102.68

16.7

9.6

118.15

123.27

g/l

10.69

898

4139

Symptoms and signs concerning food and fluid intake

837

3866

2.38

102.55

9.9

8.1

118.48

121.58

g/l

4.29

818

3769

Exclusions for E4_PCOS_BROAD

1210

6401

2.04

101.97

10.3

9.4

123.81

122.10

g/l

2.04

1180

6256

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

679

2916

2.67

101.81

13.1

8.1

114.51

120.83

g/l

13.49

668

2845

Enlarged lymph nodes

1078

5475

2.12

101.80

9.3

8.8

120.08

122.25

g/l

2.69

1047

5336

Benign neoplasm of other and ill-defined parts of digestive system

1410

7898

1.95

101.48

9.1

8.3

118.62

120.29

g/l

2.43

1383

7722

Schizophrenia

1112

5736

2.10

101.28

8.8

10.0

123.41

123.61

g/l

0.12

1087

5611

Subarachnoid haemorrhage

875

4177

2.35

100.95

13.4

7.8

120.72

g/l

0.00

854

4078

Acidosis

271

706

5.19

100.70

15.5

8.3

115.48

121.79

g/l

4.50

264

689

Malignant neoplasm of corpus uteri

665

2837

2.66

100.28

4.5

6.8

118.88

118.99

g/l

0.05

651

2765

Viral pneumonia (known virus, not influenza)

332

995

4.30

99.89

14.0

9.5

120.01

119.82

g/l

0.05

323

981

Other pulmonary heart/vessel disease

480

1776

3.29

99.87

16.6

8.4

124.78

119.25

g/l

5.57

474

1733

Postprocedural endocrine and metabolic disorders, not elsewhere classified

805

3699

2.36

99.15

10.0

7.9

120.31

120.95

g/l

0.37

787

3611

Pain in thoracic spine

1074

5510

2.10

98.85

7.2

8.9

124.99

120.82

g/l

8.53

1053

5380

Disorders of eyelid, lacrimal system and orbit

5933

32705

1.37

98.21

7.9

8.7

120.98

121.14

g/l

0.26

5795

31994

Other symptoms and signs involving the circulatory and respiratory systems

542

2112

2.89

98.07

8.3

8.6

124.70

120.64

g/l

4.26

523

2061

Fracture of shoulder and upper arm

2592

16982

1.60

98.00

9.8

8.4

117.07

120.96

g/l

19.56

2550

16593

Arterial embolism and thrombosis

549

2176

2.94

97.87

12.8

7.1

115.16

121.25

g/l

9.65

534

2125

Other degenerative diseases of the nervous system

1957

8645

1.74

97.55

6.6

7.6

120.54

119.24

g/l

2.00

1916

8446

Haemorrhage, not elsewhere classified

407

1390

3.54

97.08

15.2

8.6

114.28

120.10

g/l

5.67

396

1355

Lung diseases due to external agents

1178

6329

2.05

96.98

13.4

7.9

119.41

120.57

g/l

1.07

1142

6188

Cirrhosis of liver, NAS

569

2348

2.92

95.68

13.5

9.3

110.68

121.89

g/l

25.99

561

2291

Panic disorder

842

3978

2.25

95.35

11.4

8.4

124.28

123.09

g/l

0.90

822

3880

Other diseases of biliary tract

777

3629

2.42

95.32

13.7

7.9

113.43

120.49

g/l

17.63

765

3545

Thoracic aortic aneurysm

1208

6609

2.02

94.83

13.7

8.4

118.66

123.29

g/l

11.82

1187

6454

Disorders of calcium metabolism

547

2192

2.85

94.52

9.3

7.6

114.91

120.46

g/l

7.28

536

2136

Toxic effects of substances chiefly nonmedicinal as to source

847

4074

2.28

94.31

9.0

9.3

126.57

123.05

g/l

5.18

836

3987

Neuromuscular dysfunction of bladder

773

3614

2.41

94.11

9.4

8.7

120.95

122.04

g/l

0.78

752

3518

Unspecified misadventure during surgical and medical care

551

2243

2.90

94.08

14.3

9.1

115.55

121.23

g/l

9.05

540

2192

Sleep apnoea

6405

30816

1.35

93.62

9.3

8.7

125.86

120.75

g/l

67.40

6297

30090

Dermatitis

4290

30475

1.43

93.26

9.0

8.6

120.15

121.22

g/l

2.78

4193

29795

Diabetic retinopathy, excluding more controls

2044

7062

1.74

93.16

12.2

10.1

116.06

123.62

g/l

44.06

2009

6911

Insulin, fast-acting (human)

929

4622

2.16

93.05

12.8

8.4

113.91

123.78

g/l

34.40

906

4507

Secondary right heart disease

439

1612

3.33

92.93

16.5

8.0

124.76

119.32

g/l

4.85

433

1571

Malignant neoplasm of bronchus and lung

1479

7135

1.87

92.51

8.3

8.0

120.76

122.31

g/l

2.33

1446

6982

Other viral hepatitis, including avohilmo

498

1916

2.93

92.40

12.5

10.8

121.19

125.39

g/l

3.98

491

1881

Sequelae of other external causes

512

2019

2.93

91.97

12.0

9.5

116.20

121.49

g/l

6.28

502

1969

Other viral hepatitis

477

1805

2.99

91.60

12.6

10.8

120.94

125.49

g/l

4.30

471

1770

Other diseases of anus and rectum

2136

13576

1.65

91.29

8.8

7.9

118.08

121.33

g/l

11.04

2096

13254

Total colectomy operation

402

1416

3.41

90.79

14.4

10.1

116.65

122.35

g/l

6.22

396

1386

Total colectomy

402

1416

3.41

90.79

14.4

10.1

116.65

122.35

g/l

6.22

396

1386

Postprocedural disorders of digestive system, not elsewhere classified

355

1175

3.76

90.33

11.9

9.1

115.32

120.96

g/l

5.47

348

1151

Other and unspecified effects of external causes

1691

10191

1.75

90.32

9.7

9.1

123.55

121.82

g/l

2.77

1666

9945

Other joint disorders

5350

20696

1.38

90.23

7.9

9.4

122.89

122.14

g/l

1.72

5218

20227

Alcohol-induced chronic pancreatitis

597

2582

2.71

89.40

17.3

9.9

118.16

124.18

g/l

8.38

590

2529

Phobic anxiety disorders

731

3338

2.32

89.38

10.6

9.0

124.56

124.15

g/l

0.20

714

3261

Migraine

2721

14106

1.55

89.30

7.7

8.7

124.18

119.82

g/l

25.08

2669

13768

Migraine with aura

1318

7400

1.86

89.27

7.8

8.1

124.29

119.78

g/l

13.86

1297

7206

Chronic apical periodontitis

7320

31998

1.31

88.78

9.5

8.4

121.16

121.70

g/l

1.33

7181

31246

Gastro-oesophageal reflux disease

4530

28142

1.40

88.20

9.2

8.4

121.13

122.16

g/l

2.74

4427

27510

Abnormalities of gait and mobility

1033

5505

2.08

88.13

9.7

8.2

119.92

120.29

g/l

0.24

1016

5378

Acute upper respiratory infections

6923

32202

1.32

87.87

9.2

8.4

122.12

120.90

g/l

4.97

6788

31459

Arthropathies

5492

20733

1.37

87.86

8.4

9.4

122.10

122.13

g/l

0.03

5355

20263

Other disorders of glucose regulation and pancreatic internal secretion

676

3074

2.46

87.54

12.9

8.9

117.21

122.00

g/l

7.30

669

3002

Organic, including symptomatic, mental disorders

3945

20014

1.45

87.51

8.3

8.2

119.89

120.08

g/l

0.23

3873

19573

Soft tissue disorders related to use, overuse and pressure

1955

12361

1.67

87.27

8.7

8.8

121.49

120.81

g/l

0.78

1915

12100

Noninfective enteritis and colitis

3008

20755

1.50

87.15

9.6

8.8

119.76

121.83

g/l

6.53

2944

20273

Schizoaffective disorder

557

2332

2.67

86.62

7.8

9.8

124.97

123.96

g/l

0.53

546

2285

Polyneuropathies and other disorders of the peripheral nervous system

1717

10606

1.74

86.47

11.0

8.5

118.61

121.28

g/l

6.16

1693

10354

Pneumonitis due to solids and liquids

747

3570

2.36

86.40

16.2

8.1

117.11

121.01

g/l

5.48

723

3484

Other and unspecified nerve root and plexus disorders, also in other diseases

1456

8574

1.81

86.25

7.1

9.5

124.44

121.93

g/l

4.90

1390

8390

Disorders resulting from impaired renal tubular function

386

1380

3.46

86.22

16.8

10.1

106.90

121.97

g/l

40.21

381

1353

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1452

8387

1.79

85.70

9.8

8.8

122.64

122.10

g/l

0.44

1423

8187

Status epilepticus

361

1236

3.50

85.52

16.2

9.1

120.72

120.71

g/l

0.00

347

1204

Malignant neoplasm of ovary

390

1386

3.27

85.31

7.5

7.3

112.44

119.39

g/l

12.45

379

1349

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2191

14277

1.61

85.28

9.8

8.4

123.05

120.64

g/l

6.19

2134

13970

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

587

2568

2.62

84.47

12.0

7.6

116.54

121.97

g/l

8.34

574

2516

Other noninfective gastroenteritis and colitis

1672

10261

1.72

83.88

9.9

8.4

118.69

121.09

g/l

4.98

1634

10023

Pneumonia due to other infectious organisms, not elsewhere classified

319

1029

3.74

83.57

12.6

8.5

115.32

121.71

g/l

5.38

312

1008

Other pleural conditions

882

4537

2.17

83.48

11.0

7.7

116.03

119.85

g/l

6.52

866

4432

Carpal tunnel syndrome

4036

25544

1.42

83.44

7.3

8.8

122.18

120.91

g/l

3.69

3936

24995

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2130

13871

1.61

83.29

8.7

121.02

121.85

g/l

1.04

2071

13562

Sequelae of injuries, of poisoning and of other consequences of external causes

1609

9816

1.74

83.25

12.1

9.2

120.12

122.78

g/l

5.47

1562

9603

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1127

6249

1.95

83.11

7.8

8.8

115.80

123.06

g/l

26.07

1098

6116

Acute sinusitis

3178

20252

1.47

83.09

8.8

8.9

123.09

121.63

g/l

3.50

3101

19761

Chronic periodontitis, complicated

3978

28413

1.42

82.94

10.8

8.7

120.86

121.74

g/l

1.87

3900

27809

Certain disorders involving the immune mechanism

1327

7718

1.85

82.84

12.6

9.0

120.26

121.77

g/l

1.69

1280

7539

Other and unspecified injuries of head

634

2881

2.48

82.71

8.6

8.4

121.87

121.81

g/l

0.02

627

2807

Other systemic involvement of connective tissue (FG)

1701

10323

1.71

82.57

7.9

8.1

118.28

120.03

g/l

3.38

1668

10087

Use of disulfiram, acamprosate or naltrexone

691

3252

2.37

82.47

11.5

10.6

125.46

125.09

g/l

0.17

686

3184

Pyothorax

448

1770

3.05

82.27

16.2

9.2

114.98

122.30

g/l

11.14

441

1726

Unspecified privation

826

4154

2.19

82.27

13.0

8.6

117.18

122.31

g/l

10.17

820

4058

Cervical disc disorders

2415

16196

1.56

82.14

8.1

9.2

124.03

121.02

g/l

10.48

2364

15855

Other aneurysm

509

2124

2.79

81.98

12.2

8.5

117.61

121.69

g/l

4.18

499

2075

Disturbances of skin sensation

1726

10731

1.69

81.81

7.8

9.0

124.37

121.64

g/l

6.66

1691

10488

Disorder of lipoprotein metabolism, unspecified

994

5340

2.03

81.33

10.5

8.0

118.85

120.90

g/l

2.32

983

5201

Other arthritis (FG)

2033

13160

1.62

81.30

9.3

9.0

119.83

121.59

g/l

3.47

1994

12881

Other disorders of adrenal gland

398

1474

3.15

81.06

12.1

9.2

121.57

120.85

g/l

0.28

392

1447

Other embolism and thrombosis

983

5269

2.04

81.06

10.7

8.7

117.79

121.06

g/l

5.47

964

5150

Hydronephrosis

876

4517

2.12

80.93

9.0

7.3

112.29

122.54

g/l

44.19

859

4417

Other and unspecified polyneuropathies, also in other diseases

1513

9233

1.77

80.22

10.7

8.6

118.52

121.09

g/l

5.18

1494

9020

Rheumatoid arthritis

2122

12272

1.60

80.03

8.3

8.7

117.74

120.62

g/l

9.06

2075

12005

Short Achilles tendon (acquired)

274

829

4.01

79.57

6.5

9.8

123.95

121.59

g/l

1.10

258

808

Candidiasis

995

5371

2.00

79.38

13.8

8.7

117.19

120.89

g/l

6.99

974

5242

Alcoholic liver disease

853

4421

2.16

79.27

14.3

9.6

112.44

123.14

g/l

33.55

842

4334

Other specified and unspecified personality disorders

603

2708

2.44

79.26

10.0

9.6

123.69

123.88

g/l

0.08

598

2650

Hypoglycaemia, other or unspecified

555

2428

2.58

79.07

13.3

9.1

116.47

122.30

g/l

8.74

549

2370

Other mental disorders due to brain damage and dysfunction and to physical disease

1008

5521

2.02

78.90

7.3

7.9

121.26

119.73

g/l

1.60

997

5389

Gonarthrosis,primary

6263

29431

1.32

78.49

7.3

9.0

121.92

121.09

g/l

2.50

6108

28801

Cholecystitis

1090

6097

1.94

78.23

9.3

7.8

119.15

120.42

g/l

1.21

1071

5952

Fentanyl

789

3954

2.17

77.99

10.7

7.3

114.49

121.13

g/l

16.44

764

3861

Serous carcinoma of ovary, including Hilmo

304

998

3.69

77.61

6.5

7.0

111.61

118.81

g/l

10.54

298

973

Benign neoplasm of meninges

812

4158

2.17

77.58

7.6

8.0

121.51

119.31

g/l

3.06

801

4054

Idiopathic gout

852

4479

2.15

76.82

10.7

8.7

118.32

121.93

g/l

4.81

840

4379

Alcohol withdrawal state with delirium

615

2868

2.46

76.78

14.6

10.3

120.16

123.71

g/l

3.50

609

2809

Combinations of oral blood glucose lowering drugs

2056

13585

1.61

76.71

10.1

8.7

122.26

121.87

g/l

0.35

2025

13283

Other diseases of pancreas

714

3515

2.29

76.67

13.8

8.5

116.06

121.66

g/l

10.38

701

3426

Other viral diseases

1692

10579

1.67

76.63

11.5

9.4

119.90

122.92

g/l

7.15

1656

10353

Cervicalgia

1386

8304

1.77

76.49

7.1

8.7

123.78

120.34

g/l

8.46

1360

8124

Systemic connective tissue disorders

2337

15818

1.55

76.32

8.7

7.9

117.86

119.92

g/l

5.77

2291

15443

Mycoses, including avohilmo

5983

35520

1.31

76.22

9.5

8.7

121.74

121.65

g/l

0.12

5880

34695

Disorders of parathyroid gland

1490

9045

1.74

75.72

8.8

7.5

117.28

119.03

g/l

2.71

1462

8833

Sleep disorders (combined)

7171

29660

1.29

75.68

8.7

8.6

123.81

120.44

g/l

33.20

7037

28948

Right hemicolectomy

538

2398

2.61

75.17

14.2

7.7

111.44

120.14

g/l

19.24

527

2342

Cerebral palsy and other paralytic syndromes

818

4225

2.11

75.06

10.3

9.0

122.44

121.54

g/l

0.60

800

4130

Cytomegalovirus infection, IBD co-morbidity

250

750

4.25

75.01

17.5

10.9

108.16

122.37

g/l

20.10

240

736

Follow-up examination after treatment for conditions other than malignant neoplasms

2582

11703

1.52

74.88

9.7

8.4

119.23

121.80

g/l

8.61

2553

11400

Coagulation defects, purpura and other haemorrhagic conditions

1339

8037

1.78

74.11

11.7

8.5

115.81

121.28

g/l

17.04

1312

7860

Asthma and allergy, excluding more controls

590

2625

2.33

74.07

7.6

6.8

125.74

122.83

g/l

2.97

578

2559

Malignant neoplasm of bladder, including Hilmo

954

5152

2.00

74.00

9.0

7.9

117.25

122.79

g/l

14.46

937

5042

Exposure to other specified factors

5130

33866

1.33

74.00

9.6

8.9

121.15

121.97

g/l

2.11

5044

33086

Open wound of lower leg

1097

6236

1.89

73.99

11.5

8.7

118.54

121.40

g/l

4.62

1080

6097

Other diseases of blood and blood-forming organs, wide

1539

9598

1.71

73.64

11.4

8.7

116.95

121.31

g/l

11.01

1507

9382

Osteoporosis with pathological fracture (FG)

599

2796

2.41

73.42

8.7

6.7

113.99

118.13

g/l

6.17

581

2722

Exclusions for E4_PCOS_CONSORTIUM

3986

18326

1.39

73.08

8.4

8.3

120.45

120.33

g/l

0.14

3901

17894

L04AX Other immunosuppressants

3541

25962

1.41

72.72

10.6

8.7

118.32

121.69

g/l

19.30

3476

25379

Pneumothorax

590

2753

2.42

72.56

13.2

8.5

122.72

121.64

g/l

0.59

577

2689

Procreative management

1883

10027

1.61

72.56

10.8

10.2

122.59

123.58

g/l

1.21

1818

9810

Intracerebral haemorrhage

1013

5682

1.94

72.42

12.2

7.5

120.80

119.67

g/l

0.97

996

5549

Second line medication for Crohn's disease

3625

26683

1.40

72.29

10.5

8.8

118.42

121.77

g/l

19.41

3558

26084

Viral hepatitis, including avohilmo

533

2374

2.48

71.90

12.3

10.3

121.16

124.91

g/l

3.62

525

2331

Cytomegaloviral disease

250

769

4.09

71.87

17.5

10.8

108.16

122.21

g/l

19.93

240

754

Sleep apnoea, including avohilmo

6507

31132

1.29

71.32

9.0

8.8

125.71

120.62

g/l

68.51

6396

30397

Benign neoplasm of other and unspecified endocrine glands

976

5441

1.95

71.24

8.3

8.8

123.60

121.18

g/l

3.23

955

5308

Attention to artificial openings

389

1530

2.99

71.10

11.2

8.0

115.25

122.06

g/l

8.61

383

1499

Cytomegaloviral disease, including avohilmo

251

780

4.03

70.93

17.4

10.7

108.24

122.29

g/l

20.07

241

765

Abnormal spermatozoa

225

6652

0.31

70.86

5.2

9.6

120.55

122.39

g/l

0.64

214

6501

Diabetic nephropathy

1422

8771

1.76

70.83

13.4

10.1

110.97

122.04

g/l

72.45

1400

8587

Osteomyelitis

560

2592

2.46

70.69

11.8

9.4

111.79

122.30

g/l

25.29

549

2532

Benign neoplasm: Cerebral meninges

736

3771

2.17

70.32

7.8

8.0

121.38

119.29

g/l

2.60

726

3676

Dilated cardiomyopathy

966

5422

1.97

70.27

17.6

8.9

123.59

121.69

g/l

1.85

952

5298

Viral hepatitis

512

2266

2.50

70.25

12.5

10.3

120.93

124.88

g/l

3.77

505

2224

Polyarthrosis

1443

8023

1.72

70.25

5.8

8.5

119.64

119.51

g/l

0.09

1426

7846

Abnormal involuntary movements

980

5483

1.93

70.24

7.7

8.9

122.82

120.85

g/l

2.16

964

5362

Other and unspecified dermatitis

3439

25291

1.41

69.64

9.0

8.5

119.91

121.03

g/l

2.51

3365

24721

Laparoscopic right hemicolectomy

547

2553

2.51

69.31

7.5

8.0

113.32

120.30

g/l

15.16

542

2490

Previous suicide attempt

132

257

6.91

69.24

9.6

11.9

123.97

123.05

g/l

0.18

132

250

Mixed and other personality disorders

515

2292

2.46

69.13

8.4

10.0

124.82

124.66

g/l

0.06

506

2247

Other viral diseases, not elsewhere classified

1137

6610

1.81

69.08

11.1

9.4

120.97

122.72

g/l

1.99

1117

6461

Speech and linguistic disorders, excluding more controls

416

1552

2.68

69.04

10.9

9.3

123.20

122.40

g/l

0.29

406

1510

Pneumonia due to Streptococcus pneumoniae

347

1296

3.07

69.04

10.9

8.9

121.10

122.92

g/l

0.79

338

1273

Other/unspecified cytomegaloviral diseases

218

634

4.44

68.79

18.4

11.8

107.36

121.84

g/l

18.68

210

623

Myocardial infarction, with ST-elevation

1382

8571

1.74

68.68

9.7

8.2

120.43

120.93

g/l

0.39

1357

8371

Left ventricular outflow tract obstruction, narrow definition

414

1700

2.80

68.58

20.0

10.6

114.13

124.69

g/l

20.86

408

1669

Injuries to unspecified part of trunk, limb or body region

772

4041

2.09

68.47

11.1

8.7

117.40

121.84

g/l

7.45

762

3948

Other and unspecified local infections of skin and subcutaneous tissue

735

3788

2.12

68.20

12.1

8.9

118.12

122.32

g/l

5.95

721

3701

Fracture of skull and facial bones

1426

8869

1.70

68.07

12.3

9.0

120.97

122.95

g/l

3.06

1407

8651

Other specified/unspecified arthritis

1740

11331

1.61

67.83

9.3

9.2

120.05

121.38

g/l

1.90

1705

11084

Umbilical hernia

1861

12338

1.59

67.61

10.1

9.3

123.37

122.94

g/l

0.37

1832

12053

Malignant neoplasm of skin, including Hilmo

3311

16137

1.42

67.46

7.7

8.7

119.60

122.86

g/l

16.38

3233

15799

Assault by bodily force

502

2233

2.45

67.22

10.9

10.4

124.85

126.12

g/l

0.62

496

2189

Disorders of continuity of bone

686

3459

2.15

67.06

9.0

9.3

117.29

122.42

g/l

9.11

671

3384

Diseases of pulp and periapical tissues, including avohilmo

6634

27328

1.28

66.46

9.1

8.4

121.47

121.17

g/l

0.55

6484

26693

Appendectomy

3843

27513

1.37

65.85

9.2

9.0

122.04

122.01

g/l

0.03

3763

26883

Malignant neoplasm of bladder

585

2820

2.31

65.77

10.2

7.5

114.91

121.94

g/l

15.61

579

2768

Migraine without aura

930

5152

1.88

65.73

8.2

8.3

124.98

120.33

g/l

10.59

916

5018

Asthma and allergy

589

2748

2.21

65.72

7.6

7.2

125.77

122.45

g/l

3.74

577

2682

Glomerulonephritis

735

3851

2.10

65.42

11.6

9.4

114.08

122.20

g/l

18.96

720

3765

Other diseases of arteries and capillaries

680

3473

2.15

64.92

12.2

7.9

114.10

122.03

g/l

18.06

665

3397

Seropositive rheumatoid arthritis

1599

10286

1.62

64.52

8.4

8.3

116.95

120.29

g/l

9.52

1566

10059

Disorders of synovium and tendon

3310

20670

1.40

64.51

8.0

9.1

122.15

121.35

g/l

1.44

3231

20206

Other local infections of skin and subcutaneous tissue

763

4064

2.04

64.12

12.0

8.9

118.32

122.20

g/l

5.42

749

3970

Pneumocystosis

239

784

4.11

64.02

14.7

9.0

113.42

121.16

g/l

5.88

234

768

Pneumocystosis, including avohilmo

239

784

4.11

64.02

14.7

9.0

113.42

121.16

g/l

5.88

234

768

Cholangitis (primary sclerosing, PSC)

512

2373

2.42

63.88

13.3

8.2

112.95

121.40

g/l

15.89

505

2313

Recurrent or chronic depression

2178

10273

1.52

63.87

9.7

9.4

124.07

122.04

g/l

4.41

2141

10027

Gingivitis and periodontal diseases

6485

26755

1.28

63.63

9.3

8.3

121.22

121.50

g/l

0.49

6337

26144

Tobacco use

436

1894

2.61

63.49

9.8

10.1

123.08

122.94

g/l

0.04

424

1854

Psychotic depression

412

1729

2.61

63.20

9.3

8.5

123.75

121.31

g/l

1.47

402

1687

Noninfectious colitis NAS

929

5269

1.89

63.10

9.6

8.3

118.63

121.16

g/l

3.37

910

5149

Other diseases of liver

1212

7405

1.74

62.72

12.2

9.0

118.64

121.88

g/l

5.66

1191

7241

Fall on and from stairs and steps

1750

11639

1.58

62.46

9.4

8.6

119.80

121.30

g/l

2.42

1717

11382

Traumatic subarachnoid haemorrhage

333

1287

2.99

62.39

15.8

8.0

116.42

119.63

g/l

1.91

328

1250

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

517

2430

2.38

62.21

9.6

8.4

115.98

121.59

g/l

8.97

511

2376

Malignant neoplasm of skin

3147

15601

1.41

61.82

7.7

8.6

119.50

122.74

g/l

15.35

3069

15274

Failure and rejection of transplanted organs and tissues

160

404

5.26

61.80

21.8

10.0

106.95

124.47

g/l

18.40

155

394

Other disorders of ear

6001

30961

1.28

61.70

7.9

9.0

121.74

121.33

g/l

0.83

5857

30299

Diseases of the myoneural junction and muscle

929

5334

1.89

61.62

10.7

8.6

121.73

121.02

g/l

0.47

912

5209

Non-small cell lung cancer

807

4381

1.97

61.49

8.2

7.6

120.11

122.32

g/l

2.54

787

4287

Myalgia

1427

9073

1.64

61.45

9.3

8.7

122.82

120.82

g/l

3.23

1395

8869

Malignant neoplasm of pancreas, including Hilmo

672

3492

2.12

61.32

9.2

7.6

114.64

121.80

g/l

18.75

659

3419

Ulcer of oesophagus

586

2923

2.26

61.08

8.9

8.5

118.03

121.80

g/l

4.16

572

2860

Hyperparathyroidism

1286

7960

1.70

60.70

8.7

7.5

117.20

119.06

g/l

2.62

1262

7763

Paracetamol or NSAID medication

908

2473

1.92

60.31

9.5

10.6

122.16

121.37

g/l

0.46

887

2406

Stomatitis and related lesions

1258

7822

1.70

60.25

10.0

8.7

119.89

121.40

g/l

1.78

1225

7643

Viral infections characterized by skin and mucous membrane lesions

2684

19415

1.43

60.16

9.5

8.9

119.90

121.81

g/l

4.98

2634

18972

Superficial injury of lower leg

1608

10571

1.59

59.86

8.4

121.30

121.42

g/l

0.09

1582

10318

Reimbursement for rheumatic diseases

3526

26461

1.36

59.79

9.3

8.4

118.53

121.05

g/l

11.55

3453

25877

Type of accident

1892

12892

1.53

59.66

8.6

8.8

120.55

121.78

g/l

1.77

1839

12604

Somatoform disorder

971

5650

1.82

59.59

8.0

8.6

123.25

121.37

g/l

2.16

954

5505

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

442

1991

2.52

59.50

11.3

7.4

115.58

122.10

g/l

8.99

430

1951

Nonorganic sleeping disorders

1245

7725

1.69

59.45

9.3

9.1

122.99

122.21

g/l

0.68

1224

7545

Diseases of oral cavity, salivary glands and jaws

3844

14922

1.36

59.36

8.4

8.2

120.80

121.17

g/l

0.49

3756

14575

Familial hypercholesterolemia

1053

6307

1.79

59.31

9.0

7.7

119.26

120.80

g/l

1.61

1048

6139

Hydrocephalus

603

3065

2.19

59.12

9.5

8.0

123.21

119.61

g/l

4.53

591

2984

Other symptoms and signs involving the nervous and musculoskeletal systems

2604

18813

1.43

59.03

8.2

8.5

124.06

120.93

g/l

12.63

2543

18390

Benign neoplasm: Sigmoid colon

1414

9148

1.65

58.82

8.7

119.61

120.65

g/l

1.16

1393

8931

Acute and transient psychotic disorders

727

3904

2.00

58.77

8.5

9.5

123.25

123.37

g/l

0.05

707

3822

Chronic gastritis

1876

12832

1.54

58.69

9.7

7.5

116.96

120.38

g/l

10.88

1845

12547

Other viral diseases, including avohilmo

2052

14055

1.49

58.48

11.3

9.4

120.66

122.84

g/l

4.86

2012

13735

Scoliosis

526

2522

2.25

58.38

8.5

8.2

116.72

120.34

g/l

4.11

511

2468

Malignant neoplasm of breast, HER2-negative, including Hilmo

2043

8930

1.51

58.24

6.6

7.7

118.10

120.69

g/l

8.72

2004

8712

Malignant neoplasm of breast, including Hilmo

2043

8930

1.51

58.21

6.6

7.7

118.10

120.69

g/l

8.72

2004

8712

Injuries to the neck

1404

9025

1.63

58.03

10.1

9.1

121.95

122.33

g/l

0.29

1377

8810

Injury of intra-abdominal organs

229

754

3.62

57.94

18.0

10.5

117.15

123.43

g/l

4.02

222

737

Inguinal hernia

3924

19924

1.35

57.91

8.8

9.1

122.98

123.01

g/l

0.03

3841

19451

Alzheimer’s disease (Atypical or mixed), excluding more controls

731

2916

2.03

57.87

4.3

6.7

119.70

117.18

g/l

2.62

716

2840

Congenital malformations of aortic and mitral valves

349

1439

2.79

57.45

20.9

10.6

113.71

124.75

g/l

19.87

344

1411

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3002

14905

1.40

57.42

7.5

8.6

119.33

122.59

g/l

15.00

2929

14590

Artrosis, including avohilmo

5200

22472

1.30

57.06

7.8

9.6

122.71

121.61

g/l

3.19

5067

21949

Arterial embolism and thrombosis of lower extremity artery

323

1294

2.91

56.82

12.3

7.2

114.82

120.87

g/l

6.06

315

1264

Injuries to the elbow and forearm

4407

29492

1.31

56.71

8.9

8.6

119.60

121.46

g/l

7.78

4310

28832

Hypertensive Renal Disease

304

1175

2.95

56.58

10.2

7.4

110.97

119.80

g/l

9.97

297

1144

Fall on same level involving ice and snow

3697

28316

1.34

56.53

8.8

8.6

121.32

121.17

g/l

0.16

3620

27672

Cerebral cysts

410

1816

2.50

56.33

13.7

9.8

122.21

122.61

g/l

0.13

400

1773

Other blood glucose lowering drugs, excl. Insulins

1132

7016

1.73

56.16

9.5

7.9

121.12

120.43

g/l

0.50

1108

6835

Persistent mood disorders

1159

7177

1.70

56.15

8.9

8.5

121.33

121.05

g/l

0.18

1143

6998

Coxarthrosis, primary

4229

27392

1.32

56.03

7.3

8.4

119.33

120.65

g/l

4.26

4136

26803

Familial hypercholesterolemia, with ischemic heart disease

688

3719

2.03

55.95

10.0

7.5

118.86

120.29

g/l

1.06

683

3631

Benign neoplasm: Colon, unspecified

1844

12734

1.53

55.74

8.9

8.5

119.04

120.76

g/l

3.25

1808

12434

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

423

1926

2.49

55.61

13.1

7.5

116.52

122.29

g/l

6.88

415

1892

Malignant neoplasm of breast, HER2-negative

1999

8853

1.50

55.30

6.7

7.7

118.10

120.62

g/l

8.17

1960

8636

Focal brain injury

473

2234

2.32

55.28

12.6

8.1

118.83

120.56

g/l

0.98

465

2174

Family history of malignant neoplasm

636

3327

2.03

55.12

7.9

7.4

120.35

122.22

g/l

1.76

612

3237

Malignant neoplasm of breast

2000

8862

1.50

55.12

6.7

7.7

118.08

120.63

g/l

8.27

1961

8645

Subjective visual disturbances

1616

10846

1.56

55.11

8.8

8.4

121.44

120.76

g/l

0.70

1582

10600

Phlebitis and thrombophlebitis (not including DVT)

1488

9834

1.59

54.96

9.1

8.6

121.52

121.20

g/l

0.24

1451

9611

Dissociative [conversion] disorders

252

888

3.15

54.92

6.8

8.4

125.91

121.15

g/l

3.18

246

868

Alzheimer disease, excluding more controls

1261

5109

1.69

54.82

5.4

7.2

119.96

118.27

g/l

2.14

1231

4988

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2887

14453

1.40

54.51

7.5

8.5

119.22

122.43

g/l

14.02

2814

14144

Dental operations

4065

16109

1.33

53.62

8.3

8.4

120.59

121.59

g/l

2.22

3965

15774

Primary_lymphoid and hematopoietic malignant neoplasms

1701

11662

1.54

53.16

10.3

8.4

111.96

121.27

g/l

62.08

1659

11400

Superficial injury of hip and thigh

1059

6530

1.72

52.88

7.5

7.8

118.74

121.26

g/l

3.70

1037

6379

Hyperkinetic disorders, excluding more controls

444

1895

2.26

52.88

9.1

127.91

124.14

g/l

3.44

438

1847

Diplopia

917

5463

1.80

52.87

9.5

8.5

121.65

121.13

g/l

0.33

897

5339

Benign neoplasm: Rectum

1326

8680

1.63

52.45

8.3

8.7

119.26

120.69

g/l

1.90

1301

8475

DVT of lower extremities

1305

8482

1.63

52.44

8.6

8.5

120.28

120.87

g/l

0.46

1274

8288

Injury of other and unspecified intrathoracic organs

510

2552

2.22

52.26

15.8

9.3

117.10

122.73

g/l

7.63

501

2489

Osteonecrosis

500

2488

2.25

52.26

10.6

9.0

114.80

121.74

g/l

11.85

492

2434

Superficial injury of thorax

1030

6329

1.73

52.25

9.2

8.6

122.07

121.90

g/l

0.09

1008

6182

Malignant neoplasm of stomach, including Hilmo

473

2299

2.28

52.11

10.8

7.7

113.12

122.02

g/l

18.55

462

2252

Amputation of foot

277

1092

3.12

51.90

13.4

9.3

108.09

121.28

g/l

23.11

271

1061

Pneumonia derived septicemia

291

1157

2.90

51.74

13.9

9.3

117.84

120.91

g/l

1.57

283

1130

Malignant neoplasm of head and neck, including Hilmo

700

3889

1.95

51.58

12.0

8.6

115.70

123.13

g/l

18.30

686

3805

Benign neoplasm: Rectum, anus and anal canal

1457

9757

1.59

51.56

8.2

8.6

119.04

120.59

g/l

2.34

1431

9523

Other viral diseases, not elsewhere classified, including avohilmo

1458

9635

1.56

51.02

11.0

9.3

121.82

122.68

g/l

0.83

1435

9417

Hepatic failure, not elsewhere classified

332

1421

2.72

50.96

24.4

9.7

111.30

121.22

g/l

12.61

325

1395

Disorders of lacrimal system

2742

20146

1.38

50.33

7.7

8.2

120.62

120.12

g/l

0.67

2670

19689

Basal cell carcinoma, including Hilmo

2875

14539

1.38

50.06

7.5

8.5

119.44

122.49

g/l

12.86

2810

14228

Necrotizing fasciitis

189

8.28

49.97

17.7

12.1

109.87

121.24

g/l

4.23

182

Other disorders of lacrimal gland

2275

16549

1.42

49.82

8.0

8.4

120.82

120.11

g/l

0.98

2220

16165

Malignant neoplasm of stomach

420

1986

2.36

49.81

11.3

7.5

113.51

122.06

g/l

15.41

411

1948

Lesion of ulnar nerve

924

5596

1.76

49.72

10.0

9.6

123.91

122.23

g/l

1.55

901

5475

Shock, not elsewhere classified

124

306

5.49

49.69

39.7

7.1

109.62

120.18

g/l

5.40

118

298

Injury of unspecified body region

559

2933

2.09

49.51

10.8

9.0

117.66

121.51

g/l

4.35

553

2860

Dermatitis and eczema

7083

34799

1.23

49.45

9.2

8.7

121.02

121.70

g/l

1.88

6933

34010

Other symptoms and signs involving general sensations and perceptions

341

1489

2.59

49.24

7.5

8.8

121.98

119.75

g/l

1.23

334

1448

Other systemic involvement of connective tissue

1730

12037

1.50

49.21

7.9

118.37

119.76

g/l

2.36

1697

11762

Other or ill-defined heart diseases

354

1558

2.48

48.86

14.0

7.9

122.56

124.09

g/l

0.65

346

1522

Volvulus

258

1000

3.03

48.71

11.4

7.9

114.92

121.10

g/l

4.73

252

969

Disorders of ocular muscles, binocular movement, accommodation and refraction

2734

20306

1.37

48.61

10.5

8.8

122.36

121.73

g/l

0.87

2686

19836

Basal cell carcinoma

2780

14159

1.38

48.46

7.3

8.4

119.48

122.40

g/l

11.49

2715

13853

Trochanteric bursitis

939

5740

1.73

48.45

7.4

7.9

120.68

119.44

g/l

1.19

922

5606

Type 1 diabetes, definitions combined

462

2247

2.17

48.28

12.2

8.7

119.67

125.40

g/l

6.62

451

2193

Follow-up examination after treatment for malignant neoplasms

721

4120

1.88

48.11

8.2

7.6

118.44

120.06

g/l

1.41

702

4013

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1150

7403

1.64

48.09

9.6

8.9

121.92

121.77

g/l

0.09

1133

7226

Protozoal diseases

276

1121

2.93

47.93

14.3

9.9

114.30

120.88

g/l

5.27

270

1100

Benign neoplasm: Adrenal gland

594

3239

2.02

47.47

8.1

8.9

122.37

121.08

g/l

0.78

586

3169

Type 1 diabetes, strict (exclude DM2)

457

2229

2.16

47.42

12.2

9.2

119.70

125.32

g/l

6.31

446

2177

Strabismus

1515

10319

1.52

47.00

10.7

8.9

122.06

121.54

g/l

0.43

1485

10076

Vascular syndromes of brain in cerebrovascular disorders

387

1829

2.42

46.97

7.3

8.2

119.55

118.98

g/l

0.22

378

1786

Duodenal ulcer

813

4859

1.80

46.63

10.8

7.9

114.50

121.42

g/l

15.03

798

4758

Benign neoplasm: Transverse colon

833

5035

1.80

46.58

8.4

8.7

120.31

120.63

g/l

0.17

820

4923

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1019

6432

1.68

46.43

9.9

8.9

122.05

121.75

g/l

0.17

1003

6285

Smoking dependency

605

3323

1.97

46.42

11.1

9.8

124.17

122.90

g/l

0.75

598

3248

Mental and behavioural disorders due to tobacco

605

3325

1.97

46.34

11.1

9.8

124.17

122.79

g/l

0.84

598

3251

Radiculopathy

1041

6602

1.66

46.27

6.6

8.5

122.94

119.94

g/l

5.01

1026

6463

Functional dyspepsia

1620

11248

1.50

46.25

9.3

8.0

122.73

121.16

g/l

2.40

1581

10996

Other arterial embolism and thrombosis

250

978

2.98

46.24

14.0

7.1

116.09

121.15

g/l

3.35

244

956

Protozoal diseases, including avohilmo

279

1157

2.84

46.21

14.2

9.8

114.26

120.89

g/l

5.44

273

1134

Adverse effects, not elsewhere classified

1085

6929

1.64

46.12

9.7

8.9

122.99

121.41

g/l

1.72

1068

6758

Artificial joint re-operation

555

3003

2.06

45.87

7.6

7.9

117.23

119.97

g/l

2.72

542

2933

Neuralgia and neuritis, unspecified

381

1788

2.36

45.80

8.6

9.6

122.55

122.20

g/l

0.12

370

1750

Extrapyramidal and movement disorders

2591

19520

1.38

45.72

6.8

8.2

122.24

120.33

g/l

5.19

2531

19089

Social phobias

408

1938

2.22

45.61

11.5

8.9

124.75

125.00

g/l

0.08

397

1895

Primary gonarthrosis, bilateral

3542

23241

1.32

45.40

6.9

8.6

120.57

120.38

g/l

0.22

3456

22741

Adenocarcinoma and ductal carcinoma of pancreas

311

1359

2.63

45.39

10.2

7.7

113.22

121.30

g/l

11.57

304

1331

Visual field defects

616

3435

1.95

45.33

10.0

8.6

121.50

120.91

g/l

0.30

597

3350

Event of undetermined intent

434

2145

2.21

45.20

10.8

10.3

122.03

124.35

g/l

1.41

426

2098

Caries of dentine, including avohilmo

5047

20833

1.26

45.18

8.6

8.4

120.82

121.05

g/l

0.31

4929

20346

Congenital malformations of the urinary system

395

1890

2.30

45.11

10.7

10.0

113.26

122.35

g/l

15.27

385

1846

Heartburn

696

4001

1.84

44.90

9.7

8.5

123.98

121.58

g/l

2.34

682

3910

Recurrent aphthous stomatitis , including avohilmo

901

5559

1.72

44.90

9.3

8.6

119.49

121.17

g/l

1.66

875

5431

Acute posthaemorrhagic anaemia

298

1282

2.66

44.83

10.7

8.1

106.39

121.81

g/l

27.83

290

1248

Other and unspecified abdominal hernia

337

1534

2.50

44.55

8.6

8.5

120.57

120.78

g/l

0.06

327

1493

Diseases of pulp and periapical tissues and dental caries

4285

17452

1.29

44.49

8.5

8.2

120.79

120.91

g/l

0.13

4190

17034

Tubulo-interstitial nephritis, not specified as acute or chronic

454

2294

2.14

44.34

8.9

7.1

117.59

121.15

g/l

3.58

446

2241

Non-Hodgkin lymphoma, all, including Hilmo

860

5283

1.73

44.04

10.1

8.5

113.53

122.73

g/l

30.60

837

5162

Malignant neoplasm of head and neck

578

3184

1.97

43.97

12.7

8.3

115.11

123.07

g/l

17.83

564

3121

Other disorders involving the immune mechanism, not elsewhere classified

260

1065

2.82

43.63

12.9

11.1

112.07

123.06

g/l

11.57

254

1044

Laparoscopic left hemicolectomy

193

695

3.54

43.51

10.8

9.0

118.15

119.89

g/l

0.61

193

681

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

249

989

2.80

43.51

15.4

10.9

111.56

126.00

g/l

18.80

240

968

Fibromyalgia

496

2587

2.03

43.37

8.2

8.3

121.74

120.61

g/l

0.65

485

2524

Zoster [herpes zoster]

1260

8483

1.56

43.04

9.1

8.0

117.88

120.04

g/l

3.31

1240

8285

Conductive and sensorineural hearing loss

5199

28266

1.25

42.99

7.5

8.8

121.52

121.04

g/l

0.93

5065

27688

Agranulocytosis

737

4384

1.80

42.91

10.9

9.0

112.41

121.18

g/l

25.21

722

4279

Malignant neoplasm of rectosigmoid junction, including Hilmo

258

1067

2.83

42.87

9.4

7.5

115.73

121.72

g/l

5.38

251

1050

Fall involving bed

308

1380

2.59

42.83

8.6

7.2

115.94

119.00

g/l

1.95

295

1348

Dental caries, including avohilmo

4739

19586

1.26

42.67

8.8

8.3

120.72

121.07

g/l

0.53

4630

19117

Pneumococcal septicemia

275

1168

2.70

42.66

14.0

9.7

118.28

120.99

g/l

1.24

267

1141

Malignant neoplasm of pancreas

523

2826

2.02

42.55

9.2

7.5

114.12

121.52

g/l

15.49

512

2762

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

506

2702

2.04

42.38

7.9

7.6

118.71

119.46

g/l

0.34

492

2634

Congenital malformations of cardiac septa

399

1889

2.21

42.30

16.9

10.1

121.93

122.55

g/l

0.22

392

1851

Benign neoplasm: Stomach

689

4056

1.84

42.21

8.4

8.2

117.84

120.11

g/l

2.34

679

3959

Hepatocellular carcinoma, including Hilmo

266

1124

2.76

42.16

15.4

7.7

116.77

122.60

g/l

4.62

261

1103

Open wound of ankle and foot

678

3951

1.83

42.16

10.9

9.1

118.32

122.78

g/l

6.26

669

3857

Congenital malformations of the urinary system, including avohilmo

412

2054

2.19

42.13

11.0

9.7

113.48

122.42

g/l

15.57

401

2008

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

5583

35956

1.23

42.11

8.6

8.9

120.92

121.70

g/l

2.07

5472

35140

Disorders of skin appendages

2786

21255

1.34

42.08

9.2

8.8

121.42

121.78

g/l

0.41

2721

20765

Parkinson's disease, excluding more controls

890

5102

1.69

42.07

5.9

7.4

121.44

118.92

g/l

3.16

862

4979

Vitreous haemorrhage

729

4359

1.80

41.99

11.8

8.8

114.35

121.40

g/l

15.02

714

4258

Generalized anxiety disorder

737

4350

1.75

41.90

9.0

8.5

124.08

122.82

g/l

0.93

727

4249

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

242

977

2.86

41.89

12.8

11.4

111.44

123.01

g/l

11.97

236

956

Non-small cell lung cancer, adenocarcinoma

471

2478

2.09

41.77

8.2

7.6

120.00

121.72

g/l

1.12

459

2430

Dermatophytosis

947

6041

1.67

41.70

7.9

9.0

122.42

121.75

g/l

0.41

927

5909

Other disorders of skin and subcutaneous tissue, not elsewhere classified

944

6012

1.66

41.58

10.1

8.3

115.04

121.17

g/l

16.48

924

5866

Disorders of muscles

650

3755

1.84

41.47

11.1

9.2

122.51

121.72

g/l

0.42

641

3667

Purpura and other haemorrhagic conditions

883

5540

1.69

41.46

10.7

8.6

113.66

121.44

g/l

22.39

865

5422

Abscess of anal and rectal regions

539

2947

1.96

41.40

10.2

9.2

121.57

125.02

g/l

3.16

530

2873

Disorders of psychological development

537

2685

1.94

41.31

10.6

10.3

124.90

123.67

g/l

0.64

526

2619

Cardiac murmurs and other cardiac sounds

494

2584

1.99

41.11

8.4

8.9

116.23

119.93

g/l

3.54

481

2519

Other and unspecified myopathies

652

3810

1.86

41.02

11.2

8.5

120.60

120.96

g/l

0.16

639

3722

Other disorders of nervous system

492

2643

2.04

41.00

8.2

9.2

121.12

121.99

g/l

0.41

486

2577

Meniscus derangement

3394

17693

1.30

40.53

7.7

9.4

123.23

121.97

g/l

2.99

3320

17301

Carcinoma in situ of other and unspecified digestive organs

381

1901

2.29

40.44

10.1

8.9

116.97

121.36

g/l

3.97

373

1858

Other symptoms and signs involving the urinary system

738

4466

1.77

40.44

7.8

8.9

120.05

122.17

g/l

2.10

727

4356

Malignant neoplasm of small intestine, including Hilmo

257

1089

2.73

40.34

8.0

7.9

117.24

121.63

g/l

2.51

247

1069

Other sleep disorders

704

4194

1.78

40.15

7.6

8.8

124.11

120.99

g/l

3.47

694

4089

Other problems related to primary support group, including family circumstances

529

2804

1.92

39.96

12.5

9.8

120.65

122.48

g/l

1.21

519

2747

Benign neoplasm: Ascending colon

1023

6727

1.62

39.94

8.1

8.5

118.89

120.33

g/l

1.46

1013

6577

Other other unspecified disorders of the circulatory system

296

1339

2.52

39.85

10.7

9.0

114.62

120.88

g/l

5.93

286

1309

Artificial joint operation, meniscal resection

5949

31787

1.22

39.82

7.6

8.9

121.68

121.41

g/l

0.46

5814

31086

Oxicams

1578

6266

1.48

39.67

6.8

9.8

122.27

119.35

g/l

6.20

1545

6118

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

814

4334

1.68

39.61

10.4

9.9

126.20

124.20

g/l

1.94

798

4234

Symptoms and signs involving speech and voice

2067

15383

1.39

39.49

9.1

8.2

122.32

120.40

g/l

4.71

2032

15031

Sulfasalazine

1604

11439

1.45

39.34

8.5

8.4

118.82

121.37

g/l

5.85

1570

11167

Fracture of neck

476

2573

2.04

39.23

14.0

8.5

117.79

121.85

g/l

4.39

468

2511

Toxic effect of other and unspecified substances

116

318

4.40

39.07

14.2

13.1

126.67

124.43

g/l

0.51

116

311

Use of biperiden

381

1907

2.21

39.05

7.1

9.9

121.10

122.89

g/l

0.94

375

1868

Postmenopausal osteoporosis with pathological fracture

494

2709

2.01

38.96

7.6

6.2

113.76

117.02

g/l

3.51

478

2649

Migraine with aura and triptan purchases

721

4335

1.73

38.65

7.0

9.1

124.87

120.90

g/l

6.38

710

4229

Type 1 diabetes, strict definition, subgroup 1

304

1369

2.33

38.59

13.0

8.4

121.63

127.06

g/l

4.00

296

1333

Acute gastritis

519

2881

1.95

38.59

7.7

8.4

119.69

121.34

g/l

0.98

512

2817

Fracture of foot, except ankle

1381

9626

1.49

38.51

9.6

9.1

120.97

122.13

g/l

1.30

1351

9399

Speech and linguistic disorders

428

2110

2.05

38.49

12.4

10.4

122.97

123.40

g/l

0.15

417

2066

Other fall from one level to another

1344

9336

1.50

38.40

10.7

9.2

121.08

122.56

g/l

1.83

1311

9129

Injuries to the ankle and foot

4127

28578

1.26

38.37

9.6

9.2

122.46

122.19

g/l

0.36

4048

27905

Other disorders of eyelid

2949

21816

1.31

38.28

7.8

8.1

120.33

119.87

g/l

0.62

2890

21328

Superficial injury of abdomen, lower back and pelvis

935

6051

1.62

37.84

9.0

8.5

121.66

122.02

g/l

0.21

911

5912

Hypopituitarism

461

2476

2.01

37.71

10.6

10.3

127.42

124.54

g/l

1.86

448

2423

Sulfonylureas

2291

13804

1.37

37.63

9.2

7.5

116.84

120.14

g/l

11.80

2246

13477

Diseases of the ear and mastoid process

6882

29184

1.20

37.61

8.4

9.1

122.60

121.55

g/l

3.77

6722

28556

Childhood asthma (age<16), excluding more controls

420

1653

2.04

37.58

10.4

7.6

125.09

125.86

g/l

0.28

409

1610

Rheumatoid arthritis, including avohilmo

2288

17404

1.36

37.55

8.1

118.11

120.15

g/l

5.36

2239

17011

Cystic kidney disease

251

1084

2.64

37.53

11.0

10.0

109.91

121.82

g/l

16.38

246

1062

Sensorineural hearing loss

4966

27373

1.23

37.47

7.3

8.8

121.56

120.95

g/l

1.25

4832

26822

Bronchiectasis

551

3151

1.90

37.36

8.6

7.8

121.87

118.65

g/l

3.38

537

3079

Benign neoplasm: Caecum

787

4957

1.71

37.34

9.3

8.4

117.96

120.24

g/l

2.65

778

4842

Cervicocranial syndrome

638

3777

1.78

37.15

6.4

8.4

124.96

120.41

g/l

6.88

627

3684

Other diseases of oesophagus

656

3944

1.78

36.77

9.1

8.1

119.00

121.38

g/l

2.05

646

3852

Cystic kidney disease, including avohilmo

266

1189

2.53

36.67

11.4

10.1

110.27

121.68

g/l

16.34

260

1163

Presence of other functional implants

3738

20611

1.27

36.51

7.6

118.54

121.73

g/l

17.72

3652

20168

Alcohol-induced acute pancreatitis

303

1441

2.40

36.33

19.7

10.0

117.11

124.80

g/l

6.68

298

1412

Malignant neoplasm of endocrine gland, including Hilmo

464

2522

1.96

36.29

7.9

9.0

122.81

122.15

g/l

0.29

453

2457

Disorders of the thyroid gland

5746

31283

1.21

36.21

8.8

8.6

121.11

121.29

g/l

0.27

5614

30588

Congenital malformations and deformations of the musculoskeletal system

439

2325

1.98

36.06

10.7

10.1

123.57

122.81

g/l

0.33

432

2271

Exposure to other and unspecified inanimate mechanical forces

494

2752

1.93

36.03

12.1

9.7

120.65

123.69

g/l

2.34

482

2688

Inflammatory diseases of the central nervous system

535

3059

1.88

35.86

12.3

9.3

120.20

122.35

g/l

1.57

525

2990

Parkinson's disease, strict definition, excluding more controls

815

4829

1.66

35.74

6.0

7.4

121.39

118.80

g/l

3.10

790

4714

Polycystic kidney disease

212

872

2.81

35.46

11.5

10.3

108.81

121.61

g/l

16.49

207

852

Oesophagitis

401

2114

2.08

35.42

13.8

8.6

117.26

122.55

g/l

5.47

392

2072

Primary coxarthrosis, bilateral

1956

14720

1.38

35.36

7.2

8.1

119.58

120.03

g/l

0.46

1904

14394

Periapical abscess

2789

21932

1.31

35.34

9.1

9.3

122.81

122.29

g/l

0.65

2728

21433

Asthma and opportunity respiratory infection

349

1762

2.21

35.29

9.0

7.8

122.05

118.81

g/l

2.27

340

1722

Other condition

868

5629

1.62

35.10

9.5

9.0

121.47

122.37

g/l

0.62

854

5494

Other extrapyramidal and movement disorders in other diseases

1568

11403

1.43

35.04

7.1

8.4

122.05

120.45

g/l

2.49

1534

11150

In situ neoplasms

2488

19331

1.33

34.94

7.9

7.8

117.89

119.71

g/l

4.96

2430

18878

Malignant neoplasm of endocrine gland

410

2169

2.02

34.94

8.0

9.1

123.66

122.10

g/l

0.81

400

2116

Zoster [herpes zoster], including avohilmo

3296

25537

1.28

34.89

8.3

8.2

119.87

120.56

g/l

1.20

3233

24965

Childhood asthma (age<16)

420

1698

1.98

34.88

10.4

8.4

125.09

125.67

g/l

0.20

409

1656

Hypocalcemia

201

815

2.88

34.87

11.0

8.8

114.42

120.66

g/l

3.89

196

799

Other congenital malformations of the digestive system

277

1268

2.37

34.59

11.8

9.8

118.75

121.41

g/l

1.21

270

1241

Other and unspecified visual disturbances

678

4174

1.73

34.50

8.0

8.5

120.93

121.18

g/l

0.12

653

4074

Other coagulation defects

464

2570

1.94

34.47

12.7

8.9

119.69

121.38

g/l

0.95

455

2510

Mental retardation, excluding more controls

212

835

2.67

34.40

9.9

124.96

122.85

g/l

0.64

207

817

Infective dermatitis

728

4565

1.69

34.36

8.9

8.8

120.84

121.71

g/l

0.50

706

4463

Other inflammatory liver diseases

446

2453

1.98

34.35

10.9

9.1

116.61

121.86

g/l

5.59

434

2401

Type 1 diabetes, strict definition

318

1530

2.17

34.20

13.1

8.6

121.25

126.97

g/l

4.57

310

1491

Other necrotizing vasculopathies

504

2890

1.90

34.03

9.6

8.3

115.57

120.38

g/l

6.01

492

2820

Other/unspecified seropositive rheumatoid arthritis

1582

11579

1.42

33.90

8.5

8.1

116.98

119.93

g/l

7.66

1549

11319

Seropositive rheumatoid arthritis, wide

1598

11716

1.42

33.87

8.4

8.1

116.97

119.92

g/l

7.75

1565

11451

Examination and encounter for administrative purposes

572

3392

1.81

33.82

8.3

8.4

123.16

122.34

g/l

0.42

561

3299

Haemorrhoids and perianal venous thrombosis

2054

15497

1.35

33.68

6.9

8.1

121.00

121.51

g/l

0.55

2009

15127

Other necrotizing vasculopathies (FG)

418

2270

2.01

33.61

9.6

8.8

116.22

120.75

g/l

4.56

409

2216

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

192

777

2.90

33.56

10.7

8.0

116.71

121.66

g/l

2.67

186

764

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1554

11361

1.42

33.56

8.5

8.2

116.95

119.97

g/l

7.86

1522

11107

Immunodeficiencies

312

1531

2.24

33.54

15.7

9.7

117.46

121.01

g/l

2.21

299

1496

Lesion of lateral popliteal nerve

358

1851

2.13

33.53

12.5

10.1

118.85

122.26

g/l

2.21

351

1806

Hypercalcemia

340

1740

2.19

33.27

8.2

114.75

120.19

g/l

4.72

333

1700

Toxic effect of ethanol

262

1206

2.39

33.05

11.4

10.9

126.79

124.23

g/l

1.12

255

1182

Intestinal malabsorption

323

1618

2.19

32.92

12.5

9.6

114.58

122.43

g/l

9.78

312

1582

Hypothyroidism, strict autoimmune

4202

22687

1.24

32.78

8.4

8.1

120.31

121.57

g/l

3.77

4114

22165

Embolic stroke

356

1851

2.12

32.74

10.6

7.3

118.55

119.37

g/l

0.32

346

1806

Left bundle-branch block

441

2441

1.93

32.69

8.0

7.2

122.81

121.38

g/l

0.75

436

2382

Orchitis and epididymitis

658

4088

1.72

32.59

11.0

10.1

122.58

123.86

g/l

0.76

647

4000

Sarcoidosis

813

5301

1.62

32.47

11.3

9.1

123.63

121.88

g/l

1.50

783

5171

Early complications of trauma

324

1636

2.18

32.45

11.2

10.3

119.41

122.47

g/l

1.68

317

1598

!Aliquae complicationes praecoces traumatis

324

1636

2.18

32.45

11.2

10.3

119.41

122.47

g/l

1.68

317

1598

Methotrexate

790

5105

1.62

32.33

10.0

8.1

116.10

120.50

g/l

8.57

778

4982

Disorders of sclera, cornea, iris and ciliary body

3256

26330

1.26

32.28

8.6

8.7

121.01

121.63

g/l

0.99

3195

25719

Thiazolidinediones

763

4931

1.65

32.18

10.7

8.3

119.76

120.88

g/l

0.83

748

4806

Other strabismus

1131

7829

1.49

32.10

11.1

9.0

122.80

121.83

g/l

0.83

1107

7642

Other diseases of hard tissues of teeth

3536

14791

1.26

32.00

8.7

8.2

120.93

121.22

g/l

0.35

3464

14451

Coxarthrosis, primary, with hip surgery

3139

23507

1.27

31.92

7.0

8.2

118.55

120.30

g/l

5.54

3074

22991

Nonalcoholic fatty liver disease

614

3760

1.73

31.87

12.7

9.6

121.60

122.99

g/l

0.79

607

3683

Malignant neoplasm of small intestine

195

815

2.79

31.78

7.2

8.2

116.11

122.16

g/l

3.58

188

803

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

540

3161

1.78

31.71

10.6

9.6

123.51

122.68

g/l

0.42

532

3094

Other diseases of upper respiratory tract

6841

30604

1.18

31.71

8.9

8.7

122.78

120.85

g/l

11.50

6688

29928

Ulcerative colitis, NAS

779

5042

1.62

31.65

9.8

9.0

120.51

123.02

g/l

2.70

760

4933

Degeneration of macula and posterior pole

3292

20583

1.27

31.61

7.5

7.9

118.37

120.21

g/l

6.19

3231

20105

Inflammatory bowel disease

1749

13118

1.37

31.46

9.7

9.3

120.78

122.46

g/l

2.82

1714

12810

Leisure time condition

1080

7494

1.50

31.40

7.8

8.6

119.99

121.30

g/l

1.27

1039

7330

Progressive vascular leukoencephalopathy

333

1731

2.16

31.38

7.1

6.3

117.82

118.35

g/l

0.19

333

1686

Fracture of forearm

3201

23230

1.26

31.36

8.9

8.3

118.40

120.77

g/l

9.39

3126

22717

Secondary uncertain malignant neoplasm

823

5418

1.60

31.28

7.7

8.3

114.84

122.61

g/l

22.20

805

5297

Ovarian cyst

1682

7076

1.39

31.10

7.5

8.0

119.52

117.80

g/l

3.21

1649

6915

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

532

3173

1.80

31.02

8.7

7.6

112.84

119.63

g/l

13.30

522

3102

Malignant neoplasm of breast, HER-positive

1499

8127

1.41

30.97

6.4

7.4

118.00

120.37

g/l

5.82

1465

7933

Malignant neoplasm of breast, ER-positive, including Hilmo

1501

8132

1.41

30.91

6.4

7.4

118.01

120.37

g/l

5.79

1467

7938

Budesonide

775

5035

1.61

30.81

8.7

8.6

119.53

121.83

g/l

2.46

761

4914

Other infectious diseases, including avohilmo

594

3651

1.73

30.64

11.3

8.4

117.62

121.05

g/l

3.39

579

3562

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3114

24281

1.26

30.62

10.3

9.2

123.80

121.46

g/l

8.35

3025

23750

D07AA Corticosteroids, weak (group I)

780

5069

1.60

30.56

8.1

9.3

121.39

122.32

g/l

0.59

761

4949

Gonarthrosis, primary, with knee surgery

3847

24735

1.24

30.50

6.9

8.6

120.18

120.40

g/l

0.30

3761

24206

Other diseases of lip and oral mucosa

2454

19353

1.30

30.47

9.1

8.6

121.18

121.05

g/l

0.12

2404

18937

Nephrotic syndrome

231

1053

2.47

30.46

12.4

10.1

108.59

122.06

g/l

16.38

226

1034

Migraine without aura and triptan purchases

691

4366

1.63

30.39

7.6

9.1

125.06

121.07

g/l

6.44

681

4261

Injury of urinary and pelvic organs

174

703

2.86

30.28

12.1

11.4

118.16

123.02

g/l

2.08

174

684

Corns and callosities

451

2587

1.88

30.27

8.9

9.2

119.01

121.82

g/l

1.96

442

2524

Embolic stroke with flimmer

208

909

2.58

30.16

8.3

6.8

117.31

119.14

g/l

0.61

202

889

Other diseases of stomach and duodenum

443

2532

1.89

30.08

11.9

8.1

114.96

121.34

g/l

8.70

433

2473

Hypothyroidism, other/unspecified

5216

29020

1.20

30.07

8.6

8.5

120.88

121.02

g/l

0.18

5093

28368

Diabetic retinopathy

2561

12597

1.31

30.04

11.5

10.0

116.29

122.00

g/l

34.59

2514

12344

Other symptoms and signs involving the digestive system and abdomen

916

6196

1.53

30.01

7.9

117.20

120.20

g/l

4.74

898

6050

Benign neoplasm: Small intestine

311

1604

2.18

30.00

8.8

8.5

116.42

120.29

g/l

2.68

302

1567

Ulcerative colitis

1352

9823

1.42

29.95

9.4

9.1

120.72

122.64

g/l

2.87

1320

9595

Sequelae of injuries of lower limb

559

3398

1.74

29.86

11.1

9.1

119.69

123.27

g/l

3.71

546

3323

malignant neoplasm of male genital organs, including Hilmo

1934

8839

1.36

29.78

7.6

9.9

121.71

125.34

g/l

11.28

1879

8674

Retinal vascular occlusion

844

5672

1.58

29.75

8.3

7.7

118.33

119.90

g/l

1.46

830

5537

Benign neoplasm of brain and other parts of central nervous system

429

2443

1.90

29.59

8.8

9.2

125.01

121.19

g/l

3.91

423

2386

Other congenital malformations of the digestive system, including avohilmo

304

1529

2.13

29.57

12.5

9.9

118.78

121.37

g/l

1.28

297

1495

Other noninfective disorders of lymphatic vessels and lymph nodes

260

1255

2.29

29.44

10.0

9.2

119.94

120.86

g/l

0.30

253

1229

Causalgia

126

437

3.34

29.17

8.1

11.3

125.65

121.67

g/l

1.29

121

431

Retinal vascular disorders

851

5752

1.57

29.11

8.3

7.7

118.23

119.90

g/l

1.62

837

5617

255

4.51

29.01

6.5

8.1

122.06

119.70

g/l

0.55

246

Hypothyreosis and Thyroxine purchase for inclusion criteria

5403

30132

1.19

28.96

8.5

120.84

120.96

g/l

0.15

5276

29458

Cyst of kidney

519

3145

1.79

28.95

10.1

8.8

119.23

121.06

g/l

1.27

507

3074

Diseases of male genital organs

3280

13387

1.26

28.91

9.9

10.7

124.86

124.58

g/l

0.29

3204

13112

Persons with potential health hazards related to communicable diseases

1698

12696

1.35

28.74

11.5

9.4

120.58

122.89

g/l

5.06

1670

12396

Complications of other internal prosthetic devices, implants and grafts

288

1456

2.17

28.69

12.8

7.1

116.20

120.91

g/l

3.83

280

1412

Diseases of salivary glands

1853

14211

1.34

28.66

9.5

8.5

121.34

121.06

g/l

0.24

1821

13888

Polyuria

1445

10727

1.40

28.56

8.4

8.5

121.05

121.65

g/l

0.54

1420

10464

Abscess of lung

146

561

3.10

28.54

11.4

8.3

115.89

122.05

g/l

2.97

141

551

Malignant neoplasm of liver and intrahepatic bile ducts

249

1202

2.32

28.54

12.6

7.7

115.73

122.16

g/l

5.06

241

1182

Hepatocellular carcinoma

196

862

2.62

28.52

13.8

8.0

116.23

122.53

g/l

3.79

191

846

Chronic sinusitis

2410

19078

1.29

28.48

8.8

123.41

120.97

g/l

7.45

2357

18650

5-aminosalicylic acid

1091

7700

1.46

28.46

9.7

9.0

120.96

122.63

g/l

1.94

1065

7517

Urticaria and erythema

1899

14610

1.33

28.33

9.3

8.7

121.63

121.11

g/l

0.52

1844

14285

malignant neoplasm of male genital organs

1892

8707

1.35

28.29

7.5

9.9

121.78

125.27

g/l

10.19

1841

8544

Oter anti-inflammatory and antirheumatic agents, non-steroids

1477

5955

1.41

28.21

8.2

9.6

120.24

119.16

g/l

1.16

1453

5817

Abnormal findings on antenatal screening of mother

279

1377

2.10

28.12

4.3

8.7

123.43

120.72

g/l

1.46

269

1341

Brachial plexus disorders

473

2785

1.78

28.07

6.3

9.9

125.73

122.61

g/l

2.55

458

2723

Spondyloarthritis

999

6971

1.49

27.98

8.2

8.7

119.07

121.88

g/l

4.40

983

6807

Any dementia, excluding more controls

2449

13345

1.30

27.94

5.6

7.5

120.05

119.26

g/l

1.13

2393

13046

Use of pramipexole

1364

10079

1.41

27.84

8.0

8.2

120.81

120.21

g/l

0.52

1333

9857

Anaemia in chronic diseases classified elsewhere

201

904

2.55

27.75

12.2

9.6

102.60

122.70

g/l

40.48

193

885

Other bursopathies

807

5430

1.56

27.71

8.7

9.0

122.40

121.12

g/l

1.07

787

5306

Septal defects

342

1802

1.98

27.69

16.8

10.4

121.28

122.46

g/l

0.47

336

1767

Other disorders of bone

1043

7350

1.47

27.67

8.5

9.1

122.26

122.87

g/l

0.42

1017

7178

Irritable bowel syndrome

1374

10122

1.39

27.63

7.6

8.0

123.33

121.39

g/l

3.02

1345

9865

Other enthesopathies

1640

12420

1.36

27.54

7.4

9.1

123.53

121.15

g/l

5.05

1596

12150

Car occupant injured in other and unspecified transport accidents

977

6805

1.49

27.54

9.7

9.0

122.13

122.34

g/l

0.11

949

6644

Sequelae of injuries of neck and trunk

219

1018

2.41

27.48

14.6

10.4

118.62

122.76

g/l

2.26

212

998

Benign neoplasm: Descending colon

512

3138

1.77

27.42

9.3

8.5

119.34

121.30

g/l

1.40

503

3064

Malignant neoplasm of thyroid gland, including Hilmo

392

2209

1.88

27.36

7.8

8.9

124.08

122.10

g/l

1.11

384

2152

Olecranon bursitis

440

2588

1.84

27.21

12.1

10.3

121.59

123.07

g/l

0.73

434

2528

Rheumatism, unspecified

726

4788

1.58

27.18

6.1

8.1

120.33

119.25

g/l

0.82

709

4683

Immunodeficiency with predominantly antibody defects

178

760

2.62

27.12

19.2

10.2

116.81

121.25

g/l

1.83

170

745

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

831

5600

1.54

27.02

7.7

6.9

116.52

121.34

g/l

9.33

808

5479

Gangrene, not elsewhere classified

258

4.35

27.02

10.9

8.0

108.24

119.24

g/l

5.29

249

Overexertion and strenuous or repetitive movements

582

3673

1.67

26.78

12.6

9.3

120.93

123.05

g/l

1.71

577

3592

Non-allergic asthma

523

3218

1.72

26.72

7.8

9.3

124.56

121.66

g/l

2.43

510

3142

Acute appendicitis

3944

30678

1.21

26.70

9.0

9.2

123.46

122.04

g/l

4.23

3859

29975

Unspecified jaundice

338

1845

1.98

26.70

11.2

8.6

114.95

120.82

g/l

5.57

327

1804

Primary biliary cholangitis, wide definition

172

731

2.67

26.69

14.0

7.8

112.35

120.21

g/l

4.54

164

713

Open wound of forearm

594

3770

1.66

26.67

9.0

8.8

120.57

122.50

g/l

1.49

586

3684

Hyperplasia of prostate

2522

11334

1.29

26.66

9.0

10.4

123.50

123.35

g/l

0.12

2459

11124

Multiple myeloma, including Hilmo

316

1696

2.04

26.64

9.0

7.6

107.94

121.63

g/l

26.22

307

1662

Adenocarcinoma and papillary adenocarcinoma of stomach

217

1017

2.38

26.62

10.3

7.2

112.80

121.92

g/l

9.39

212

998

Other skin changes

1265

9303

1.41

26.61

8.2

8.3

119.40

120.46

g/l

1.05

1224

9089

Agoraphobia

158

635

2.67

26.55

18.6

10.3

126.03

123.74

g/l

0.63

151

622

Malignant neoplasm of thyroid gland

361

2005

1.91

26.50

7.7

9.0

124.51

121.99

g/l

1.50

353

1956

Varicose veins

3712

23364

1.22

26.41

7.5

8.1

120.14

120.56

g/l

0.62

3623

22829

Drug-induced neutropenia

457

2738

1.79

26.34

10.5

9.2

111.81

121.10

g/l

18.12

447

2678

Fracture at wrist and hand level

1966

15306

1.31

26.33

9.5

9.4

121.95

122.79

g/l

1.04

1914

14942

Other shoulder lesions

531

3289

1.69

26.11

6.9

9.2

123.58

121.93

g/l

1.01

516

3206

Hallux valgus (acquired)

1809

9973

1.33

25.55

6.9

8.8

120.51

120.00

g/l

0.51

1769

9746

Diseases of appendix

4232

32047

1.20

25.29

9.1

123.39

121.94

g/l

4.68

4140

31318

Appendicitis, broad definition

4195

31873

1.20

25.16

9.1

123.43

121.95

g/l

4.77

4104

31148

Flat foot [pes planus] (acquired)

543

3419

1.67

25.07

7.5

9.6

121.69

120.63

g/l

0.64

530

3342

Abnormal results of function studies

514

3199

1.70

25.03

10.6

8.8

121.18

122.23

g/l

0.51

499

3132

Voice disturbances

1526

11630

1.35

24.97

8.8

8.4

122.05

120.35

g/l

2.95

1499

11365

Sequelae of injuries of head

343

1922

1.92

24.93

15.8

10.1

119.66

124.10

g/l

3.03

331

1880

Crohn disease

683

4531

1.57

24.84

9.9

9.2

120.16

123.00

g/l

3.08

670

4429

Viral warts

541

3410

1.66

24.84

9.5

9.2

119.95

122.56

g/l

2.03

528

3336

Malignant neoplasm of prostate, including Hilmo

1867

8558

1.33

24.78

7.4

9.8

121.75

125.13

g/l

9.55

1812

8401

Evidence of alcohol involvement determined by blood alcohol level

120

445

3.13

24.78

9.4

10.3

127.44

123.41

g/l

1.06

120

436

Other disorders of eye and adnexa

772

5258

1.53

24.74

9.3

8.8

121.47

121.28

g/l

0.09

761

5138

Alzheimer’s disease (Atypical or mixed)

785

5329

1.53

24.61

4.3

6.4

119.54

117.87

g/l

1.52

767

5203

Other disorders of optic [2nd] nerve and visual pathways

396

2323

1.83

24.53

9.9

9.4

120.90

121.37

g/l

0.17

382

2267

Other hammer toe(s) (acquired)

1000

6501

1.45

24.50

7.4

8.3

118.73

119.32

g/l

0.44

975

6355

Other secondary gonarthrosis

365

2103

1.88

24.42

8.3

9.6

119.57

121.32

g/l

0.89

356

2055

Other infectious diseases

487

3021

1.72

24.39

11.6

8.6

116.76

120.82

g/l

4.05

476

2948

Carbimazole or st.post thyroidectomy, condition for graves disease

1089

7918

1.42

24.20

9.9

8.5

122.17

120.56

g/l

1.80

1063

7736

Communicating hydrocephalus

172

770

2.56

24.07

12.1

8.8

122.14

120.56

g/l

0.50

167

755

Type1 diabetes, definitions combined, early onset

250

1255

2.07

24.06

14.2

11.3

120.14

126.12

g/l

3.81

244

1223

Ptosis of eyelid

735

5017

1.55

24.00

9.0

8.5

120.64

120.04

g/l

0.36

723

4894

Polycystic ovarian syndrome, consortium definition

3369

16012

1.22

23.95

7.9

7.4

120.19

118.55

g/l

5.46

3283

15655

Trigger finger

822

5705

1.50

23.95

8.3

9.1

121.54

121.05

g/l

0.29

806

5573

Disorders of optic nerve and visual pathways

518

3266

1.67

23.87

9.3

9.2

120.85

121.87

g/l

0.52

500

3192

Primary hyperparathyroidism

675

4531

1.57

23.85

6.2

8.1

121.98

119.15

g/l

3.19

660

4420

Benign neoplasm: Duodenum

211

1035

2.33

23.72

9.6

8.4

116.75

120.39

g/l

1.72

206

1014

Vitamin B12 deficiency anaemia

656

4377

1.58

23.70

8.2

7.4

113.92

120.84

g/l

15.91

642

4273

Faecal incontinence

534

3399

1.65

23.70

7.6

7.0

118.66

119.21

g/l

0.27

520

3322

Early lumbar disc prolapse, operated

421

2508

1.74

23.66

8.2

11.0

129.74

125.06

g/l

4.33

406

2459

Collagenous colitis

554

3565

1.64

23.63

9.8

8.2

118.56

120.79

g/l

1.72

543

3479

Amenorrhoea

265

1374

2.01

23.48

10.6

9.3

119.53

119.37

g/l

0.05

259

1340

Benign neoplasm: Pituitary gland, craniopharyngeal duct

323

1812

1.92

23.40

9.2

9.4

126.34

122.04

g/l

3.72

311

1767

Acute appendicitis, no complications

2972

24449

1.23

23.38

8.6

9.4

123.91

122.35

g/l

3.90

2903

23870

Other congenital malformations

416

2488

1.75

23.33

12.2

10.0

120.12

122.32

g/l

1.33

405

2433

Malignant neoplasm of prostate

1826

8440

1.32

23.30

7.3

9.8

121.72

125.02

g/l

8.92

1775

8284

Exposure to unspecified smoke, fire and flames

313

3.62

23.29

6.1

12.3

127.59

121.35

g/l

1.75

306

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1877

12779

1.30

23.25

7.0

8.3

119.89

119.45

g/l

0.44

1832

12487

Cardiomyopathy, Hypertrophic obstructive

132

529

2.83

23.20

18.6

7.7

119.19

122.31

g/l

0.80

132

514

Dermatophytosis, including avohilmo

3848

31981

1.20

23.05

8.9

8.8

122.80

121.95

g/l

1.76

3786

31240

Non-small cell lung cancer, adenocarcinoma, helper endpoint

471

2956

1.72

23.00

8.2

8.1

120.00

120.10

g/l

0.04

459

2885

2045

14040

1.29

22.93

6.9

7.1

117.49

119.33

g/l

4.26

2002

13709

Monoamine oxidase A inhibitors

642

4288

1.56

22.83

8.7

8.9

121.31

121.15

g/l

0.07

636

4185

Follicular cysts of skin and subcutaneous tissue

1060

7762

1.41

22.80

9.1

9.2

121.82

121.83

g/l

0.00

1033

7588

Vitamin deficiency

299

1651

1.95

22.73

10.7

8.9

118.80

120.71

g/l

0.78

292

1606

Vitamin deficiency, wide

299

1651

1.95

22.73

10.7

8.9

118.80

120.71

g/l

0.78

292

1606

Glaucoma suspect

2262

18314

1.27

22.72

7.1

8.2

120.64

120.03

g/l

0.75

2187

17910

Persons encountering health services in other circumstances

2229

17784

1.26

22.64

8.4

8.1

121.54

121.85

g/l

0.29

2190

17323

Thrombocytopenia, unspecified

461

2881

1.71

22.50

11.7

9.1

112.50

121.63

g/l

15.74

451

2807

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

294

1603

1.91

22.49

8.5

9.1

122.73

121.47

g/l

0.51

289

1567

Postprocedural disorders of nervous system

326

1845

1.85

22.26

6.3

9.8

124.87

122.71

g/l

1.20

315

1805

Mucosal proctocolitis

664

4485

1.54

22.20

9.9

9.4

119.65

123.65

g/l

5.54

652

4387

Other intracranial haemorrhages

244

1284

2.11

22.14

10.0

7.5

117.71

120.02

g/l

1.03

238

1247

Other/unspecified rheumatoid arthritis

735

5090

1.51

22.09

8.6

7.7

115.08

119.63

g/l

8.39

717

4964

Pregnancy hypertension

1644

11426

1.31

22.08

7.0

8.2

119.91

119.63

g/l

0.23

1603

11159

Covid-19 suspected case

994

7230

1.41

21.79

9.3

8.4

121.80

122.25

g/l

0.30

973

7053

Mental retardation

214

1061

2.15

21.66

10.0

12.1

124.85

122.39

g/l

0.82

209

1040

Ventricular septal defect, a heart condition

124

493

2.75

21.60

25.0

11.3

121.60

121.32

g/l

0.05

124

485

Papulosquamous disorders

2291

18668

1.26

21.57

9.2

8.8

121.49

121.45

g/l

0.03

2246

18259

Diabetic neuropathy

855

6129

1.48

21.55

11.5

10.6

115.79

121.73

g/l

13.25

843

6012

Abnormal blood-pressure reading, without diagnosis

256

1365

2.00

21.48

7.3

8.2

121.23

119.97

g/l

0.45

247

1329

Iridocyclitis

1263

9578

1.36

21.47

8.6

8.8

120.03

121.56

g/l

1.91

1240

9353

Alzheimer’s disease (Late onset), excluding more controls

931

4334

1.45

21.41

5.0

7.0

119.48

117.94

g/l

1.54

916

4227

Personal history of malignant neoplasm

438

2722

1.69

21.38

8.4

7.3

118.56

120.33

g/l

1.33

432

2652

Other follicular disorders

403

2454

1.73

21.37

9.0

9.8

122.81

123.49

g/l

0.27

393

2405

Primary adrenocortical insufficiency

316

3.39

21.34

12.4

9.8

122.52

120.86

g/l

0.33

310

Glaucoma

3608

26030

1.20

21.32

7.2

8.2

119.96

120.28

g/l

0.42

3518

25461

Secondary thrombocytopenia

112

438

3.04

21.30

14.7

8.7

109.85

121.47

g/l

6.75

112

430

Lesion of radial nerve

247

1319

2.04

21.10

10.7

10.1

119.85

121.32

g/l

0.51

241

1285

Paralytic strabismus

446

2814

1.69

21.01

9.5

8.7

120.61

121.01

g/l

0.15

438

2742

Inflammatory disease of uterus

576

3809

1.56

21.01

7.2

7.8

120.79

119.29

g/l

1.15

565

3714

Hypoparathyroidism

242

1290

2.06

20.95

9.3

7.5

117.44

119.17

g/l

0.67

237

1261

Benign neoplasm of urinary organs

324

1889

1.86

20.91

7.2

8.3

122.90

120.55

g/l

1.37

315

1840

Impingement syndrome of shoulder

1366

10517

1.34

20.90

8.2

9.4

124.13

121.45

g/l

4.99

1318

10287

Other specified/unspecified hearing loss

578

3864

1.58

20.90

8.0

8.4

120.80

119.98

g/l

0.47

572

3767

Arthropod-borne viral fevers and viral haemorrhagic fevers

568

3783

1.58

20.88

7.9

9.5

123.51

122.87

g/l

0.28

554

3688

Localized swelling, mass and lump of skin and subcutaneous tissue

1837

14676

1.28

20.72

8.4

8.7

121.04

121.12

g/l

0.06

1807

14345

Barrett oesophagus

354

2124

1.81

20.67

10.6

9.2

118.60

122.90

g/l

3.91

346

2077

Other disorders of veins

2299

18513

1.25

20.59

8.6

8.2

120.00

120.61

g/l

0.75

2269

18095

Mental retardation, wide definition

226

1164

2.06

20.59

9.8

12.0

124.42

122.40

g/l

0.64

220

1139

Urticaria

1451

11251

1.32

20.56

9.5

8.9

122.38

121.28

g/l

1.26

1406

10995

Squamous cell neoplasms and carcinomas of the skin

653

4483

1.53

20.55

7.8

6.7

115.47

121.36

g/l

10.80

635

4386

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1683

13318

1.29

20.54

8.8

9.4

123.39

122.73

g/l

0.66

1651

13003

Dislocation, sprain and strain of joints and ligaments at neck level

735

5138

1.48

20.43

7.8

9.4

125.21

122.85

g/l

2.36

719

5019

Suggestive for eosinophilic asthma

538

3556

1.59

20.41

7.4

9.2

123.65

121.30

g/l

1.82

522

3469

Other and unspecified tonsillitis

1513

9766

1.31

20.40

10.1

10.4

125.96

124.54

g/l

1.73

1479

9535

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1789

14046

1.28

20.37

9.5

9.4

124.59

122.62

g/l

3.74

1755

13707

Alcoholic gastritis

123

513

2.79

20.34

13.1

9.4

121.51

122.76

g/l

0.22

123

504

Non-follicular lymphoma

621

4248

1.55

20.28

10.8

8.4

112.42

120.82

g/l

19.85

604

4149

Secondary and unspecified malignant neoplasm of lymph nodes

482

3116

1.63

20.18

8.5

8.6

114.33

122.54

g/l

13.70

471

3051

Weight loss

629

4308

1.53

20.15

9.6

8.6

118.63

120.47

g/l

1.52

612

4208

Conjunctivitis (acute, non atopic)

1479

11490

1.31

20.09

8.8

9.0

122.36

121.72

g/l

0.56

1449

11226

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2070

19776

0.80

20.07

7.3

8.6

119.72

120.59

g/l

1.27

2011

19326

Viral haemorrhagic fevers, not elsewhere classified/unspecified

466

3003

1.64

19.97

8.0

9.8

124.19

122.79

g/l

0.67

453

2933

Diffuse large B-cell lymphoma, helper endpoint

314

1837

1.84

19.95

11.6

7.8

110.90

122.23

g/l

17.30

305

1799

Diffuse large B-cell lymphoma, including Hilmo

314

1837

1.84

19.95

11.6

7.8

110.90

122.23

g/l

17.30

305

1799

Diffuse large B-cell lymphoma

314

1837

1.84

19.95

11.6

7.8

110.90

122.23

g/l

17.30

305

1799

Generalized epilepsy

215

1109

2.07

19.92

8.3

10.3

123.26

122.72

g/l

0.15

209

1087

Other disorders of central nervous system

356

3.11

19.85

8.0

10.0

121.03

122.42

g/l

0.27

348

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

160

738

2.32

19.83

15.7

11.5

119.66

123.21

g/l

1.16

154

723

Adhesive capsulitis of shoulder

937

6884

1.41

19.79

8.4

9.0

121.06

120.89

g/l

0.09

915

6735

Disorders of speech understanding and production

226

1165

2.03

19.76

10.7

9.2

121.33

121.19

g/l

0.03

217

1139

Behavioural syndromes associated with physiological disturbances and physical factors

5417

32146

1.15

19.70

8.4

9.0

123.14

121.39

g/l

8.13

5325

31394

Pruritus

624

4271

1.52

19.66

9.1

8.0

119.67

120.29

g/l

0.31

608

4163

Gingival hyperplasia

235

1266

2.02

19.62

12.4

10.4

115.75

121.69

g/l

3.72

229

1242

Benign neoplasm: Kidney

252

1400

1.98

19.36

6.7

8.2

123.00

120.11

g/l

1.58

246

1370

Fibroblastic disorders

1386

10800

1.32

19.36

9.2

8.7

119.76

120.95

g/l

1.34

1361

10565

Papillary adenocarcinoma of thyroid gland

267

1496

1.90

19.24

8.9

8.7

123.26

122.04

g/l

0.43

261

1465

Xerosis cutis

142

647

2.51

19.19

6.9

8.7

118.49

121.19

g/l

0.80

137

631

Urolithiasis

1983

16141

1.26

19.15

8.2

8.9

122.36

121.79

g/l

0.60

1936

15777

Irregular menses

2001

12136

1.26

19.14

8.2

7.9

121.47

119.22

g/l

6.22

1950

11863

Autoimmune hepatitis, wide definition

274

1554

1.89

19.13

11.4

8.2

117.00

122.43

g/l

4.01

265

1519

Internal derangement of knee

2021

16271

1.25

19.13

8.8

9.5

122.54

122.07

g/l

0.46

1974

15922

Gout due to impairment of renal function

107

435

2.98

19.13

10.1

8.4

112.92

120.11

g/l

2.69

101

426

Lyme disease

1191

15467

0.75

19.12

7.9

8.9

122.66

121.06

g/l

2.26

1183

15112

Lyme disease, including avohilmo

1191

15467

0.75

19.12

7.9

8.9

122.66

121.06

g/l

2.26

1183

15112

Other (seronegative) rheumatoid arthritis, wide

1074

8112

1.37

19.03

8.8

8.1

116.53

120.08

g/l

7.24

1052

7922

Enthesopathies of lower limb, excluding foot

1165

8874

1.35

19.01

8.3

9.3

123.26

121.07

g/l

3.11

1146

8686

Polymyalgia rheumatica

871

6398

1.42

18.91

7.4

7.3

116.96

119.47

g/l

3.63

858

6240

Biomechanical lesions, not elsewhere classified

326

1955

1.79

18.91

8.2

8.6

121.60

120.75

g/l

0.31

321

1909

Dermatitis due to substances taken internally

315

1863

1.80

18.90

11.0

8.7

119.16

121.37

g/l

1.15

308

1818

Inflammatory diseases of female pelvic organs

2877

16490

1.21

18.89

7.8

7.5

120.56

118.55

g/l

7.36

2817

16114

Redundant prepuce, phimosis and paraphimosis

1215

9181

1.34

18.89

10.1

10.7

124.96

125.31

g/l

0.21

1188

8987

Other peripheral vascular diseases

438

2813

1.63

18.79

6.8

8.1

119.98

121.87

g/l

1.12

427

2746

Injury of nerves and spinal cord at neck level

170

838

2.28

18.73

12.6

9.9

120.26

121.83

g/l

0.44

165

820

Benign thyroid growths and nodules

1826

13690

1.27

18.72

6.9

7.8

120.18

119.08

g/l

1.61

1793

13380

Disorders of vestibular function (Vertigo)

2805

23011

1.21

18.67

7.0

8.2

122.07

120.12

g/l

6.07

2738

22506

Gestational [pregnancy-induced] hypertension

919

6743

1.39

18.67

6.6

8.2

120.56

119.99

g/l

0.39

895

6578

Impotence

403

2564

1.69

18.66

9.2

10.6

124.95

124.04

g/l

0.36

388

2512

Other spirochaetal diseases

1207

15595

0.76

18.64

7.9

8.9

122.69

121.08

g/l

2.31

1199

15237

Vitamin D deficiency

121

515

2.60

18.58

9.5

10.0

121.84

120.87

g/l

0.18

116

501

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

909

4151

1.40

18.51

7.4

8.2

120.15

121.80

g/l

1.64

884

4054

Spirochaetal infections, other/unspecified, including avohilmo

1206

15569

0.76

18.50

7.8

8.9

122.69

121.07

g/l

2.34

1198

15211

Heterophoria

396

2490

1.66

18.44

9.5

9.1

123.92

121.88

g/l

1.20

385

2427

Other and unspecified injuries of lower leg

406

2570

1.65

18.42

9.2

9.3

121.59

122.64

g/l

0.47

397

2519

Haemolytic anaemias

228

1245

1.99

18.33

12.5

9.7

108.00

120.50

g/l

13.93

223

1220

Disturbance of activity and attention

422

2609

1.61

18.33

9.3

10.5

127.88

124.17

g/l

3.36

416

2543

Any event in hilmo or specialist outpatient

+∞

18.30

39.6

0.0

119.64

—

g/l

—

Erythema intertrigo

182

925

2.18

18.28

7.3

8.0

122.98

120.54

g/l

0.78

177

906

2704

20474

1.22

18.26

7.2

7.7

118.74

119.64

g/l

1.60

2630

20033

Malnutrition

156

750

2.32

18.21

16.1

9.1

114.05

120.01

g/l

2.77

150

733

Other spirochaetal diseases, including avohilmo

1227

15773

0.76

18.21

7.8

8.9

122.71

121.09

g/l

2.37

1218

15412

Calculus of kidney and ureter

1815

14728

1.26

18.09

8.2

9.0

122.57

121.79

g/l

0.87

1770

14402

Myocardial infarction, unclassifiable

1434

10107

1.31

18.08

9.0

7.3

119.13

119.76

g/l

0.52

1394

9877

Diabetic retinopathy, strict definition

1156

7913

1.36

18.08

14.1

10.4

113.17

122.75

g/l

44.40

1132

7753

Other specified/unspecified systemic involvement of connective tissue

317

1906

1.77

17.96

9.5

8.5

119.28

120.16

g/l

0.34

309

1863

Specific development disorders of speech and language

272

1501

1.83

17.86

10.1

9.9

121.47

122.25

g/l

0.23

263

1466

Other obstetric conditions, not elsewhere classified

935

4328

1.38

17.75

7.5

8.2

120.16

121.84

g/l

1.76

910

4230

Spondylopathies in diseases classified elsewhere

105

435

2.81

17.69

8.0

8.6

112.44

119.84

g/l

3.34

430

Superficial injury of forearm

520

3506

1.54

17.66

8.4

9.2

123.35

122.87

g/l

0.21

510

3421

Hyperkinetic disorders

448

2832

1.58

17.62

9.2

11.0

127.78

124.23

g/l

3.30

442

2760

Speech disturbances, not elsewhere classified

562

3871

1.53

17.60

9.8

8.2

123.51

120.23

g/l

3.78

554

3781

Multiple myeloma and malignant plasma cell neoplasms

330

2032

1.76

17.57

8.9

8.0

108.14

120.69

g/l

24.46

321

1983

Diseases of inner ear

3255

26684

1.19

17.55

7.2

8.4

122.18

120.46

g/l

5.52

3174

26109

Acquired absence of organs, not elsewhere classified

101

412

2.84

17.50

9.9

8.6

117.67

121.28

g/l

0.89

101

402

Other disorders of bladder

738

5341

1.44

17.48

8.4

8.6

121.39

121.66

g/l

0.13

724

5204

Non-small cell lung cancer, squamous

305

1833

1.77

17.34

8.1

7.2

120.73

121.62

g/l

0.33

298

1800

Fissure and fistula of anal and rectal regions

1253

9768

1.31

17.29

9.2

8.5

121.71

122.58

g/l

0.80

1225

9534

Other general symptoms and signs

241

1334

1.87

17.26

11.9

9.0

120.20

122.26

g/l

0.86

236

1303

Diabetic maculopathy

850

5975

1.41

17.24

11.8

10.6

112.63

122.54

g/l

34.70

831

5853

Superficial injury of ankle and foot

579

4000

1.49

17.21

10.1

9.2

123.06

123.09

g/l

0.01

571

3908

Injuries to the wrist and hand

5920

34927

1.14

17.13

9.4

8.8

122.79

121.46

g/l

5.14

5801

34131

Hemiplegia

291

1733

1.78

17.11

11.1

8.9

123.59

120.77

g/l

1.61

286

1692

Malignant neoplasm of breast, ER-negative, including Hilmo

960

6755

1.36

16.99

7.2

7.1

117.45

119.81

g/l

3.83

947

6591

Wet age-related macular degeneration

1164

8723

1.33

16.92

7.0

6.9

117.25

118.48

g/l

1.36

1139

8505

Abnormal weight loss

576

4019

1.50

16.89

10.0

8.5

119.16

120.60

g/l

0.98

561

3925

Salpingitis and oophoritis

810

5963

1.40

16.83

9.1

7.8

119.63

118.61

g/l

0.86

789

5815

Normal-pressure hydrocephalus

336

2106

1.72

16.73

4.2

7.3

124.53

119.51

g/l

4.92

329

2054

Non-Hodgkin lymphoma, all

284

1698

1.79

16.69

12.3

7.8

108.83

121.38

g/l

19.49

275

1665

IBD patients in KELA-register

1124

8697

1.32

16.43

9.3

9.5

121.02

123.22

g/l

3.01

1098

8498

Epidural haemorrhage

253

3.26

16.41

13.3

9.5

123.97

121.96

g/l

0.32

246

Polyarthritis, unspecified

224

1257

1.92

16.39

9.0

9.7

117.75

122.16

g/l

2.49

218

1229

Vascular dementia (mixed)

163

833

2.19

16.36

6.8

7.0

119.62

117.96

g/l

0.47

157

813

Thyrotoxicosis

1302

10278

1.30

16.35

9.9

8.1

121.14

119.93

g/l

1.33

1276

10040

Right bundle-branch block

215

1189

1.93

16.35

13.8

7.7

121.43

121.79

g/l

0.09

210

1159

Psoriasis

1581

12771

1.27

16.34

9.6

9.1

121.91

121.97

g/l

0.04

1554

12482

Thyroiditis, ILD-related definition

546

3776

1.50

16.30

9.7

8.5

120.99

120.34

g/l

0.33

536

3686

Other hearing loss

1779

14100

1.25

16.29

7.4

7.8

119.69

119.58

g/l

0.08

1736

13777

Acute and subacute iridocyclitis

1017

7789

1.34

16.27

8.6

8.9

119.88

121.66

g/l

2.02

997

7607

Keratitis

1950

16100

1.23

16.16

8.7

8.9

121.21

121.69

g/l

0.46

1911

15720

Panniculitis affecting regions of neck and back

208

1143

1.95

16.16

10.3

9.3

121.37

121.13

g/l

0.06

202

1121

Other Crohn's disease

350

2210

1.66

16.16

9.3

9.2

118.36

124.53

g/l

6.55

344

2161

Pleural plaque

625

4473

1.47

16.13

6.9

7.5

124.90

119.90

g/l

7.44

612

4368

Intussusception

139

668

2.28

16.09

7.4

8.6

119.02

119.60

g/l

0.12

129

651

Any dementia

2627

15384

1.21

16.06

5.5

7.5

119.89

119.14

g/l

1.12

2565

15041

Multiple myeloma

194

1054

2.02

16.03

7.9

7.2

105.22

120.60

g/l

20.72

186

1036

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

194

1054

2.02

16.03

7.9

7.2

105.22

120.60

g/l

20.72

186

1036

Convergence insufficiency and excess

305

2.94

16.02

6.1

8.6

123.29

120.76

g/l

0.50

298

Abnormal findings on diagnostic imaging of central nervous system

275

1645

1.77

15.90

10.8

9.2

123.32

121.89

g/l

0.58

270

1612

Necrosis of pulp, including avohilmo

3117

26491

1.18

15.88

9.5

9.3

123.12

122.40

g/l

1.16

3042

25880

Neovascular glaucoma

259

1533

1.81

15.82

8.5

8.4

115.82

120.70

g/l

3.21

254

1495

Anterior Iridocyclitis

1071

8294

1.33

15.79

8.6

8.9

119.95

121.71

g/l

2.08

1050

8103

Other epidermal thickening

272

1630

1.78

15.78

8.8

9.9

120.52

121.29

g/l

0.23

264

1591

Symptoms and signs involving emotional state

165

846

2.09

15.74

9.6

9.5

124.74

121.52

g/l

1.29

165

826

Trigeminal neuralgia

323

2019

1.69

15.71

7.2

9.2

123.45

120.20

g/l

2.28

316

1972

Adenocarcinoma of pancreas

197

1083

1.98

15.62

8.6

7.7

113.52

121.16

g/l

7.14

192

1063

Seborrhoeic keratosis

1492

12051

1.27

15.62

7.3

8.1

120.20

120.62

g/l

0.35

1461

11759

Acute suppurative otitis media

1046

7495

1.32

15.58

10.2

9.8

123.81

123.76

g/l

0.02

1027

7308

Benign paroxysmal vertigo

1694

13866

1.25

15.57

7.0

8.1

121.92

119.78

g/l

4.66

1659

13540

Viral warts, including avohilmo

1061

8208

1.32

15.55

8.8

9.3

121.73

122.41

g/l

0.48

1039

8015

Cerebral palsy

362

2.72

15.53

8.8

12.6

123.90

122.98

g/l

0.15

351

Pure hyperglyceridaemia

149

746

2.19

15.52

15.3

8.8

125.25

122.77

g/l

0.66

149

729

Thyrotoxicosis, other and/or unspecified

1020

7863

1.33

15.46

10.6

8.2

121.12

120.09

g/l

0.86

999

7682

Cluster headache, strict, including avohilmo

249

1461

1.80

15.36

8.5

10.7

126.16

123.78

g/l

0.95

244

1433

Cluster headache, wide,, including avohilmo

266

1591

1.76

15.30

8.2

10.4

125.88

123.74

g/l

0.87

261

1560

Sequelae of injuries of upper limb

528

3685

1.49

15.28

9.7

9.5

121.67

123.36

g/l

1.05

510

3602

Dislocation, sprain and strain of joints and ligaments of thorax

207

1158

1.91

15.27

6.5

10.0

125.32

122.21

g/l

1.23

202

1136

Paraplegia, diplegia of upper limbs

150

760

2.18

15.26

11.5

9.5

120.97

121.14

g/l

0.03

143

745

Acute generalized exanthematous pustulosis

257

1531

1.79

15.23

11.6

8.9

118.26

120.50

g/l

1.01

251

1499

Malignant neoplasm of breast, HER-negative

883

6414

1.36

15.18

7.2

7.1

117.46

119.69

g/l

3.19

870

6254

Other specified/unspecified dorsopathies

199

1103

1.93

15.10

10.8

9.1

118.86

120.61

g/l

0.64

194

1082

Crohn's disease NAS

329

2083

1.66

15.10

8.5

9.3

119.70

123.81

g/l

3.26

322

2036

Erectile dysfunction

539

3813

1.50

15.10

18.8

9.0

121.97

121.75

g/l

0.09

517

3729

Skin changes due to chronic exposure to nonionizing radiation

2546

19636

1.20

15.07

7.2

7.6

118.66

119.55

g/l

1.52

2473

19213

Lichen simplex chronicus and prurigo

372

2433

1.61

15.04

10.4

8.5

118.74

121.84

g/l

2.13

362

2373

Nail disorders

452

3071

1.54

15.03

9.7

9.4

119.35

122.67

g/l

2.72

443

3005

Persistent delusional disorders

427

2873

1.56

15.02

9.3

8.8

123.00

121.71

g/l

0.63

418

2809

Dislocation, sprain and strain of joints and ligaments of knee

3134

24461

1.17

14.96

8.4

9.2

125.13

122.59

g/l

9.70

3062

23892

Excessive, frequent and irregular menstruation

1681

7275

1.25

14.93

8.3

8.0

119.78

117.79

g/l

4.00

1643

7107

Inflammatory bowel disease, strict (require KELA)

1124

8811

1.30

14.90

9.3

9.5

121.02

123.14

g/l

2.83

1098

8610

Acute pharyngitis

660

4737

1.41

14.88

9.6

10.2

125.17

124.03

g/l

0.70

649

4646

Hypertrophic disorders of skin

272

1648

1.73

14.81

8.7

9.1

120.33

122.08

g/l

0.75

267

1609

Other/unspecified synovitis and tenosynovitis

591

4225

1.45

14.81

8.5

8.9

119.96

121.30

g/l

0.86

581

4125

Actinic keratosis

2482

19234

1.20

14.73

7.2

7.6

118.45

119.55

g/l

2.08

2410

18824

Liposarcoma, including Hilmo

349

2.86

14.73

10.7

7.6

117.22

124.44

g/l

2.96

343

Lack of expected normal physiological development

197

3.07

14.68

19.6

12.4

122.38

123.87

g/l

0.19

192

Panhypopituitarism

128

623

2.30

14.65

14.1

10.3

125.53

122.29

g/l

1.02

120

611

Ocular pain

425

2864

1.54

14.64

8.2

9.1

122.58

121.51

g/l

0.54

420

2800

Pre-eclampsia or eclampsia

824

6202

1.36

14.62

6.8

8.2

118.30

119.47

g/l

0.97

798

6051

Other disorders of binocular movement

124

590

2.27

14.59

8.0

9.2

123.05

121.49

g/l

0.38

119

577

Other neurotic disorders

281

1738

1.72

14.48

7.5

9.0

123.24

121.93

g/l

0.48

273

1697

Pre-eclampsia

747

5552

1.37

14.41

6.7

8.3

118.37

119.75

g/l

1.14

722

5417

Herpesviral [herpes simplex] infections

594

4273

1.44

14.40

8.7

8.8

119.22

121.50

g/l

2.00

585

4169

Meralgia paraesthetica

204

1159

1.89

14.40

7.7

10.7

123.74

120.58

g/l

1.44

199

1131

Sleep disorders

5102

31343

1.13

14.35

8.3

8.9

123.32

121.39

g/l

9.12

5009

30602

Chronic tubulo-interstitial nephritis

201

1134

1.88

14.34

7.3

7.6

113.30

120.72

g/l

6.33

194

1111

Pre-eclampsia or poor fetal growth

1075

8365

1.30

14.28

8.0

8.2

118.38

120.15

g/l

2.29

1041

8166

Generalized skin eruption due to drugs and medicaments

225

1317

1.82

14.27

11.9

8.7

117.63

120.71

g/l

1.49

220

1289

Memory loss

558

3999

1.46

14.27

7.4

8.0

119.42

119.22

g/l

0.08

543

3904

Toxic effect of alcohol

138

695

2.18

14.24

11.6

10.6

122.79

122.92

g/l

0.02

138

681

Foreign body in alimentary tract

315

2010

1.66

14.24

10.5

9.6

121.21

121.69

g/l

0.15

309

1962

Acute nasopharyngitis (common cold)

609

4370

1.43

14.23

9.0

10.5

126.17

125.76

g/l

0.17

594

4286

Glaucoma secondary to other eye disorders

260

1587

1.75

14.21

8.5

8.8

115.87

120.63

g/l

3.11

255

1548

Benign neoplasm: Bronchus and lung

105

482

2.50

14.12

9.3

7.7

125.59

120.51

g/l

1.83

105

474

Primary biliary cholangitis (PBC)

138

697

2.17

14.08

14.2

7.3

115.84

119.89

g/l

1.27

130

679

Lactose intolerance, other/unspecified

138

691

2.13

14.08

14.1

9.2

119.98

120.96

g/l

0.23

131

677

Colitis, primary sclerosing, strict definition

275

2.96

14.07

17.0

13.4

117.54

124.48

g/l

1.68

267

Melanocytic naevi

1576

12928

1.24

14.00

8.5

8.9

120.59

121.40

g/l

0.84

1531

12632

Unknown and unspecified causes of morbidity

330

2124

1.61

13.98

6.1

8.5

123.76

122.69

g/l

0.42

325

2076

Hypothyroidism, strict autoimmune, 3 medication purchases required

4622

27583

1.14

13.98

8.1

8.3

120.26

120.66

g/l

0.67

4526

26954

Somnolence

366

2.66

13.96

13.0

9.7

117.77

121.89

g/l

1.00

358

Hyperfunction of pituitary gland

226

1326

1.79

13.91

10.8

9.5

121.21

121.38

g/l

0.04

219

1296

Early lumbar disc prolapse operation

434

2959

1.51

13.89

8.5

10.9

129.80

125.92

g/l

3.30

419

2896

Viral infections of the central nervous system, including avohilmo

396

2664

1.55

13.86

8.7

9.5

122.58

122.41

g/l

0.05

389

2604

Seronegative rheumatoid arthritis

605

4400

1.42

13.81

8.7

8.6

117.31

120.56

g/l

3.84

594

4297

Acute laryngitis and tracheitis

459

3114

1.49

13.71

11.7

9.4

124.49

123.77

g/l

0.29

449

3039

Biological medication for rheuma

799

6054

1.35

13.70

10.1

9.7

120.81

123.29

g/l

2.85

788

5911

Divergent concomitant strabismus

369

2452

1.57

13.67

10.5

9.3

121.83

122.47

g/l

0.23

359

2399

Nummular dermatitis

499

3538

1.47

13.48

9.8

8.9

120.43

121.89

g/l

0.82

489

3456

Degenerative diseases of the nervous system

2407

14786

1.19

13.46

5.4

7.4

119.69

119.13

g/l

0.69

2352

14439

Other and unspecified vascular occlusions

590

4310

1.43

13.46

8.0

7.7

118.62

120.09

g/l

0.98

578

4212

Other factor of the environment

399

2.57

13.43

7.9

8.7

118.69

121.47

g/l

0.61

390

Lactose intolerance

150

787

2.02

13.38

13.6

9.0

120.75

121.11

g/l

0.08

143

769

Any prescribed medicine buy

8.02

13.32

6.9

7.2

121.96

122.67

g/l

0.04

Pedestrian injured in transport accident

376

2530

1.55

13.22

9.3

9.2

120.45

122.33

g/l

1.02

370

2473

Superficial injury of wrist and hand

974

7621

1.30

13.12

9.8

9.4

124.27

122.26

g/l

2.32

956

7441

Chronic rhinitis, nasopharyngitis and pharyngitis

1659

13767

1.23

13.07

9.7

8.9

123.41

120.74

g/l

6.31

1629

13460

Meningitis

266

1663

1.69

13.07

11.0

10.0

120.22

122.49

g/l

1.00

260

1627

Melanocytic naevi of trunk

632

4671

1.40

13.07

8.6

9.1

120.07

122.08

g/l

1.64

617

4566

Burns and corrosions

688

5153

1.37

12.96

10.9

9.9

121.95

123.52

g/l

1.09

674

5033

Metatarsalgia

475

3349

1.47

12.94

8.2

8.8

120.61

121.04

g/l

0.18

462

3273

Other congenital malformations, including avohilmo

562

4072

1.42

12.91

10.9

9.4

120.44

122.39

g/l

1.47

549

3989

Other ulcerative colitis

301

1941

1.63

12.90

9.5

9.3

120.24

123.64

g/l

2.14

292

1900

Need for immunization against other single viral diseases

128

653

2.16

12.87

15.7

10.9

111.27

123.29

g/l

9.27

128

642

Spondylopathies (FG)

628

4640

1.39

12.83

8.0

9.8

121.09

123.05

g/l

1.59

617

4534

Other enthesopathy of foot (+metatarsalgia)

504

3602

1.44

12.69

8.0

8.9

120.68

121.14

g/l

0.21

491

3520

Ovarian dysfunction

243

1481

1.69

12.68

6.5

7.6

124.43

120.38

g/l

2.85

237

1448

Hydrocele

722

5480

1.36

12.66

9.3

9.8

121.58

122.82

g/l

0.78

695

5368

Reactive arthropathies, FINNGEN

349

2331

1.56

12.65

9.7

9.8

119.61

123.14

g/l

2.58

342

2276

Allergic urticaria

380

2581

1.53

12.60

8.4

9.2

121.47

121.37

g/l

0.03

367

2522

Malignant melanoma of skin, including Hilmo

760

5805

1.35

12.59

7.4

8.5

120.92

122.70

g/l

1.63

744

5674

Disorders of refraction and accommodation

1314

10651

1.25

12.56

10.9

9.1

122.59

122.04

g/l

0.44

1293

10403

Benign neoplasm of middle ear and respiratory system

456

3225

1.48

12.56

9.6

9.1

121.59

121.90

g/l

0.12

449

3148

Seropositive rheumatoid arthritis, strict definition

794

6110

1.34

12.52

9.5

8.5

117.61

120.63

g/l

4.17

780

5966

Lateral epicondylitis

643

4792

1.38

12.50

6.5

9.7

126.01

121.91

g/l

5.88

623

4684

Chronic lymphocytic leukaemia

192

1123

1.85

12.48

11.9

7.6

110.53

121.38

g/l

9.40

187

1102

Chronic lymphocytic leukaemia, helper endpoint

192

1123

1.85

12.48

11.9

7.6

110.53

121.38

g/l

9.40

187

1102

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

192

1123

1.85

12.48

11.9

7.6

110.53

121.38

g/l

9.40

187

1102

L01XE Protein kinase inhibitors

323

2147

1.60

12.46

9.1

8.5

118.46

120.84

g/l

1.12

314

2097

Viral infections of the central nervous system

365

2472

1.54

12.44

8.4

9.4

122.34

122.26

g/l

0.03

358

2421

Mental and behavioural disorders due to hallucinogens

112

4.05

12.40

5.5

14.0

130.26

130.77

g/l

0.06

105

Coxibs

1545

6654

1.24

12.33

7.3

9.8

122.65

119.58

g/l

6.52

1512

6495

Reactive arthropathies

437

3065

1.48

12.33

9.9

9.6

119.82

122.71

g/l

2.18

430

2990

1400

10758

1.25

12.31

6.3

6.9

117.63

118.80

g/l

1.52

1371

10503

Insomnia

4932

30829

1.12

12.30

8.2

8.9

123.31

121.38

g/l

8.97

4841

30105

Crushed, pushed or stepped on by crowd or human stampede

328

2170

1.56

12.29

9.4

10.2

122.84

125.03

g/l

1.10

321

2125

Recurrent dislocation of patella

184

1051

1.81

12.28

9.8

10.8

126.44

123.73

g/l

0.98

178

1030

Excessive vomiting in pregnancy

291

1876

1.60

12.16

5.4

8.4

120.94

119.87

g/l

0.46

283

1835

Psoriasis vulgaris

997

7925

1.29

12.10

9.6

9.4

121.83

122.17

g/l

0.20

978

7755

Retinal detachments and breaks

2142

18345

1.19

12.09

8.6

8.3

119.43

121.24

g/l

3.87

2098

17914

Bell's palsy

607

4515

1.39

12.08

9.1

9.2

120.45

121.29

g/l

0.48

597

4409

Psoriatic and enteropathic arthropathies

568

4181

1.40

12.02

8.6

9.8

121.50

122.52

g/l

0.57

555

4084

Other inflammation of eyelid

769

5924

1.34

12.00

7.9

8.8

121.09

120.67

g/l

0.23

755

5782

Other diseases of blood and blood-forming organs

395

2750

1.51

11.89

11.3

9.4

126.94

121.91

g/l

3.18

390

2684

Striking against or struck by other objects

1703

14282

1.21

11.83

9.9

9.7

122.98

123.22

g/l

0.19

1664

13964

Malignant neoplasm of anus and anal canal, including Hilmo

416

2.43

11.82

12.0

7.3

113.27

121.47

g/l

4.10

410

Crohn's disease of large intestine

251

1584

1.66

11.81

10.6

9.3

117.77

123.45

g/l

4.73

245

1553

Infective bursitis

190

1129

1.82

11.71

10.9

10.5

121.16

123.16

g/l

0.65

183

1102

Embedded teeth, including avohilmo

331

2212

1.54

11.70

8.8

9.7

119.74

123.57

g/l

2.77

316

2167

Isolated patent ductus arteriosus

186

3.10

11.69

14.6

16.3

121.72

120.28

g/l

0.15

181

Perforation of oesophagus

184

3.42

11.64

23.6

7.7

116.67

119.32

g/l

0.31

179

Open wound of shoulder and upper arm

123

640

2.08

11.54

8.7

9.8

119.92

122.66

g/l

0.72

118

625

Mouth breathing

2173

18664

1.18

11.50

8.9

9.7

124.93

122.57

g/l

5.97

2122

18244

Nontoxic multinodular goitre

1027

8248

1.28

11.44

6.5

7.4

119.99

118.73

g/l

1.29

1009

8054

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

760

5875

1.32

11.43

9.0

9.7

121.24

123.27

g/l

1.95

741

5742

Malignant melanoma, including Hilmo

905

7165

1.30

11.38

7.6

8.3

121.08

122.63

g/l

1.51

884

7005

Contact with heat and hot substances

279

1825

1.60

11.29

9.6

10.3

119.67

123.21

g/l

1.92

272

1788

Other and unspecified urticaria

886

6999

1.29

11.18

10.3

8.7

122.27

121.38

g/l

0.65

856

6836

Other diseases of peritoneum

242

1541

1.66

11.16

7.1

8.4

119.72

120.13

g/l

0.12

232

1507

Burns and corrosions of external body surface, specified by site

538

3978

1.39

11.15

10.4

9.8

121.59

123.35

g/l

1.06

526

3886

Peritonsillar abscess

965

7705

1.28

11.08

9.7

9.6

123.44

122.48

g/l

0.75

947

7531

Speech therapy

1428

11904

1.23

11.07

9.4

8.5

119.28

120.58

g/l

1.67

1391

11639

Hypertension, portal

120

4.15

11.03

20.9

10.0

107.84

122.29

g/l

3.33

115

Adalimumab

447

3210

1.43

11.01

9.3

9.9

121.80

123.93

g/l

1.30

440

3141

Personal history of medical treatment

318

2.56

10.94

14.7

8.4

116.41

119.54

g/l

0.64

310

Carcinoma in situ of other and unspecified genital organs

115

597

2.09

10.92

5.9

7.6

121.02

118.34

g/l

0.81

115

585

Tuberculosis, IBD comorbidity

398

2818

1.47

10.90

8.7

7.4

118.88

120.12

g/l

0.56

386

2757

Acetic acid derivatives and related substances

1537

6602

1.22

10.89

7.5

9.8

122.00

119.55

g/l

4.49

1511

6443

Disease of hard tissues of teeth, NOS

3104

14298

1.15

10.75

8.3

122.58

121.38

g/l

2.48

3040

13966

Vascular dementia

594

4328

1.37

10.75

6.0

6.6

118.66

117.60

g/l

0.64

576

4229

Malignant melanoma

806

6340

1.31

10.75

7.7

8.4

121.03

122.55

g/l

1.34

789

6196

Occupational exposure to risk-factors

209

1303

1.72

10.74

5.6

9.9

129.00

122.40

g/l

4.20

202

1274

Other and specified injuries of hip and thigh

139

775

1.93

10.61

6.8

8.7

119.66

121.21

g/l

0.43

132

760

Sicca syndrome [Sjögren]

420

3015

1.45

10.57

8.6

8.0

117.18

119.02

g/l

1.23

409

2942

Restless leg syndrome

748

5847

1.32

10.52

7.9

8.6

121.52

120.75

g/l

0.50

736

5704

Erosion of teeth , including avohilmo

1210

9959

1.23

10.47

11.7

9.1

121.66

122.57

g/l

0.79

1190

9712

Tumor necrosis factor alpha inhibitors

688

5311

1.32

10.44

10.1

9.7

120.78

123.51

g/l

2.93

678

5184

Giant cell arteritis

264

1755

1.60

10.29

7.7

7.6

118.11

119.05

g/l

0.35

257

1713

Coarctation of the aorta

270

2.63

10.26

24.0

12.1

118.50

124.37

g/l

1.41

263

Thyrotoxicosis with toxic multinodular goitre

333

2313

1.51

10.23

8.1

7.7

120.37

118.81

g/l

0.74

328

2259

Corneal ulcer

919

7379

1.27

10.21

8.3

9.0

122.31

122.15

g/l

0.08

899

7209

Rash and other nonspecific skin eruption

487

3602

1.40

10.18

9.8

8.8

118.86

120.51

g/l

1.05

481

3521

Tuberculosis, wide

407

2940

1.44

9.97

8.7

7.5

118.79

119.94

g/l

0.50

395

2874

Convalescence

256

1690

1.58

9.95

18.0

7.7

116.28

122.40

g/l

4.98

246

1656

Rare circulating lymphoid malignancy, including Hilmo

164

977

1.79

9.93

10.2

9.2

111.87

122.34

g/l

6.68

158

962

Malignant melanoma of skin

620

4773

1.34

9.85

7.4

8.5

120.96

122.83

g/l

1.51

609

4669

Tuberculosis, wide, including avohilmo

411

2983

1.43

9.80

8.7

7.5

118.87

119.95

g/l

0.46

399

2916

Injury of muscle and tendon at shoulder and upper arm level

2119

18445

1.17

9.76

7.9

9.3

123.13

122.38

g/l

0.92

2063

18045

Diabetes mellitus in pregnancy

953

4852

1.26

9.75

7.2

9.1

120.54

121.04

g/l

0.32

925

4745

Benign neoplasm of ovary

795

6318

1.29

9.75

7.3

7.4

118.14

118.24

g/l

0.06

782

6171

Other benign neoplasms of skin

2069

17967

1.17

9.74

7.6

8.2

120.50

120.52

g/l

0.02

2015

17555

Non-small cell lung cancer, squamous, helper endpoint

305

2106

1.52

9.69

8.1

7.6

120.73

119.93

g/l

0.30

298

2064

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

834

6668

1.28

9.63

9.3

9.7

121.17

123.22

g/l

2.16

814

6515

Background retinopathy and retinal vascular changes

134

764

1.90

9.62

13.6

9.0

114.29

120.68

g/l

2.61

127

752

Fitting and adjustment of other devices

1514

15682

0.84

9.58

6.8

7.5

120.39

121.19

g/l

0.81

1483

15349

Lifestyle-related condition

364

2.35

9.58

8.1

8.5

117.44

121.57

g/l

0.99

355

Entropion and trichiasis of eyelid

525

3981

1.37

9.53

7.8

7.6

118.13

119.34

g/l

0.73

517

3883

Crohn's disease of small intestine

323

2254

1.48

9.50

9.2

9.3

120.70

123.67

g/l

1.72

318

2207

Bacterial, viral and other infectious agents, including avohilmo

437

3213

1.40

9.49

12.5

10.1

120.51

124.44

g/l

3.51

429

3145

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

164

3.22

9.42

12.4

10.0

116.75

122.75

g/l

0.98

158

Pain associated with micturition

612

4736

1.33

9.35

7.2

8.4

120.47

120.98

g/l

0.26

592

4614

Ulcerative colitis (strict definition, require KELA)

771

6131

1.28

9.34

9.1

9.6

121.15

123.21

g/l

2.04

751

5993

Disorders of purine and pyrimidine metabolism

194

2.97

9.30

11.8

9.2

117.88

122.29

g/l

0.69

187

Other benign neoplasms of connective and other soft tissue

492

3702

1.37

9.25

7.6

8.8

122.10

121.79

g/l

0.12

483

3621

Other specified and unspecified retinal disorders

211

1366

1.64

9.24

8.3

8.8

118.23

120.98

g/l

1.19

205

1338

Other noninflammatory disorders of uterus, except cervix

1080

5925

1.24

9.16

6.2

7.8

119.44

117.23

g/l

3.43

1063

5791

Superficial injury of shoulder and upper arm

602

4660

1.33

9.14

6.2

8.8

122.98

122.28

g/l

0.37

591

4551

Coeliac disease

558

4275

1.34

9.13

9.0

8.7

118.71

122.12

g/l

3.58

543

4173

Disorders of vitreous body and globe

3032

25632

1.13

9.02

8.8

8.4

119.81

120.56

g/l

1.27

2965

25084

Bacterial, viral and other infectious agents

408

2994

1.41

9.01

12.5

10.2

120.65

124.41

g/l

3.02

401

2932

Blepharochalasis

1645

14150

1.18

8.95

7.3

8.1

120.81

119.48

g/l

2.01

1606

13815

Other keratitis

542

4149

1.34

8.94

9.5

9.0

120.46

122.44

g/l

1.43

533

4058

Chondrocostal junction syndrome [Tietze]

191

1216

1.65

8.86

7.2

8.9

124.30

120.09

g/l

2.33

186

1190

Isolated proteinuria

159

971

1.74

8.86

10.2

9.3

117.86

121.98

g/l

1.46

159

949

Other and unspecified mononeuropathies, also in other diseases

165

1017

1.72

8.85

8.8

9.3

118.88

120.08

g/l

0.29

160

996

Glucosamine medication

2771

19688

1.14

8.81

7.2

7.9

119.12

119.40

g/l

0.33

2723

19240

Other and unspecified intracranial injuries

169

1049

1.70

8.77

9.9

9.1

120.45

121.78

g/l

0.32

164

1022

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1359

11505

1.20

8.76

8.7

9.5

124.40

122.55

g/l

2.66

1338

11243

Fourth [trochlear] nerve palsy

138

818

1.82

8.72

8.5

8.4

120.60

120.18

g/l

0.09

138

801

Burn and corrosion of trunk

161

989

1.72

8.71

10.2

10.1

121.40

122.18

g/l

0.17

156

971

Bullous disorders

325

2320

1.46

8.69

7.2

8.3

118.14

120.31

g/l

1.10

320

2264

Nontoxic goitre/thyroid nodule

1492

12760

1.19

8.68

6.5

7.7

119.97

118.94

g/l

1.26

1465

12462

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

328

2331

1.45

8.65

9.2

10.3

125.51

124.36

g/l

0.45

322

2283

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

343

2462

1.43

8.59

7.1

8.3

119.52

119.37

g/l

0.05

337

2402

Otitis externa

1148

9607

1.22

8.57

8.1

9.0

122.91

121.64

g/l

1.36

1127

9380

Atopic dermatitis, strict definition with reimbursement

1192

9590

1.21

8.53

8.3

9.3

122.65

122.71

g/l

0.03

1168

9359

Orthopaedic devices associated with adverse incidents

749

0.31

8.52

7.4

7.7

118.48

119.83

g/l

0.17

735

Suppurative and unspecified otitis media

1506

11388

1.18

8.51

9.9

9.2

123.08

122.76

g/l

0.23

1475

11112

Scabies, including avohilmo

607

4740

1.30

8.49

9.1

9.6

125.59

123.60

g/l

1.50

594

4633

Postmenopausal atrophic vaginitis

900

6004

0.80

8.48

6.4

8.0

120.30

117.45

g/l

5.01

892

5870

Maternal care for other conditions predominantly related to pregnancy

629

4798

1.29

8.46

9.1

8.8

120.67

120.51

g/l

0.07

610

4694

Otitis externa, unspecified

541

4175

1.33

8.45

8.0

9.1

123.68

122.26

g/l

0.95

530

4083

Aspergillosis, including avohilmo

318

2.38

8.44

11.2

8.1

117.43

121.37

g/l

0.90

312

Acne vulgaris

254

1720

1.50

8.43

11.2

10.1

123.44

124.56

g/l

0.36

249

1681

Other and/or unspecified nontoxic goitre

408

3032

1.39

8.41

7.0

7.8

119.21

119.08

g/l

0.05

403

2952

Acne

333

2364

1.43

8.40

10.8

10.1

122.72

124.26

g/l

0.66

328

2311

Bronchitis, not specified as acute or chronic

411

3056

1.38

8.34

9.0

9.1

122.44

121.11

g/l

0.63

397

2989

Alzheimer disease

2104

13203

1.16

8.32

4.7

7.0

119.49

118.69

g/l

1.08

2055

12888

Intentional self-harm by jumping from a high place

121

3.24

8.30

27.7

13.5

115.11

124.08

g/l

1.55

115

Lymphoid leukaemia

316

2268

1.46

8.25

11.6

8.9

112.74

120.97

g/l

9.39

307

2216

Achilles tendinitis

508

3905

1.34

8.20

9.0

9.6

125.05

121.28

g/l

3.56

501

3819

Malignant neoplasm of palate

3.94

8.18

15.3

9.4

111.97

123.94

g/l

2.30

conjunctival haemorrhage

430

3242

1.38

8.18

10.3

8.3

118.91

120.67

g/l

1.00

416

3170

Inguinal or femoral hernia, bilateral

634

5032

1.30

8.16

8.6

8.9

122.33

122.52

g/l

0.08

621

4897

Other and unspecified mononeuropathies of upper limb

154

953

1.70

8.09

8.7

11.3

120.86

122.06

g/l

0.28

148

934

Perineal laceration during delivery

261

3032

0.69

8.09

5.9

8.5

119.37

121.59

g/l

1.02

253

2962

Other and unspecified psoriasis

371

2739

1.41

8.09

12.1

9.7

120.89

122.08

g/l

0.51

364

2675

Other disorders of white blood cells

288

2039

1.47

8.07

11.0

9.6

116.92

121.02

g/l

2.50

278

1998

Inguinal hernia, bilateral

624

4952

1.30

8.05

8.6

8.9

122.32

122.60

g/l

0.12

611

4821

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

480

3684

1.35

8.01

9.1

8.9

120.96

121.44

g/l

0.19

475

3603

Pedal cyclist injured in transport accident

1077

9018

1.21

8.00

9.0

9.2

122.13

122.57

g/l

0.30

1047

8809

Colonic or urogenital fistula

1390

11915

1.19

7.89

9.7

8.9

120.99

121.76

g/l

0.73

1360

11641

Other and unspecified erythematous conditions

174

1120

1.64

7.83

8.9

8.8

120.68

120.26

g/l

0.09

169

1095

Ulcerative colitis (strict) with PSC

202

2.63

7.82

17.4

9.6

117.29

125.36

g/l

1.54

194

Lichen simplex chronicus

185

1208

1.61

7.81

10.1

8.7

120.08

122.44

g/l

0.80

178

1179

Calcific tendinitis of shoulder

274

1930

1.47

7.79

6.7

10.2

122.06

121.87

g/l

0.05

267

1887

Hyposplenism

5.42

7.76

20.2

20.4

108.16

123.26

g/l

1.91

Other erythematous conditions

191

1258

1.60

7.75

8.7

8.8

120.10

120.24

g/l

0.03

186

1229

Disorders of vitreous body

2924

25053

1.12

7.69

8.9

8.5

119.73

120.53

g/l

1.35

2859

24521

Temporomandibular joint disorders, including avohilmo

1933

16425

1.15

7.69

6.8

8.8

122.86

121.04

g/l

3.97

1892

16045

Other specified/unspecified bacterial intestinal infections

347

2557

1.41

7.65

9.9

9.1

118.07

121.51

g/l

2.46

340

2497

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

230

1577

1.52

7.65

6.6

10.1

122.48

121.53

g/l

0.28

225

1545

Parkinson's disease, including avohilmo

945

7879

1.23

7.65

6.0

8.0

121.45

119.92

g/l

1.51

916

7702

Melanocytic naevi, other sites/unspecified

403

3035

1.37

7.61

7.9

9.4

120.32

122.12

g/l

0.96

391

2968

Scar conditions and fibrosis of skin

187

1227

1.59

7.59

10.3

9.1

120.03

121.22

g/l

0.37

180

1196

Aspergillosis

312

2.31

7.56

11.3

7.8

117.97

121.53

g/l

0.77

306

Temporal arteritis

221

1515

1.54

7.55

8.0

7.4

118.39

118.92

g/l

0.16

216

1478

Other/unspecified reactive arthropathies

313

2271

1.43

7.55

10.1

9.5

119.70

122.74

g/l

1.89

307

2220

Pediculosis, acariasis and other infestations

293

2103

1.44

7.52

10.8

10.0

122.36

124.06

g/l

0.67

288

2061

Injury of muscle and tendon at wrist and hand level

695

5619

1.27

7.50

9.0

9.9

123.03

123.15

g/l

0.05

680

5487

Perforation of tympanic membrane

493

3827

1.32

7.49

10.1

8.5

120.76

121.71

g/l

0.48

480

3740

Diseases of tongue

313

2274

1.42

7.47

7.3

7.9

119.80

120.81

g/l

0.38

303

2215

Benign lipomatous neoplasm

1557

13527

1.17

7.45

7.9

8.8

123.69

121.07

g/l

5.76

1518

13223

Pedal cyclist injured in other and unspecified transport accidents

539

4235

1.30

7.40

8.9

9.3

122.18

122.94

g/l

0.35

522

4147

Other disorders of patella

728

5910

1.25

7.39

7.6

10.0

123.48

122.26

g/l

0.90

714

5785

Myopia

516

4024

1.31

7.38

12.3

9.1

123.07

123.09

g/l

0.01

507

3932

Degeneration of the brain due to alcohol

147

931

1.70

7.34

12.0

11.1

116.19

121.81

g/l

2.32

147

907

Thyroiditis

317

2314

1.41

7.32

8.5

122.76

120.49

g/l

1.33

309

2267

Disorders of tooth development and eruption

714

4695

1.26

7.32

9.7

8.8

121.65

122.56

g/l

0.57

701

4583

Menorrhagia

1443

6905

1.18

7.31

8.0

119.70

117.63

g/l

3.76

1405

6741

Plantar fascial fibromatosis

451

3469

1.33

7.28

7.7

8.9

121.26

121.09

g/l

0.06

443

3391

Degeneration of nervous system due to alcohol

147

934

1.70

7.25

12.0

10.8

116.19

122.38

g/l

2.73

147

911

Caught, crushed, jammed or pinched in or between objects

256

1807

1.47

7.25

11.0

10.6

126.37

124.48

g/l

0.73

244

1771

Medical abortion

2753

13350

1.13

7.23

7.6

7.5

118.98

118.32

g/l

1.05

2705

13033

Convergent concomitant strabismus

228

1571

1.50

7.23

12.9

10.1

120.70

123.07

g/l

0.91

221

1536

Giant cell arteritis with polymyalgia rheumatica

221

1529

1.53

7.23

8.0

7.4

118.39

119.11

g/l

0.22

216

1492

Other menopausal disorders

874

5884

0.82

7.21

7.3

8.3

119.84

117.84

g/l

2.59

860

5752

Spontaneous rupture of synovium and tendon

429

3291

1.34

7.18

8.3

9.3

123.12

121.05

g/l

1.30

422

3207

Benign neoplasm of mouth and pharynx

558

4429

1.29

7.16

8.9

8.7

120.94

121.39

g/l

0.20

547

4326

Ankylosing spondylitis

395

2993

1.35

7.12

8.6

9.7

120.20

122.50

g/l

1.50

388

2930

Juvenile rheumatoid arthirtis

454

1.93

7.01

10.5

12.6

118.44

122.44

g/l

1.05

446

Pleural plaque with presence of asbestos

454

3540

1.33

6.98

6.1

8.3

125.92

120.32

g/l

6.72

442

3456

Dementia

2720

16754

1.12

6.97

5.6

7.7

120.19

119.40

g/l

1.25

2657

16372

Lesion of sciatic nerve

240

1693

1.48

6.97

6.5

7.4

122.92

119.45

g/l

1.83

235

1654

Impaction of intestines

228

2.46

6.94

12.4

7.2

116.16

121.32

g/l

1.01

221

Hypermetropia

324

2393

1.39

6.92

7.7

8.9

120.80

122.12

g/l

0.57

318

2338

Ganglion

926

7755

1.21

6.88

7.9

9.0

122.46

121.11

g/l

1.15

904

7590

Injury of eye and orbit

652

5280

1.26

6.87

9.9

9.5

124.28

124.09

g/l

0.08

637

5157

Other specified and unspecified disorders of eye and adnexa

188

1267

1.55

6.86

12.9

8.7

118.62

120.76

g/l

0.77

188

1237

Contact with other hot fluids

143

908

1.65

6.78

7.4

10.6

122.05

122.74

g/l

0.15

138

889

Atopic dermatitis, strict definition

1119

9313

1.19

6.77

8.4

9.6

122.54

122.73

g/l

0.11

1097

9103

Hyperkinetic disorders (excl. ADHD)

328

2.07

6.70

7.4

13.6

126.52

126.14

g/l

0.05

319

Seronegative juvenile rheumatoid arthritis

327

2.08

6.69

11.6

10.8

116.05

122.15

g/l

1.69

318

Malignant neoplasm of other and unspecified parts of mouth

214

2.52

6.67

13.4

7.1

112.28

123.55

g/l

3.16

214

Other and unspecified disorders of white blood cells

210

1458

1.51

6.65

10.3

9.6

116.21

120.82

g/l

2.28

203

1429

Other female pelvic inflammatory diseases

655

5327

1.25

6.65

7.9

7.5

121.06

118.55

g/l

2.96

637

5199

Other and unspecified follicular disorders

205

1416

1.51

6.60

8.5

10.3

123.97

123.03

g/l

0.25

199

1390

Unspecified/other endometriosis

300

2161

1.38

6.46

5.3

8.6

123.88

119.11

g/l

4.59

295

2111

Erythema multiforme

121

750

1.71

6.46

8.0

8.7

120.54

120.77

g/l

0.04

115

737

Isolated proteinuria with specified morphological lesion

380

2.04

6.43

7.5

8.0

113.86

121.59

g/l

2.09

372

Polyhydramnios

144

923

1.60

6.40

6.5

8.0

120.31

121.58

g/l

0.30

138

903

Benign neoplasm: Parotid gland

414

3219

1.33

6.39

11.3

8.9

121.42

121.36

g/l

0.02

409

3143

Premature rupture of membranes

398

3678

0.76

6.39

8.1

8.8

121.49

120.87

g/l

0.28

386

3597

Tuberculosis

325

2444

1.37

6.35

9.0

7.6

119.30

119.67

g/l

0.12

317

2387

Other disorders of penis

544

4370

1.28

6.31

10.2

10.7

124.83

124.18

g/l

0.27

531

4281

Crohn disease (strict definition, require KELA, min 2 HDR)

265

1934

1.41

6.18

10.7

9.7

121.29

123.77

g/l

1.05

259

1891

Presbycusis

849

7063

1.21

6.16

6.0

7.0

117.59

118.00

g/l

0.24

819

6900

Tooth eruption problems

447

3379

1.29

6.15

11.3

9.9

119.71

123.23

g/l

3.14

429

3310

Certain zoonotic bacterial diseases, including avohilmo

155

1030

1.58

6.13

7.7

9.0

122.32

121.44

g/l

0.21

149

1007

Psoriatic arthropathies

462

3651

1.29

6.13

9.1

9.9

121.69

122.18

g/l

0.20

452

3568

Hallux rigidus

686

5665

1.24

6.12

8.1

9.0

120.32

120.28

g/l

0.02

672

5545

Herpesviral [herpes simplex] infections, including avohilmo

1104

9486

1.18

6.10

8.1

8.8

120.71

121.43

g/l

0.59

1085

9259

Endometriosis

1387

7005

1.16

6.09

6.9

8.0

119.94

117.77

g/l

4.07

1357

6843

Benign neoplasm: salivary glands, exclude unknown (D119)

452

3577

1.30

6.07

11.0

8.8

121.36

121.47

g/l

0.04

446

3494

Parkinson's disease

891

7556

1.21

6.07

5.9

8.0

121.45

119.89

g/l

1.51

863

7388

Secondary malignant neoplasm of respiratory and digestive organs

107

657

1.74

6.05

6.0

7.3

115.44

121.67

g/l

2.70

102

646

Effects of heat and light

249

2.26

6.00

11.1

10.1

125.47

120.47

g/l

0.83

241

Ulcerative enterocolitis

144

945

1.59

5.98

11.2

9.4

116.55

122.55

g/l

2.85

139

925

Pediculosis, acariasis and other infestations, including avohilmo

715

5929

1.22

5.98

8.9

9.6

124.75

123.12

g/l

1.24

701

5793

Seborrhoeic dermatitis

512

4115

1.28

5.97

8.6

123.38

122.50

g/l

0.42

493

4026

Polycystic ovarian syndrome, broad definition

282

2080

1.37

5.96

7.2

7.5

125.20

120.38

g/l

4.33

276

2030

Palmar fascial fibromatosis [Dupuytren]

853

7213

1.21

5.95

9.0

8.7

119.88

121.18

g/l

1.09

836

7058

Crohn disease (strict definition, require KELA)

268

1973

1.40

5.94

10.6

9.7

121.33

123.88

g/l

1.12

262

1929

Postzoster neuralgia

103

631

1.76

5.92

7.3

7.5

115.21

119.68

g/l

1.60

103

617

UC patients in KELA-register (code 208), prior to 1994

225

1620

1.45

5.90

10.9

9.5

119.07

122.10

g/l

1.35

220

1586

Fall on and from ladder

427

3375

1.31

5.88

9.8

9.6

124.54

122.87

g/l

0.93

419

3300

Other osteochondrodysplasias, including avohilmo

347

2.02

5.88

9.4

10.1

114.69

120.43

g/l

1.60

341

Autoimmune hyperthyroidism

258

1891

1.40

5.87

8.2

7.9

121.64

121.38

g/l

0.07

250

1842

Certolizumab pegol

416

1.89

5.87

12.8

9.5

115.83

121.15

g/l

1.38

407

Preterm labour and delivery

927

7877

1.19

5.87

7.7

8.5

121.19

119.56

g/l

1.96

906

7683

Special screening examination for other diseases and disorders

526

4234

1.26

5.85

10.8

8.1

118.56

122.07

g/l

3.57

511

4123

Nonspecific lymphadenitis

254

1860

1.41

5.85

8.9

9.8

121.26

122.95

g/l

0.70

247

1819

Bacterial meningitis

171

1172

1.53

5.84

11.2

10.4

117.94

122.14

g/l

1.80

166

1147

Deficiency of other B group vitamins

113

709

1.68

5.79

10.3

8.5

117.38

119.98

g/l

0.66

113

697

Hordeolum and other deep inflammation of eyelid

280

2089

1.38

5.76

8.9

9.9

122.96

121.93

g/l

0.35

274

2039

Deviated nasal septum

1792

15979

1.13

5.73

9.4

9.6

124.34

122.37

g/l

3.76

1745

15615

Simple and mucopurulent chronic bronchitis

196

1382

1.47

5.68

7.8

8.5

121.73

119.07

g/l

1.23

191

1353

Migraine without aura, drug-induced

259

2.14

5.67

5.3

10.7

126.19

120.66

g/l

1.17

254

Disorders of synovium and tendon in diseases classified elsewhere

119

761

1.65

5.66

7.4

10.5

125.21

122.87

g/l

0.61

112

739

Effects of foreign body entering through natural orifice

1198

10432

1.16

5.65

9.4

9.8

124.44

123.25

g/l

1.18

1167

10204

Residual foreign body in soft tissue

238

1736

1.41

5.65

8.6

10.5

123.82

123.69

g/l

0.03

233

1696

Acute appendicitis, with complications

972

8339

1.18

5.63

10.0

9.1

122.11

121.95

g/l

0.09

956

8157

Anti-inflammatory and antirheumatic products, non-steroids

1531

6771

1.15

5.59

8.7

9.9

121.67

119.63

g/l

3.11

1494

6611

Nosocomial condition (hospital)

197

2.39

5.54

11.0

7.5

112.76

119.99

g/l

1.63

192

Polypectomy (DHB20)

348

2700

1.33

5.54

8.5

9.7

123.55

122.78

g/l

0.28

333

2639

Dental pulpitis, including avohilmo

4778

28503

1.08

5.54

9.0

9.4

124.44

122.09

g/l

12.01

4672

27856

Haemangioma and lymphangioma, any site

422

3348

1.29

5.51

7.4

9.0

120.23

121.75

g/l

0.80

414

3274

Atrophic disorders of skin

710

5942

1.22

5.50

7.6

8.3

120.05

120.14

g/l

0.04

692

5806

Other disorders of the genitourinary system

618

5114

1.24

5.49

8.8

7.7

118.95

118.77

g/l

0.08

603

4986

Disorders of optic nerve, not elsewhere classified

119

769

1.64

5.49

9.6

8.9

117.43

120.55

g/l

0.82

113

754

Alzheimer disease, including avohilmo

2326

14589

1.12

5.48

4.9

7.2

119.71

118.82

g/l

1.37

2271

14248

Aortic hypoplasia

7.16

5.43

50.6

47.5

115.31

118.58

g/l

0.21

Infections of genitourinary tract in pregnancy

320

2454

1.33

5.34

6.8

8.5

120.65

119.32

g/l

0.61

315

2397

Chromosomal abnormalities, not elsewhere classified

465

1.79

5.33

15.6

12.3

125.11

123.60

g/l

0.24

453

Complications of labour and delivery

2073

12781

0.89

5.31

7.8

8.2

119.65

119.14

g/l

0.58

2029

12489

Toxic effect of other gases, fumes and vapours

174

2.42

5.27

7.9

14.7

132.26

124.56

g/l

1.24

169

Benign neoplasm of major salivary glands

500

4072

1.26

5.27

10.6

8.7

121.14

121.18

g/l

0.01

490

3978

Haemangioma, any site

396

3139

1.29

5.25

7.4

8.9

120.44

121.75

g/l

0.62

388

3068

Myeloproliferative diseases

433

3476

1.28

5.23

9.2

8.4

117.71

121.03

g/l

2.22

426

3395

Respiratory tuberculosis, confirmed and not-confirmed

279

2118

1.36

5.21

9.4

7.9

119.63

119.70

g/l

0.02

271

2072

Respiratory tuberculosis

279

2118

1.36

5.21

9.4

7.9

119.63

119.70

g/l

0.02

271

2072

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

280

2120

1.35

5.21

10.5

9.5

121.27

123.96

g/l

1.27

274

2075

Shoulder region

513

1.77

5.18

9.0

9.1

119.12

121.94

g/l

0.63

504

Lichen planus

655

5484

1.22

5.18

7.6

8.6

120.78

120.42

g/l

0.17

637

5350

Dementia, including avohilmo

2891

18098

1.10

5.17

5.7

7.9

120.28

119.43

g/l

1.46

2826

17705

Endometriosis diagnosis and infertility diagnosis occurring together

325

2508

1.32

5.16

5.8

8.4

120.91

120.41

g/l

0.19

318

2452

Other and unspecified primary disorders of muscles

244

2.17

5.14

8.6

11.0

122.58

121.85

g/l

0.09

239

Other disorders of cornea

481

3909

1.26

5.13

8.5

8.6

120.06

121.39

g/l

0.73

470

3815

Otalgia

365

2870

1.30

5.12

9.1

8.8

123.03

120.65

g/l

1.55

358

2806

Dermatographic urticaria

268

2023

1.36

5.09

7.9

9.3

122.84

121.27

g/l

0.61

258

1978

Other disorders of bone density and structure

114

738

1.61

5.09

7.5

9.8

125.68

121.37

g/l

1.45

114

721

222

2.16

5.05

7.4

11.7

127.33

121.82

g/l

0.87

215

Nonalcoholic steatohepatitis

274

2.05

4.97

9.7

11.3

116.79

123.06

g/l

1.20

267

Chondropathies

669

5626

1.21

4.96

8.1

9.4

123.31

122.50

g/l

0.48

650

5494

Use of antiglaucoma preparations and miotics

425

3427

1.27

4.95

7.7

7.0

118.00

118.86

g/l

0.40

412

3357

Contact with other sharp object(s)

278

2121

1.34

4.92

11.4

10.3

124.13

124.85

g/l

0.21

273

2079

Phantom limb syndrome with pain

3.19

4.90

12.6

8.0

118.36

121.51

g/l

0.27

Inflammatory diseases of prostate (prostatitis)

729

6202

1.20

4.87

8.2

10.2

125.98

123.60

g/l

2.24

702

6083

Excessive attrition of teeth

3023

27613

1.09

4.82

8.8

9.2

123.13

122.02

g/l

2.33

2969

26971

Additional codes for the location of defect, injury or illness

281

2160

1.34

4.82

8.6

9.8

122.21

121.18

g/l

0.36

274

2107

Disorders of conjunctiva

4385

31759

1.08

4.77

8.9

8.8

121.16

121.46

g/l

0.46

4299

31028

Inflammatory disorders of breast

221

1636

1.38

4.76

8.1

7.8

118.94

119.73

g/l

0.25

215

1598

Congenital malformations of spine and bony thorax, including avohilmo

155

2.37

4.71

11.1

12.9

119.41

123.14

g/l

0.54

150

Injury of nerves at wrist and hand level

178

1282

1.44

4.68

11.1

10.9

120.51

123.99

g/l

1.43

173

1254

Hypersplenism

145

2.50

4.66

11.7

11.6

111.44

122.01

g/l

2.01

145

Prepatellar bursitis

233

1755

1.37

4.65

8.3

10.6

123.04

123.43

g/l

0.10

227

1713

Urethritis and urethral syndrome

104

675

1.61

4.65

7.7

10.0

120.26

120.99

g/l

0.15

104

660

Cysts of oral region, not elsewhere classified

285

2208

1.33

4.63

9.3

10.1

123.50

122.76

g/l

0.22

273

2162

Infections with a predominantly sexual mode of transmission

1116

9779

1.15

4.61

10.5

9.0

119.84

122.57

g/l

4.80

1090

9536

Parkinson's disease, strict definition

815

7034

1.18

4.59

6.0

7.9

121.39

119.89

g/l

1.34

790

6884

Visual impairment including blindness (binocular or monocular)

346

2752

1.29

4.54

9.4

7.8

118.99

119.90

g/l

0.39

340

2684

Macular pucker

914

7965

1.17

4.53

8.4

8.2

118.66

120.61

g/l

2.34

896

7781

Bitten or struck by other mammals

462

3785

1.24

4.52

11.6

9.1

121.97

122.83

g/l

0.40

452

3706

Impacted cerumen

435

5303

0.80

4.52

8.9

8.3

121.25

120.44

g/l

0.38

426

5176

Ulcerative colitis (strict definition, all Crohn cases excluded)

615

5180

1.21

4.51

8.9

9.4

121.24

123.44

g/l

1.82

602

5064

Amblyopia ex anopsia

164

1170

1.44

4.51

10.7

9.5

122.92

121.66

g/l

0.31

158

1145

Benign neoplasm: Skin of eyelid, including canthus

787

6777

1.18

4.51

7.8

8.2

119.82

120.05

g/l

0.12

769

6617

Other and unspecified disorders of psychological development

164

2.22

4.49

24.8

15.6

126.75

124.80

g/l

0.19

158

Folate deficiency anaemia

392

1.82

4.38

10.6

9.6

110.33

121.93

g/l

3.42

385

Granulomatous disorders of skin and subcutaneous tissue

117

790

1.54

4.37

9.3

8.8

117.61

120.40

g/l

0.79

117

773

Bicipital tendinitis

236

1801

1.35

4.32

8.3

10.1

125.81

122.69

g/l

1.48

230

1757

L01XX Other antineoplastic agents

312

2475

1.30

4.31

9.3

8.3

113.72

120.42

g/l

6.09

307

2422

Other/unspecified enthesopathies, not elsewhere classified

391

3171

1.26

4.31

7.8

9.0

122.98

121.08

g/l

1.04

381

3092

Exposure to other and unspecified man-made environmental factors

569

1.64

4.29

8.1

10.6

123.88

122.03

g/l

0.33

557

Other abnormal uterine and vaginal bleeding

996

6260

1.16

4.28

7.3

7.7

118.69

117.32

g/l

1.58

971

6113

All dysplastic lesions of the cervix uteri, vagina or vulva

947

8064

1.15

4.28

8.2

8.0

119.01

120.15

g/l

1.09

925

7865

Use of donepezil

992

10740

0.87

4.28

4.2

6.8

121.01

118.25

g/l

4.74

961

10482

Carcinoma in situ, bladder

223

1701

1.37

4.26

7.0

8.6

120.82

121.16

g/l

0.08

216

1661

Urethral stricture

320

2551

1.29

4.23

7.7

9.3

122.76

122.51

g/l

0.07

310

2491

Use of ropinirole

199

1495

1.39

4.21

6.3

9.0

124.39

121.08

g/l

1.52

191

1463

Propionic acid derivatives

1503

6769

1.13

4.21

8.7

9.9

122.08

119.63

g/l

4.28

1469

6609

Exposure to excessive natural heat

3.19

4.18

7.3

9.0

120.42

121.06

g/l

0.04

Superficial injury of neck

516

1.65

4.18

8.8

10.1

121.67

124.54

g/l

0.62

504

Amputation of ankle

4.08

4.17

13.6

9.8

111.50

117.48

g/l

0.51

Burns and corrosions of multiple body regions

277

1.94

4.15

12.1

10.9

122.08

121.70

g/l

0.04

272

Retinal detachment with retinal break

693

5958

1.19

4.12

8.7

119.54

121.67

g/l

1.83

680

5821

Retinal breaks without detachment

617

7225

0.84

4.10

8.8

9.1

120.67

121.52

g/l

0.49

601

7057

Medicines for HER+ breast cancer

1675

14145

1.11

4.09

6.2

7.5

118.17

118.39

g/l

0.21

1637

13839

Foreign body or object entering through skin

280

2201

1.30

4.08

11.0

10.1

122.38

124.57

g/l

1.00

273

2158

Injury of muscle and tendon at lower leg level

744

6433

1.17

4.06

9.4

9.6

124.65

123.11

g/l

1.24

733

6304

Motorcycle rider injured in other and unspecified transport accidents

235

1805

1.33

4.05

13.3

11.1

126.82

126.26

g/l

0.15

228

1772

Demyelinating diseases of the central nervous system

319

2545

1.28

4.04

9.9

9.7

123.25

122.70

g/l

0.21

310

2489

Polyglandular dysfunction

3.08

4.04

11.4

16.9

115.11

120.92

g/l

0.76

APECED

9.04

4.02

14.6

11.3

116.38

125.75

g/l

—

Other disorders of conjunctiva

733

6341

1.18

4.01

9.9

8.4

119.55

120.56

g/l

0.67

711

6188

HSIL lesion of the cervix uteri, vagina or vulva

612

5202

1.19

4.00

8.3

8.0

119.56

120.17

g/l

0.33

599

5075

Use of levodopa decarboxylase inhibitor

792

6899

1.17

4.00

5.9

7.9

121.67

119.73

g/l

1.96

770

6747

Other noninflammatory disorders of vulva and perineum

375

3052

1.25

3.97

8.7

8.1

118.72

117.96

g/l

0.38

369

2981

Nasal polyp

995

8793

1.15

3.96

8.1

9.1

124.51

121.71

g/l

4.14

969

8597

False labour

859

4628

1.16

3.96

5.6

9.3

123.89

120.82

g/l

5.15

833

4523

Other and unspecified bullous disorders

365

1.79

3.93

7.6

8.3

121.70

119.50

g/l

0.37

357

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

329

2654

1.27

3.93

7.8

9.7

124.04

122.15

g/l

0.94

321

2594

Injury of muscle and tendon at hip and thigh level

470

3924

1.22

3.92

10.2

9.7

122.06

123.68

g/l

0.99

461

3836

Rhabdomyosarcoma

6.21

3.91

11.5

19.1

105.60

118.05

g/l

—

Other and unspecified haemorrhagic conditions

512

1.65

3.91

11.4

8.5

113.10

121.14

g/l

2.92

504

Myeloproliferative diseases (CML excluded)

381

3125

1.25

3.89

9.0

8.2

118.86

120.83

g/l

0.87

375

3050

Tetraplegia

270

1.94

3.89

16.4

10.3

117.67

122.75

g/l

1.10

263

Conductive hearing loss, unspecified

383

3139

1.25

3.88

9.2

9.0

119.80

121.39

g/l

0.86

376

3068

Pedal cyclist injured in noncollision transport accidents

500

4201

1.21

3.86

10.3

9.6

122.15

123.27

g/l

0.64

490

4109

Carcinoma in situ of other and unspecified sites

235

1831

1.33

3.86

6.9

8.5

120.61

121.14

g/l

0.14

228

1788

Varus deformity, not elsewhere classified

313

1.83

3.85

10.1

7.7

122.59

121.47

g/l

0.20

304

Other facial nerve disorders

129

914

1.46

3.81

6.0

10.6

126.51

120.27

g/l

3.10

121

896

Single spontaneous delivery

1458

8533

0.89

3.80

6.3

7.8

119.11

117.86

g/l

1.85

1430

8354

Nonsuppurative otitis media

865

6567

1.15

3.79

11.5

9.0

122.75

122.33

g/l

0.24

850

6401

Epidermolysis bullosa

4.65

3.77

19.9

8.5

116.92

119.90

g/l

0.22

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

7.86

3.74

10.0

10.5

133.78

115.65

g/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

198

1511

1.35

3.72

10.3

9.8

119.49

121.30

g/l

0.56

193

1476

Haemorrhage in early pregnancy

922

7889

1.14

3.72

6.0

8.5

121.74

119.42

g/l

3.38

900

7710

Tularaemia, including avohilmo

656

1.55

3.71

6.4

10.4

122.89

121.73

g/l

0.22

643

Vasomotor and allergic rhinitis

1644

14627

1.11

3.68

8.5

9.2

124.17

121.20

g/l

7.31

1609

14298

Diseases of external ear

1853

16992

1.10

3.67

8.0

8.7

122.37

121.31

g/l

1.49

1817

16607

Carcinoma in situ of stomach

4.82

3.66

5.2

7.3

116.58

121.21

g/l

0.39

Female genital prolapse

1283

6396

1.13

3.64

6.1

8.0

119.03

117.47

g/l

2.35

1247

6249

Ectopic pregnancy

602

5160

1.18

3.63

7.1

7.9

120.73

118.97

g/l

1.50

588

5034

Uterine polyps

1230

6434

1.13

3.62

7.6

8.0

119.41

117.57

g/l

2.81

1211

6288

Prolonged pregnancy

266

2862

0.79

3.62

5.5

9.1

119.86

121.03

g/l

0.45

259

2804

Conjunctivitis

3786

28652

1.07

3.61

8.9

8.7

121.40

g/l

0.00

3716

28000

2.77

3.58

15.1

16.9

111.63

126.47

g/l

1.52

Poor fetal growth

305

2453

1.26

3.56

10.9

8.3

118.33

121.07

g/l

1.68

294

2390

Macular hole

315

2564

1.26

3.55

6.8

7.7

119.71

120.02

g/l

0.10

310

2496

Congenital absence, atresia and stenosis of large intestine

5.77

3.55

11.0

19.3

122.00

120.61

g/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

622

5357

1.17

3.52

7.3

7.7

121.77

119.13

g/l

3.22

614

5226

Cardiovascular devices associated with adverse incidents

4.52

3.51

31.8

10.4

117.83

117.77

g/l

0.00

Scleritis and episcleritis

256

2032

1.29

3.49

7.9

9.5

121.89

122.08

g/l

0.05

250

1980

Other vitreous opacities

203

1571

1.33

3.46

6.7

8.8

123.03

121.09

g/l

0.73

197

1535

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

626

5416

1.17

3.46

8.1

9.1

125.38

121.65

g/l

4.45

611

5290

Traumatic amputation of part of head

3.39

3.45

14.1

11.2

125.14

119.96

g/l

0.42

Biological medicines for asthma

632

1.53

3.45

7.2

10.1

132.41

122.74

g/l

5.42

622

Malignant neoplasm of testis

456

1.62

3.42

12.1

13.0

120.99

128.17

g/l

1.90

444

Other and unspecified types of non-Hodgkin lymphoma, hilmo

218

1711

1.32

3.39

10.3

8.2

111.00

120.83

g/l

10.38

209

1668

Struck by thrown, projected or falling objec

235

1856

1.30

3.37

8.0

9.9

125.36

124.64

g/l

0.19

225

1821

Other/unspecified soft tissue disorders related to use, overuse and pressure

128

927

1.42

3.36

9.5

10.6

122.00

122.13

g/l

0.02

123

909

Aphakia

482

1.60

3.35

9.8

8.8

119.07

120.33

g/l

0.18

466

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

6.18

3.35

26.5

4.9

123.63

125.00

g/l

—

Thyrotoxicosis with diffuse goitre

568

4887

1.18

3.34

8.5

8.4

121.15

120.33

g/l

0.43

550

4767

Other disorders of amino-acid metabolism

145

2.19

3.34

15.3

7.2

112.76

121.21

g/l

1.46

140

Beningn neoplasm: Meninges, unspecified

550

1.57

3.33

8.8

7.4

121.93

119.75

g/l

0.49

541

Carcinoma in situ of skin of trunk

192

1489

1.34

3.33

7.8

7.5

117.59

119.74

g/l

0.75

187

1453

Spinal enthesopathy

128

926

1.42

3.31

4.5

5.8

118.67

118.58

g/l

0.02

128

906

Unspecified visual impairment (binocular)

480

1.59

3.22

10.9

10.4

118.23

121.06

g/l

0.60

470

Open wound of wrist and hand

2272

20401

1.08

3.21

10.2

9.5

123.64

123.00

g/l

0.75

2229

19921

Ulcerative rectosigmoiditis

345

2857

1.23

3.20

10.0

9.1

121.51

123.53

g/l

1.06

338

2793

Autoimmune polyglandular failure

3.90

3.20

13.3

24.6

117.58

125.95

g/l

0.98

Postmenopausal bleeding

1273

6021

1.12

3.20

7.0

7.9

119.00

117.32

g/l

2.48

1243

5884

Carcinoma in situ of breast, intraductal

354

2943

1.23

3.18

7.2

7.8

117.66

118.46

g/l

0.38

345

2867

Spasmodic torticollis

138

1025

1.39

3.15

5.8

8.7

124.28

120.56

g/l

1.50

138

1005

Severe mental retardation

2.84

3.14

9.1

16.9

123.13

124.06

g/l

0.05

Use of levodopa decarbox-comt-inhibitor

179

1388

1.34

3.13

4.6

8.2

123.57

120.43

g/l

1.34

173

1355

Mixed conductive and sensorineural hearing loss

621

5419

1.16

3.12

7.6

8.2

120.37

120.03

g/l

0.16

607

5288

L02BA Anti-estrogens

693

6084

1.15

3.12

6.2

7.8

117.82

118.91

g/l

0.97

678

5947

Postpartum care and examination

333

1713

1.23

3.10

6.7

9.3

120.20

122.35

g/l

1.17

321

1678

Disorders of vagus nerve

3.86

3.09

9.7

9.5

119.33

121.00

g/l

0.11

Malignant neoplasm of testis, including Hilmo

533

1.54

3.08

11.2

12.3

119.80

127.31

g/l

2.31

520

Soft tissue disorders in diseases classified elsewhere

5.76

3.06

3.9

11.2

122.75

120.22

g/l

—

Mixed connective tissue disease

543

1.54

3.05

7.8

9.2

118.34

120.43

g/l

0.39

533

Intercostal neuropathy

260

1.81

3.05

6.6

11.2

124.84

120.96

g/l

0.67

254

Osteitis due to dental implant

292

1.77

3.03

11.6

10.0

114.75

120.02

g/l

1.07

287

Rhabdomyosarcoma, including Hilmo

3.20

3.02

10.1

13.6

111.23

122.60

g/l

1.06

Malignant neoplasm of parotid gland, including Hilmo

330

1.70

3.01

6.9

7.6

117.72

122.16

g/l

0.95

324

Vulvovaginal ulceration/inflammation in other diseases

213

1684

1.28

3.00

7.1

7.7

119.73

120.04

g/l

0.09

207

1641

Disorders of orbit

186

1452

1.31

2.99

9.2

9.5

120.18

121.07

g/l

0.24

180

1418

Carcinoma in situ of skin of other and unspecified parts of face

487

4200

1.18

2.96

7.1

6.8

115.65

118.69

g/l

3.31

477

4102

Asphyxiation

4.27

2.95

20.4

8.5

130.20

123.31

g/l

—

Alcohol abuse counselling and surveillance

549

1.52

2.93

9.8

11.6

119.85

124.50

g/l

1.07

538

Alcohol induced polyneuropathy

398

1.63

2.91

13.9

10.0

118.92

121.24

g/l

0.34

391

Polyp of the female genital tract

1276

6565

1.11

2.91

7.1

7.9

118.79

117.58

g/l

1.46

1253

6412

Other contact dermatitis

329

2742

1.22

2.89

9.1

8.6

122.31

122.00

g/l

0.10

315

2676

Short stature, not elsewhere classified

319

1.64

2.89

13.3

18.2

121.87

121.40

g/l

0.05

313

Albinism

7.55

2.89

2.8

14.7

127.50

118.40

g/l

—

Benign neoplasm of eye and adnexa

513

4445

1.17

2.88

8.7

8.4

119.14

120.73

g/l

1.06

498

4341

Localized adiposity

139

2.09

2.87

8.4

11.1

121.33

120.60

g/l

0.07

134

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

2.87

2.86

21.3

20.6

115.27

121.44

g/l

0.58

Diseases of middle ear and mastoid

2646

20261

1.07

2.85

9.5

8.9

122.50

122.17

g/l

0.34

2585

19792

Malignant neoplasm of other and unspecified male genital organs

4.21

2.83

24.7

10.7

113.70

121.94

g/l

—

Endometriosis ASRM stages 1,2

567

4942

1.16

2.82

6.5

8.1

120.92

119.82

g/l

0.73

553

4825

Erythema nodosum

125

932

1.38

2.82

7.1

8.1

117.75

120.36

g/l

0.82

125

912

Guillain-Barre syndrome

571

1.50

2.82

17.4

8.5

118.85

121.73

g/l

0.62

560

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1239

7979

0.91

2.81

7.0

8.9

121.67

119.95

g/l

2.56

1210

7793

Lichen planus, including avohilmo

934

8414

1.12

2.81

7.6

8.7

121.30

120.45

g/l

0.65

910

8225

Cutaneous lupus erythematosus

109

797

1.42

2.81

7.3

8.1

117.19

119.48

g/l

0.70

109

777

Certain conditions originating in the perinatal period

213

1503

1.27

2.81

14.9

11.9

120.60

123.27

g/l

1.07

208

1469

Other superficial mycoses, including avohilmo

414

3529

1.19

2.80

8.3

9.4

124.09

123.47

g/l

0.23

407

3456

Acute mastoiditis

235

1.79

2.80

12.8

9.8

118.30

121.00

g/l

0.44

229

Nonadministration of surgical and medical care

2.85

2.78

8.3

9.1

127.07

118.45

g/l

0.83

Malignant neoplasm of uterus, part unspecified

3.73

2.77

4.7

3.0

110.09

121.76

g/l

1.04

Motor- or nonmotor-vehicle accident in traffic area

191

1.88

2.77

8.6

13.6

127.15

122.66

g/l

0.54

186

Superficial frostbite

222

1.83

2.76

10.6

12.2

125.84

122.51

g/l

0.44

216

Otitis media in diseases classified elsewhere

4.82

2.76

6.8

11.9

129.75

117.95

g/l

—

Cellulitis of external ear

369

1.62

2.75

7.4

9.7

123.63

119.90

g/l

0.74

360

Other congenital malformations of limb(s)

133

2.04

2.74

31.2

10.4

120.12

122.08

g/l

0.18

127

Benign neoplasm: Appendix

387

1.61

2.74

9.6

8.2

122.46

120.38

g/l

0.32

382

Ankylosing spondylitis, ICD10

373

3164

1.20

2.73

8.8

9.9

120.35

123.51

g/l

2.41

366

3096

Congenital malformations of genital organs

276

2257

1.23

2.72

11.0

9.4

121.06

121.55

g/l

0.15

269

2204

Tongue abnormality

284

2356

1.23

2.71

7.1

8.7

119.73

119.97

g/l

0.07

274

2306

Disorders of puberty, all

258

1.71

2.71

11.7

13.7

124.19

123.10

g/l

0.11

249

Supervision of high-risk pregnancy

554

2891

1.16

2.70

6.8

9.9

121.78

121.05

g/l

0.39

540

2838

Torsion of testis

467

1.52

2.66

12.2

13.9

131.23

130.13

g/l

0.15

454

Profound mental retardation

4.06

2.65

18.8

8.7

113.78

126.69

g/l

—

Hypertrophy of tongue papillae

462

1.54

2.65

9.3

9.5

117.46

121.55

g/l

0.84

453

Fetal alcohol syndrome (dysmorphic)

8.22

2.65

31.6

4.6

128.40

125.00

g/l

—

Hypersomnia

421

1.56

2.64

12.2

11.4

126.03

121.48

g/l

0.99

413

Noninflammatory disorders of female genital tract

1577

7288

1.09

2.63

7.3

8.0

119.43

117.77

g/l

2.88

1543

7120

Other and unspecified trigeminal disorders

471

1.52

2.61

9.1

8.1

121.00

119.90

g/l

0.17

463

Delivery

1495

8547

0.92

2.61

6.7

7.8

118.87

117.86

g/l

1.35

1468

8368

Burn and corrosion, body region unspecified

189

1.87

2.59

12.0

9.6

116.24

123.11

g/l

1.19

183

Other and unspecified acne

333

1.61

2.59

9.1

10.5

118.83

123.29

g/l

0.72

325

Melanocytic naevi of other and unspecified parts of face

241

1977

1.24

2.56

7.1

9.0

123.14

121.23

g/l

0.84

236

1936

Episcleritis

210

1698

1.26

2.55

8.1

9.4

122.20

122.33

g/l

0.03

205

1659

Melanocytic naevi of scalp and neck

102

750

1.40

2.55

8.7

9.1

116.75

121.27

g/l

1.34

736

Hereditary retinal dystrophy

466

1.52

2.55

6.1

9.1

120.51

121.76

g/l

0.20

455

Osteomalacia

227

1.77

2.54

6.5

10.6

122.92

121.73

g/l

0.09

222

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

3.30

2.53

10.7

8.5

120.00

127.36

g/l

0.53

Use of rivastigmine

894

8069

1.12

2.53

4.3

6.8

119.94

118.25

g/l

1.87

865

7879

Juvenile osteochondrosis

111

826

1.37

2.53

10.2

11.9

123.17

123.96

g/l

0.14

104

807

Glaucoma, exfoliation

573

5058

1.15

2.52

5.8

6.9

120.13

118.51

g/l

1.29

556

4942

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

155

1.98

2.50

11.6

7.8

118.68

118.67

g/l

0.00

150

Hypertrichosis

424

1.52

2.49

9.4

8.1

125.35

120.05

g/l

1.32

418

Benign neoplasm of bone and articular cartilage

346

2945

1.19

2.47

9.5

122.08

122.91

g/l

0.34

338

2882

Endometriosis of pelvic peritoneum

553

4420

1.15

2.45

6.3

8.9

120.96

118.43

g/l

2.53

540

4315

Benign neoplasm: Skin of trunk

184

1476

1.28

2.44

7.5

9.5

121.54

121.04

g/l

0.12

178

1449

Spinal instabilities

111

834

1.37

2.42

7.8

11.2

121.58

120.80

g/l

0.15

111

818

Other infestations, including avohilmo

666

0.62

2.39

5.2

9.4

121.56

120.95

g/l

0.06

653

Need for immunization against combinations of infectious diseases

5.40

2.39

8.7

5.7

104.17

129.08

g/l

—

Chronic iridocyclitis

208

1699

1.25

2.35

7.6

9.4

120.57

121.28

g/l

0.19

202

1654

Fenamates

703

4279

1.13

2.34

7.3

9.8

120.42

118.90

g/l

1.24

687

4174

Lesion of plantar nerve

257

2146

1.22

2.33

5.5

8.2

123.10

119.32

g/l

2.56

252

2098

Contact with machinery

548

4853

1.15

2.33

8.5

10.2

125.84

123.78

g/l

1.36

533

4746

Unspecific neurodegenerative disorder

2554

16518

1.07

2.30

5.1

7.5

119.98

119.11

g/l

1.44

2492

16154

Thyroiditis, unspecified

426

1.51

2.30

7.9

7.2

119.97

119.73

g/l

0.03

417

Fat embolism (traumatic)

2.49

2.28

13.8

6.2

113.80

120.63

g/l

0.68

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

340

1.59

2.26

8.8

10.2

116.39

119.47

g/l

0.48

334

Colorectal neuroendocrine tumor and carcinoma

420

1.51

2.26

7.2

7.5

116.67

122.83

g/l

1.50

415

Carcinoma in situ of skin

450

3947

1.16

2.25

7.8

7.7

118.44

119.47

g/l

0.51

437

3855

Traumatic amputation of forearm

4.39

2.24

42.9

14.9

108.86

117.85

g/l

—

Family history of certain disabilities and chronic diseases leading to disablement

149

1176

1.29

2.23

10.1

8.1

123.24

123.84

g/l

0.13

144

1144

Outcome of delivery

298

2163

0.84

2.22

7.4

9.7

119.92

121.84

g/l

1.00

292

2121

Drug-induced aplastic anaemia

2.90

2.22

5.8

3.5

107.64

124.98

g/l

1.39

Other lesions of median nerve

127

988

1.32

2.22

6.2

7.9

119.33

119.32

g/l

0.00

121

965

Congenital malformations of eye, ear, face and neck

217

1788

1.23

2.22

10.9

10.0

122.17

122.79

g/l

0.18

209

1749

Lichen ruber planus, wide definition including periferal and oral lichen planus

1088

10005

1.10

2.22

7.6

8.6

121.78

120.37

g/l

1.53

1060

9770

Unspecified drowning and submersion

3.20

2.21

2.0

24.5

137.60

123.87

g/l

—

Other disorders of Eustachian tube

131

1023

1.31

2.21

10.7

9.2

121.74

120.71

g/l

0.23

125

1003

Other inflammation of eyelid, including avohilmo

2001

18800

1.07

2.21

8.4

8.9

122.84

121.28

g/l

3.04

1969

18363

Other and unspecified rosacea

389

3377

1.17

2.20

8.1

8.8

121.34

120.96

g/l

0.13

380

3307

Long labour

566

5397

0.88

2.20

8.8

8.7

118.95

120.86

g/l

1.54

553

5260

Other demyelinating diseases of the central nervous system

125

969

1.32

2.19

15.6

10.6

122.86

123.14

g/l

0.06

120

951

Endometriosis of intestine

283

1.59

2.17

9.0

9.1

121.18

120.24

g/l

0.12

278

Chronic suppurative otitis media

275

2326

1.20

2.16

9.8

8.9

120.43

121.42

g/l

0.34

268

2267

MS-disease / Multiple Sclerosis

245

2053

1.21

2.12

6.7

9.6

124.92

122.67

g/l

1.14

239

2010

Acute poliomyelitis

453

1.48

2.10

5.7

7.3

122.20

120.71

g/l

0.22

444

Hypertrophy of breast in women and men

744

6735

1.11

2.10

8.3

8.8

121.80

120.45

g/l

1.14

731

6576

Interstitial emphysema and related conditions originating in the perinatal period

3.40

2.09

12.0

28.3

113.13

119.42

g/l

—

Caries of enamel

4778

32489

0.96

2.09

9.9

9.0

121.69

122.08

g/l

0.66

4712

31732

459

4054

1.15

2.08

14.5

9.4

112.84

122.36

g/l

14.79

453

3965

Acute poliomyelitis, including avohilmo

454

1.47

2.08

5.7

7.3

122.20

120.63

g/l

0.24

445

Antenatal screening

479

3045

0.88

2.08

6.1

9.9

121.75

120.94

g/l

0.43

473

2991

Periodic paralysis

4.54

2.07

2.8

11.1

121.33

119.31

g/l

—

Stenosis and insufficiency of lacrimal passages

423

3715

1.15

2.06

6.1

8.2

120.05

119.59

g/l

0.19

409

3626

Failed attempted abortion

185

1.72

2.06

4.5

9.3

124.77

119.39

g/l

0.69

179

Pregnancy examination and test

371

1985

1.17

2.06

7.9

9.5

121.29

122.04

g/l

0.30

361

1948

Muscular dystrophy

250

1.64

2.05

4.3

11.1

124.23

121.91

g/l

0.28

244

Crossbite

218

1666

1.22

2.05

14.5

10.8

123.12

122.37

g/l

0.20

210

1635

Familial chondrocalcinosis

0.00

2.04

0.0

6.2

—

117.83

—

Injury of blood vessels at ankle and foot level

2.92

2.04

24.0

7.4

120.40

120.80

g/l

—

Diving or jumping into water causing injury other than drowning or submersion

150

1.85

2.03

15.6

13.5

130.96

126.09

g/l

0.52

145

Arthropathic psoriasis

488

4329

1.14

2.03

9.2

9.4

121.71

122.30

g/l

0.26

479

4228

Carcinoma in situ of skin of eyelid, including canthus

2.24

2.03

3.3

7.9

112.35

118.60

g/l

0.62

Benign neoplasm: Skin of other and unspecified parts of face

491

4361

1.14

2.02

7.1

8.2

121.93

120.35

g/l

0.99

476

4260

Melanocytic naevi of lower limb, including hip

181

1484

1.24

2.02

7.5

10.0

119.24

121.26

g/l

0.63

174

1448

Testicular hypofunction

168

1369

1.26

2.02

12.4

12.1

130.02

127.52

g/l

0.63

162

1340

Flatulence and related conditions

307

1.56

2.01

9.6

8.1

117.65

118.81

g/l

0.13

301

Symptoms and signs involving appearance and behaviour

227

1.66

2.01

4.4

7.9

120.75

120.73

g/l

0.00

220

Sequelae of tuberculosis

644

1.38

2.00

7.9

6.9

120.78

118.48

g/l

0.48

630

Labour and delivery complicated by fetal stress [distress]

468

3448

0.88

1.99

5.6

8.6

120.10

122.02

g/l

1.34

460

3365

Mental and behavioural disorders associated with the puerperium

195

1.69

1.99

6.5

10.3

119.22

119.89

g/l

0.08

190

Pain and other conditions associated with female genital organs and menstrual cycle

678

5111

1.12

1.99

9.1

8.7

121.13

118.68

g/l

2.97

662

4998

Chronic myeloproliferative disease

562

1.42

1.98

9.3

9.1

104.82

120.48

g/l

7.90

550

Otitis media, unspecified

366

2933

1.16

1.96

12.0

10.0

124.63

122.48

g/l

1.20

356

2868

Acquired epidermolysis bullosa

5.31

1.96

3.8

3.2

130.00

125.17

g/l

—

Foreign body entering into or through eye or natural orifice

344

2991

1.17

1.96

9.4

10.1

125.55

123.74

g/l

0.87

339

2925

Injury of muscle and tendon at ankle and foot level

102

785

1.33

1.95

6.4

10.8

125.17

122.76

g/l

0.57

765

HSIL lesion of the cervix uteri

504

4485

1.13

1.94

8.7

8.1

119.63

120.58

g/l

0.52

492

4373

Other maternal disorders predominantly related to pregnancy

2031

11979

1.06

1.91

7.3

8.4

121.08

119.36

g/l

3.74

1976

11723

Other congenital malformations of skull and face bones

2.34

1.91

10.1

25.8

119.46

126.19

g/l

0.61

Pregnancy with abortive outcome

2723

13475

1.06

1.91

7.5

119.24

118.33

g/l

1.71

2671

13156

Q fever, including avohilmo

4.29

1.91

25.8

10.8

115.50

118.67

g/l

—

Persons encountering health services in circumstances related to reproduction

2587

16470

1.06

1.90

10.5

10.3

123.47

123.55

g/l

0.07

2513

16126

Infections with a predominantly sexual mode of transmission, including avohilmo

1424

12164

1.08

1.89

9.7

9.2

121.19

122.73

g/l

2.18

1393

11870

Benign neoplasm: Other parts of oropharynx

313

1.54

1.88

8.1

10.6

122.26

121.03

g/l

0.15

307

Other osteochondropathies

281

2416

1.18

1.87

8.6

10.0

122.31

123.66

g/l

0.52

275

2369

Rat-bite fevers, including avohilmo

3.53

1.86

18.4

8.4

113.71

120.88

g/l

—

Routine general health check-up of defined subpopulation

418

1.44

1.86

9.0

8.0

121.56

122.37

g/l

0.12

409

All dysplastic lesions of the cervix uteri

748

6708

1.10

1.85

8.2

8.1

118.91

120.43

g/l

1.36

731

6543

Sequelae of tuberculosis, including avohilmo

662

1.35

1.84

8.4

6.8

120.77

118.25

g/l

0.55

647

Disorders of amino-acid transport

2.55

1.82

11.7

6.4

121.18

124.19

g/l

0.17

Contact with other specified venomous animals

202

1.67

1.82

12.0

11.2

122.13

122.63

g/l

0.05

197

Oral lichen planus

123

982

1.29

1.82

9.6

9.2

122.87

119.60

g/l

1.10

118

964

Testicular dysfunction

186

1550

1.22

1.82

11.9

129.86

127.51

g/l

0.64

180

1521

Chronic suppurative otitis media, including avohilmo

320

2789

1.16

1.78

9.6

9.3

120.44

121.54

g/l

0.42

312

2721

Hereditary angioödema type 1

3.00

1.78

5.0

8.6

128.50

118.45

g/l

—

Spermatocele

400

3545

1.15

1.78

7.2

10.1

123.88

122.90

g/l

0.39

394

3471

Tinnitus

1154

10749

1.08

1.77

8.9

9.0

122.48

121.02

g/l

1.75

1134

10502

Disorders of optic chiasm

3.70

1.76

8.8

9.7

124.50

122.47

g/l

—

Allergic rhinitis

1143

10497

1.08

1.76

8.3

9.6

124.67

122.27

g/l

3.70

1118

10246

Other appendicitis

350

3077

1.15

1.73

10.3

9.0

123.41

122.61

g/l

0.28

342

3010

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

355

3127

1.15

1.73

6.9

9.1

124.08

121.42

g/l

1.69

343

3055

Psoriatic arthropathies, ICD10

445

3973

1.13

1.73

9.1

9.7

121.77

122.46

g/l

0.30

436

3881

Postpartum haemorrhage

597

5438

0.90

1.72

7.1

8.9

115.56

120.83

g/l

8.86

582

5301

Organ-limited amyloidosis

175

1.70

12.1

7.4

123.39

120.85

g/l

0.24

170

Drug phototoxic response

3.15

1.69

8.4

9.9

119.57

115.19

g/l

—

Other and unspecified disease of Bartholin gland

110

875

1.29

1.68

7.6

8.0

120.18

118.04

g/l

0.60

110

854

Cryptococcosis

4.44

1.67

2.6

18.0

131.40

120.33

g/l

—

Cryptococcosis, including avohilmo

4.44

1.67

2.6

18.0

131.40

120.33

g/l

—

Carcinoma in situ of other/unspecified male genital organs

4.44

1.67

4.6

9.6

120.40

126.07

g/l

—

Foreign body in respiratory tract

205

1737

1.20

1.67

9.6

10.1

124.59

121.03

g/l

1.88

198

1701

Type 1 diabetes, wide definition, subgroup 2

449

0.63

1.66

12.0

6.9

118.10

119.92

g/l

0.18

437

Neurological devices associated with adverse incidents

4.34

1.66

4.0

11.1

126.80

115.07

g/l

—

Disorders of breast

2011

16787

1.06

1.66

7.9

7.5

119.56

118.70

g/l

1.36

1969

16397

Underdevelopment of the second kidney

2.97

1.65

3.0

29.0

110.86

126.00

g/l

—

Ankyloglossia

261

1.52

1.65

17.7

13.0

127.51

123.80

g/l

0.40

252

Primary angle-closure glaucoma

209

1782

1.20

1.63

6.2

8.0

120.02

118.92

g/l

0.32

202

1732

Primary open-angle glaucoma

1764

16080

1.06

1.61

6.8

7.6

119.71

119.33

g/l

0.36

1719

15717

Respiratory and cardiovascular disorders specific to the perinatal period

316

1.44

1.60

18.9

18.8

118.04

120.91

g/l

0.37

311

Other specified transport accidents

177

1.66

1.60

16.5

14.0

119.00

124.55

g/l

0.73

170

297

1.46

1.55

17.8

15.8

119.75

121.69

g/l

0.24

291

Whooping cough

108

1.82

1.55

14.6

8.5

119.68

125.77

g/l

0.40

103

Other psoriatic arthropathies

430

3861

1.13

1.55

8.8

9.7

121.96

122.42

g/l

0.18

421

3772

Squamous cell neoplasms and carcinoma of rectum

2.63

1.54

6.6

8.7

112.44

122.90

g/l

—

Colorectal squamous cell carcinoma

2.62

1.53

6.6

8.7

112.44

122.90

g/l

—

Clubfoot

235

1.54

1.53

14.9

11.3

118.66

124.45

g/l

0.78

228

Malignant neoplasm of meninges

2.98

1.53

4.9

9.4

118.71

125.10

g/l

—

Delivery, wide proxy

1274

7203

0.93

1.53

6.7

7.4

118.05

117.73

g/l

0.24

1247

7038

Acne, including avohilmo

613

4521

1.10

1.53

10.5

9.5

122.81

123.45

g/l

0.33

604

4405

Exposure to vibration

3.69

1.52

3.2

16.4

138.60

115.88

g/l

—

Disorders of puberty

226

1.53

1.52

10.3

14.6

121.74

123.31

g/l

0.15

218

Iridocyclitis in diseases classified elsewhere

657

1.31

1.51

9.2

9.3

121.51

120.44

g/l

0.19

642

Tic and related disorders

194

1.57

1.50

10.0

10.4

120.27

123.30

g/l

0.40

187

Pervasive developmental disorders excl. Autism + Asperger

216

1.54

1.50

6.2

15.4

125.61

122.57

g/l

0.43

207

Q fever

3.87

1.49

18.4

11.4

112.80

116.12

g/l

—

343

1.41

1.49

18.8

16.5

119.10

122.01

g/l

0.44

337

Macrocephaly

3.41

1.48

9.0

17.8

120.80

117.69

g/l

—

Medullary carcinoma of thyroid gland, including Hilmo

2.25

1.47

5.8

8.2

124.36

124.75

g/l

0.02

Polyclonal hypergammaglobulinaemia

2.49

1.46

17.9

12.2

119.22

118.98

g/l

—

Benign neoplasm: Trachea

2.47

1.45

15.4

6.2

120.78

121.31

g/l

—

L02BG Aromatase inhibitors

1335

12435

1.07

1.45

6.4

7.5

118.16

118.20

g/l

0.03

1304

12161

Disorders of male genital organs in diseases classified elsewhere

223

1.55

1.45

11.6

16.1

131.79

125.03

g/l

0.84

215

Allergic colitis

379

1.39

1.44

19.3

11.3

123.69

122.66

g/l

0.13

370

Nonsuppurative otitis media, including avohilmo

1205

9784

1.07

1.44

9.9

9.1

122.84

122.06

g/l

0.67

1187

9540

Dislocation, sprain and strain of joints and ligaments of elbow

229

1985

1.17

1.43

8.5

9.7

123.95

123.00

g/l

0.29

224

1941

Benign leiomyoma with endometriosis

532

5828

0.91

1.43

7.2

7.3

118.25

118.21

g/l

0.02

519

5690

Burn and corrosion of head and neck

698

1.29

1.43

9.3

11.9

125.64

123.61

g/l

0.33

682

hereditary angioödema type 3

3.24

1.41

2.4

7.8

132.20

116.24

g/l

—

Chronic laryngitis and laryngotracheitis

644

5933

1.09

1.39

9.6

8.8

122.74

120.16

g/l

2.65

633

5801

Benign neoplasm: Choroid

303

2690

1.14

1.38

8.7

8.3

119.39

120.47

g/l

0.42

294

2635

Severe bullous disorders, KELA reimbursement

2.01

1.37

6.9

6.5

110.29

118.94

g/l

0.74

Pedal cyclist injured in collision with motor vehicle

119

981

1.23

1.36

7.3

9.6

121.05

122.30

g/l

0.26

114

962

Rat-bite fevers

3.25

1.36

19.0

8.9

115.00

124.33

g/l

—

Complications associated with artificial fertilization

274

1.45

1.35

4.2

9.4

121.23

120.69

g/l

0.06

268

Chorioretinal inflammation

118

974

1.24

1.35

13.2

9.0

120.22

121.42

g/l

0.28

111

951

Chronic diseases of tonsils and adenoids

3619

23611

0.96

1.34

8.7

9.3

124.33

121.42

g/l

13.98

3526

23083

Other disorders of amniotic fluid and membranes

260

2851

0.88

1.33

7.7

9.1

121.46

120.89

g/l

0.19

255

2795

Benign neoplasm: Skin of lip

468

1.35

1.31

7.2

7.8

121.66

119.76

g/l

0.28

457

131

1.69

1.31

9.2

10.2

124.24

124.85

g/l

0.05

125

Other hypersecretion of intestinal hormones

3.23

1.31

26.8

11.8

100.60

123.53

g/l

—

Carcinoma in situ of lip

2.45

1.30

4.4

7.1

120.75

123.19

g/l

—

Malignant neoplasm of parotid gland

280

1.45

1.28

7.4

7.7

117.49

122.93

g/l

0.95

275

Inhalation and ingestion of food causing obstruction of respiratory tract

349

1.39

1.27

14.6

9.7

121.89

120.25

g/l

0.22

342

Other conditions originating in the perinatal period

2.92

1.26

2.0

16.3

120.00

114.47

g/l

—

Other prurigo

375

1.38

1.26

13.1

7.0

119.24

122.16

g/l

0.58

367

Presence of other devices

1111

11582

0.94

1.26

7.7

7.1

120.67

120.64

g/l

0.02

1084

11304

Contact with and exposure to communicable diseases

882

9377

0.93

1.25

8.6

9.6

124.11

123.17

g/l

0.71

858

9150

Medical treatment for female infertility

510

4625

1.10

1.25

6.4

8.3

120.11

121.26

g/l

0.72

497

4503

Sexual dysfunction

604

1.29

1.24

10.4

12.9

123.16

124.37

g/l

0.18

589

Alzheimer’s disease (Late onset)

1363

10644

1.06

1.24

4.4

6.8

119.22

118.13

g/l

1.26

1333

10390

Acute myringitis

206

1.51

1.24

7.7

11.4

124.13

121.16

g/l

0.45

201

Use of apomorphine

2.76

1.23

17.0

8.8

106.14

128.19

g/l

—

LSIL lesion of the cervix uteri, vagina or vulva

408

3703

1.11

1.23

8.6

8.1

117.89

120.35

g/l

1.93

400

3613

Migraine, single triptan purchase ok & required. ICD-code if available is included

3211

22495

0.96

1.22

8.2

9.3

124.20

121.80

g/l

9.33

3153

21974

Triptan medication for migraine, single purchase ok

3211

22495

0.96

1.22

8.2

9.3

124.20

121.80

g/l

9.33

3153

21974

Female infertility

950

5335

1.07

1.22

7.0

8.8

119.99

118.41

g/l

1.75

924

5216

Ankle and foot

266

1.44

1.21

9.9

7.2

120.54

120.68

g/l

0.01

260

Raynaud syndrome

342

3083

1.12

1.21

6.2

9.1

121.69

121.65

g/l

0.01

332

3021

Other nonthrombocytopenic purpura

353

1.38

1.20

3.9

9.5

117.70

121.13

g/l

0.60

345

Polyglandular dysfunction, other/unspecified

2.64

1.20

14.0

8.7

114.29

116.73

g/l

—

Shigellosis, including avohilmo

183

1.53

1.18

9.0

8.4

119.59

121.33

g/l

0.18

177

Chalazion

470

4309

1.10

1.18

8.0

9.2

122.26

121.86

g/l

0.16

456

4208

Meningococcal infection

183

1.52

1.18

15.6

7.4

128.00

125.38

g/l

0.28

177

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

246

2183

1.14

1.17

7.1

7.5

119.98

119.07

g/l

0.31

240

2138

Other peripheral vertigo

415

3790

1.11

1.16

6.8

8.4

122.93

120.21

g/l

2.13

402

3704

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

627

5817

1.08

1.16

9.9

9.0

121.85

123.16

g/l

0.93

611

5675

Unequal limb length (acquired)

167

1.53

1.15

5.4

13.4

122.88

125.41

g/l

0.21

161

Vasomotor rhinitis (mode)

301

2705

1.13

1.15

6.8

9.1

125.16

121.29

g/l

2.65

293

2645

Atypical virus infections of central nervous system

312

1.39

1.15

6.0

8.7

124.48

122.71

g/l

0.20

305

Lichen sclerosus et atrophicus

466

4278

1.10

1.15

6.1

8.1

120.26

119.70

g/l

0.28

455

4170

Subclinical iodine-deficiency hypothyroidism

2.13

1.15

6.0

8.1

131.10

116.85

g/l

—

Other congenital malformations of peripheral vascular system

355

1.35

1.13

19.6

10.6

121.85

121.28

g/l

0.06

348

Other and unspecified injuries of forearm

202

1.48

1.12

17.4

12.4

119.00

123.21

g/l

0.58

196

Other noninflammatory disorders of cervix uteri

155

1792

0.85

1.12

6.4

8.2

119.25

117.74

g/l

0.49

150

1752

Failed induction of labour

126

1066

1.19

1.11

5.0

8.7

120.36

121.27

g/l

0.21

121

1035

Infliximab

501

0.73

1.11

4.7

12.3

121.03

125.98

g/l

1.11

489

Open bite that required surgery (Lefort1 or BSSO)

169

1.51

1.10

3.2

12.1

122.24

121.36

g/l

0.09

164

Varicose veins of other sites

274

2458

1.13

1.10

7.7

9.9

125.19

123.57

g/l

0.60

266

2412

Diastasis of muscle

228

1.44

1.10

9.5

8.8

129.22

120.10

g/l

1.49

223

Crushing injury of ankle and foot

122

1.65

1.09

8.5

8.0

127.21

123.61

g/l

0.33

117

Atypical virus infections of central nervous system, including avohilmo

316

1.37

1.07

6.0

8.7

124.48

122.75

g/l

0.20

309

Peroneal tendinitis

455

1.30

1.07

11.3

10.5

125.24

120.96

g/l

0.78

450

Vitiligo

333

1.35

1.06

6.9

10.2

123.39

122.67

g/l

0.09

326

Other specified/unspecified nutritional deficiencies

205

1.46

1.06

12.1

7.3

118.21

121.50

g/l

0.39

200

Meningococcal infection, including avohilmo

188

1.48

1.06

15.6

7.3

128.00

125.47

g/l

0.27

182

Ovarian hyperstimulation (induction)

272

1.38

1.05

4.4

8.9

120.89

121.76

g/l

0.10

267

Lipodystrophy, not elsewhere classified

2.13

1.04

12.3

5.8

120.43

121.34

g/l

—

Degenerative macular diseases

599

5588

1.08

1.04

7.6

117.87

119.74

g/l

1.51

588

5454

Endometriosis ASRM stages 3,4

803

7556

1.07

1.03

7.3

7.4

118.79

118.98

g/l

0.11

779

7378

Postpartum hemorraghe, parous women as controls

597

5358

0.93

1.02

7.1

7.8

115.56

121.23

g/l

10.12

582

5223

Tuberculosis of nervous system, including avohilmo

1.92

1.01

14.2

10.6

115.56

120.12

g/l

—

Tuberculosis of nervous system

1.92

1.01

14.2

10.6

115.56

120.12

g/l

—

Carcinoma in situ of penis

1.87

1.00

9.7

19.4

119.92

123.73

g/l

0.32

Rheumatic fever without mention of heart involvement

109

1.65

1.00

12.9

8.9

122.06

119.38

g/l

0.25

109

Other porphyria

1.89

1.00

5.0

7.3

127.78

122.82

g/l

—

Benign neoplasm: Liver/bile ducts (ICD-9)

2.49

0.99

5.2

11.0

120.67

119.85

g/l

—

Use of memantine

1629

12582

1.05

0.99

4.4

6.9

120.20

118.26

g/l

3.72

1587

12283

Use of other anti-dementia drugs

1629

12582

1.05

0.99

4.4

6.9

120.20

118.26

g/l

3.72

1587

12283

Neuromyelitis optica

1.87

0.98

4.7

8.9

119.27

122.39

g/l

0.20

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

174

1.47

0.98

7.1

14.5

116.60

126.11

g/l

1.70

167

Subacute thyroiditis

134

1160

1.17

0.96

7.1

8.7

123.22

119.79

g/l

1.19

129

1133

Rosacea

511

4753

1.08

0.96

8.5

8.9

121.13

120.89

g/l

0.09

499

4645

Severe visual impairment, monocular

359

1.32

0.94

4.8

7.1

122.59

121.30

g/l

0.20

352

Scissor bite

494

1.26

0.94

11.9

13.0

119.55

122.96

g/l

0.58

485

Injury of blood vessels at wrist and hand level

246

1.39

0.93

12.5

11.2

117.24

123.41

g/l

0.88

239

Benign neoplasm: Scapula and long bones of upper limb

298

1.34

0.92

4.5

10.2

128.38

121.62

g/l

1.61

290

Adenomyosis (Endometriosis of uterus)

522

4860

1.08

0.92

7.1

7.8

119.49

117.35

g/l

1.95

515

4753

Benign lipomatous neoplasm of other sites/unspecified

385

3553

1.09

0.91

7.9

8.2

122.20

120.69

g/l

0.84

379

3468

Occupant of streetcar injured in transport accident

1.97

0.91

13.3

8.1

114.00

121.67

g/l

—

Embedded and impacted teeth

794

6082

1.06

0.91

8.5

9.7

122.94

124.07

g/l

0.83

771

5941

Malignant neoplasm of placenta, including Hilmo

2.14

0.90

6.3

5.8

126.00

116.40

g/l

—

Vascular dementia (undefined)

191

1686

1.13

0.90

4.7

6.4

117.85

117.11

g/l

0.20

182

1649

Kaposi sarcoma, including Hilmo

1.94

0.90

2.8

7.2

111.50

122.84

g/l

—

Hypertrophy of breast

575

5386

1.07

0.89

8.3

121.89

119.49

g/l

2.53

564

5262

therapeutic use

131

1142

1.16

0.89

11.5

8.0

115.78

120.85

g/l

2.42

131

1115

Noise effects on inner ear

196

1757

1.13

0.87

8.2

10.4

126.89

124.53

g/l

0.84

188

1716

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

1.68

0.85

15.8

7.0

116.54

123.15

g/l

0.55

Benign neoplasm: other/unspecified salivary gland

114

988

1.17

0.85

6.9

8.5

120.18

120.17

g/l

0.00

109

968

Need for immunization against other single infectious diseases

1.99

0.85

8.3

10.4

112.33

122.75

g/l

—

Endometriosis of ovary

609

5392

1.07

0.84

7.8

8.3

118.56

117.79

g/l

0.47

588

5261

Benign neoplasm: Connective and other soft tissue of abdomen

1.64

0.83

12.9

8.7

123.43

121.22

g/l

0.11

Dacryoadenitis

251

1.35

0.83

6.4

9.8

121.36

120.37

g/l

0.11

243

Other deformity of hallux (acquired)

260

1.35

0.82

6.0

7.8

119.50

120.68

g/l

0.11

255

Vestibular neuronitis

386

3582

1.09

0.82

7.8

8.9

122.08

121.37

g/l

0.30

376

3496

Blepharospasm

331

1.31

0.82

5.8

9.8

127.79

120.55

g/l

1.49

324

Carcinoma in situ of bronchus and lung

1.87

0.82

11.4

117.67

119.91

g/l

—

Merkel cell carcinoma of skin

1.88

0.82

5.0

5.7

122.56

121.23

g/l

—

Xanthelasma of eyelid

278

1.33

0.82

7.9

8.0

118.86

119.27

g/l

0.04

271

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

2.46

0.81

7.6

11.7

128.80

116.35

g/l

—

Discharge of firework

2.35

0.79

6.0

35.5

121.60

130.30

g/l

—

Mandibular retrognathia

188

1684

1.12

0.79

7.5

10.9

124.42

123.13

g/l

0.44

180

1651

Progressive external ophthalmoplegia

2.30

0.79

6.8

12.2

123.60

122.96

g/l

—

Other bursitis, not elsewhere classified

315

1.30

0.79

4.9

8.4

123.73

121.84

g/l

0.22

309

Other noninflammatory disorders of vagina

280

2568

1.10

0.79

7.4

8.2

118.73

117.88

g/l

0.37

274

2508

Spontaneous abortion

1510

10491

0.96

0.78

7.0

8.1

120.49

118.85

g/l

2.79

1473

10255

Use of teriflunomide

209

0.66

0.78

3.5

10.8

131.79

124.97

g/l

0.60

202

Iliac crest spur

2.22

0.77

11.0

10.5

132.20

114.96

g/l

—

Female infertility, cervical, vaginal, other or unspecified origin

859

5225

1.05

0.77

7.0

8.9

119.22

118.42

g/l

0.59

837

5111

Congenital absence, atresia and stenosis of small intestine

2.21

0.77

33.4

10.8

118.20

123.13

g/l

—

Disorders of glossopharyngeal nerve

1.73

0.77

28.9

11.0

104.45

121.96

g/l

1.18

Unattended death

356

0.74

0.77

4.6

7.5

124.70

120.37

g/l

0.50

349

Other predominantly sexually transmitted diseases, not elsewhere classified

519

4876

1.07

0.77

10.9

9.1

120.33

123.03

g/l

2.56

505

4758

Allergic conjunctivitis

2480

23190

1.03

0.76

8.8

8.6

121.07

120.93

g/l

0.14

2435

22668

Neuroendocrine tumor and carcinoma of rectum

117

1.52

0.76

8.9

8.8

112.18

123.53

g/l

1.89

117

Anomalies of dental arch relationship, including avohilmo

692

5931

1.06

0.75

8.3

9.6

124.34

122.81

g/l

1.22

674

5796

Granuloma annulare

434

1.24

0.75

10.4

7.6

115.87

119.44

g/l

0.67

426

Other assisted single delivery

323

0.73

0.75

7.2

9.6

121.92

120.57

g/l

0.12

317

Use of benzatropine

2.13

0.75

6.2

126.80

123.46

g/l

—

Undescended testicle

245

1.33

0.75

15.2

14.2

124.81

127.15

g/l

0.22

239

Carcinoma in situ of cervix uteri

253

2315

1.10

0.74

7.4

8.2

118.70

119.89

g/l

0.44

247

2256

Normotensive glaucoma

425

3980

1.08

0.74

7.3

7.6

118.73

118.96

g/l

0.10

415

3892

Anogenital herpesviral [herpes simplex] infection

179

1611

1.12

0.74

12.6

9.8

120.52

123.05

g/l

0.97

173

1575

Family history of mental and behavioural disorders

1.82

0.73

9.0

10.1

122.00

117.55

g/l

—

Erythema annulare centrifugum

1.76

0.73

4.3

8.0

117.10

123.36

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

538

5285

0.94

0.73

6.7

9.1

121.31

121.06

g/l

0.11

529

5149

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

704

1.19

0.72

8.7

8.4

115.29

119.37

g/l

1.21

690

Primary open-angle glaucoma, strict

1401

13489

1.04

0.72

6.8

7.6

119.58

119.29

g/l

0.22

1366

13184

Other superficial injuries of ankle and foot

169

1.40

0.72

9.7

7.9

125.22

123.03

g/l

0.20

163

Acquired atrophy of ovary and fallopian tube

1.66

0.71

10.1

10.9

120.00

117.64

g/l

0.16

Otosclerosis

267

2892

0.92

0.70

8.8

8.7

119.95

120.65

g/l

0.24

260

2827

Multiple system atrophy (rare forms of Parkinsonism)

103

1.53

0.69

12.6

8.4

114.20

119.79

g/l

0.45

103

Unspecified lump in breast

591

5600

1.06

0.69

8.6

7.6

119.23

118.53

g/l

0.43

579

5472

Excessive earwax

3521

31205

1.02

0.69

7.7

8.7

122.57

121.08

g/l

4.29

3452

30522

Atopic dermatitis

2438

19923

0.97

0.69

8.9

9.1

122.10

122.14

g/l

0.03

2399

19471

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2364

22034

1.03

0.69

8.9

8.5

120.92

120.96

g/l

0.03

2322

21538

Other or unspecified paralytic strabismus

215

1.34

0.68

9.2

9.0

118.21

120.81

g/l

0.21

207

Cleft lip and cleft lip and palate

180

1.36

0.67

14.2

12.1

117.71

126.20

g/l

1.06

174

Effects of air pressure and water pressure

137

1.43

0.67

12.2

13.8

126.11

124.58

g/l

0.12

132

Respiratory tuberculosis, clinically confirmed

441

1.23

0.67

14.6

8.6

115.58

119.84

g/l

0.90

434

Tonsillectomy and adenotomy

2017

14435

0.97

0.66

8.6

9.8

125.52

123.29

g/l

4.94

1959

14109

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.63

0.0

13.0

—

119.95

—

Benign neoplasm: Connective and other soft tissue of thorax

157

1.38

0.63

7.9

8.2

123.24

120.61

g/l

0.24

152

Use of anticholinesterases

1938

15350

0.97

0.62

4.4

7.2

120.49

118.81

g/l

3.42

1885

14996

N06DA Anticholinesterases

1938

15350

0.97

0.62

4.4

7.2

120.49

118.81

g/l

3.42

1885

14996

Contact with blunt object, undetermined intent

166

1.36

0.61

4.4

13.7

126.32

122.91

g/l

0.31

161

Diaper [napkin] dermatitis

1.85

0.60

8.5

9.9

101.00

123.76

g/l

—

Synovial hypertrophy, not elsewhere classified

228

1.29

0.60

10.8

13.0

124.93

124.38

g/l

0.05

222

Other histiocytosis syndromes

1.76

0.59

4.7

26.8

122.17

125.06

g/l

—

Dentofacial anomalies [including malocclusion]

3057

24410

0.98

0.59

7.6

9.3

123.21

121.80

g/l

3.60

2987

23855

Graves disease, strict definition

342

3211

1.07

0.58

7.2

8.8

121.96

120.94

g/l

0.40

332

3139

Unspecified transport accident

142

1.38

0.57

9.1

10.5

122.84

123.46

g/l

0.04

134

Maternal care for known or suspected fetal abnormality and damage

320

2891

0.93

0.56

8.1

9.3

118.28

120.96

g/l

1.87

314

2835

Miliary tuberculosis

1.52

0.56

11.2

6.3

97.11

118.26

g/l

—

Postpartum hemorraghe, all women as controls

597

6098

0.95

0.56

7.1

8.3

115.56

121.15

g/l

9.91

582

5947

Calcaneal spur

405

1.20

0.55

10.1

8.0

122.15

121.23

g/l

0.14

398

Special screening examination for infectious and parasitic diseases

736

5146

1.04

0.54

12.1

9.4

121.71

125.08

g/l

4.74

730

5018

Other obstructed labour

219

2032

1.08

0.53

7.3

8.2

120.11

120.20

g/l

0.02

212

1983

Ménière disease

406

3855

1.06

0.51

5.7

8.3

123.59

120.06

g/l

3.18

395

3769

Disorder of the sleep-wake schedule

474

1.17

0.50

4.6

11.7

126.67

121.36

g/l

1.01

463

Benign neoplasm of other and unspecified female genital organs

148

1359

1.10

0.49

6.4

7.2

118.08

118.85

g/l

0.19

148

1332

Other cestode infections, including avohilmo

129

1.36

0.48

8.5

6.8

120.53

118.15

g/l

0.21

124

Use of dimethyl fumarate

155

1.31

0.48

11.7

8.5

124.90

122.38

g/l

0.25

150

Melanoma in situ of other and unspecified parts of face

545

0.85

0.47

11.4

8.1

119.36

119.54

g/l

0.02

539

Other fusion of spine

1.45

0.47

12.0

8.1

117.57

119.20

g/l

—

Traumatic amputation of hip and thigh

1.51

0.45

8.6

7.4

124.75

121.32

g/l

—

Cleft lip and palate

139

1.32

0.45

9.9

13.2

116.50

125.68

g/l

1.00

134

Oral lichen planus, including avohilmo , including avohilmo

280

2644

1.07

0.45

7.1

8.9

123.88

120.63

g/l

2.10

271

2586

Pectus carinatum, including avohilmo

1.66

0.44

7.0

24.9

133.20

136.42

g/l

—

Exposure to ignition of highly flammable material

149

1.31

0.44

16.1

13.9

121.21

126.03

g/l

0.40

144

Other mosquito-borne viral fevers, including avohilmo

212

1.25

0.44

5.1

8.7

125.31

122.88

g/l

0.25

207

Villonodular synovitis (pigmented)

221

1.24

0.44

6.0

13.0

121.81

120.80

g/l

0.10

215

Alpha thalassaemia

1.63

0.44

4.0

10.2

107.60

112.97

g/l

—

Use of selegiline

202

1891

1.08

0.44

4.9

7.9

121.56

120.57

g/l

0.29

194

1849

Other eccrine sweat disorders

1.61

0.43

3.2

6.0

132.00

121.33

g/l

—

Other otitis externa (chronic)

267

2521

1.07

0.43

9.0

9.6

122.40

121.69

g/l

0.23

259

2461

Whooping cough, including avohilmo

342

1.18

0.42

10.2

7.9

119.78

124.26

g/l

0.59

331

FESS (DNB20)

452

4712

0.96

0.41

6.8

9.7

126.97

122.60

g/l

4.32

433

4606

Benign mammary dysplasia

544

5238

1.04

0.41

7.3

7.4

118.21

117.87

g/l

0.18

532

5121

Disorder of amino-acid metabolism, other/unspecified

1.48

0.41

19.8

7.9

109.60

122.57

g/l

—

Haemorrhagic and haematological disorders of fetus and newborn

283

1.19

0.40

26.7

18.8

112.17

121.63

g/l

2.06

278

Unspecified dementia

538

4647

1.04

0.40

4.9

6.6

119.55

118.02

g/l

1.02

523

4531

Dyshidrosis [pompholyx]

410

0.85

0.40

5.9

7.6

126.46

122.23

g/l

0.67

399

Lichen striatus

1.43

0.39

2.2

9.4

122.20

122.11

g/l

—

Multiple superficial injuries of ankle and foot

1.43

0.39

3.8

6.3

140.40

124.58

g/l

—

Interstitial myositis

1.55

0.38

1.8

7.8

130.83

120.27

g/l

—

Presbyopia

295

2807

1.06

0.38

9.0

9.6

124.22

123.08

g/l

0.45

290

2750

Benign neoplasm: Vulva

639

1.12

0.38

5.5

7.4

117.63

118.39

g/l

0.12

625

Unspecified hairloss

1.53

0.38

3.3

12.8

129.50

119.56

g/l

—

Gestational diabetes (for exclusion)

951

6358

1.03

0.38

7.1

8.8

121.10

120.88

g/l

0.13

929

6206

Proteinuria and renal glomerular damage; focal glomerulonephritis

1.50

0.37

2.3

7.1

101.33

121.24

g/l

—

Dermatitis due to ingested food

574

1.12

0.37

22.0

12.8

127.37

123.40

g/l

0.76

561

Nontoxic single thyroid nodule

245

2577

0.95

0.35

5.9

8.2

121.58

119.84

g/l

0.65

237

2510

Asymptomatic human immunodeficiency virus [HIV] infection status

182

1.23

0.35

17.8

18.3

117.73

126.41

g/l

1.30

177

Deficiency of other/unspecified vitamins

1.34

0.34

23.5

7.4

118.33

120.43

g/l

—

Dementia in Alzheimer disease

969

7905

1.03

0.34

4.1

6.8

119.85

117.98

g/l

2.26

953

7720

Palindromic rheumatism

327

0.85

0.33

10.9

9.4

124.79

122.31

g/l

0.24

322

Maternal care for known or suspected malpresentation of fetus

417

2862

1.04

0.32

7.4

9.0

120.72

121.41

g/l

0.30

401

2799

Febrile neutrophilic dermatosis [Sweet]

1.34

0.32

20.6

6.1

103.71

122.70

g/l

—

L02BB Anti-androgens

450

4655

0.96

0.32

6.2

8.3

114.77

120.90

g/l

8.32

438

4554

Sweet's syndrome

1.31

0.31

20.6

6.4

103.71

121.24

g/l

—

Use of galantamine

366

3799

0.96

0.31

4.0

6.4

121.60

118.36

g/l

2.37

360

3707

Alzheimer’s disease, strict definition

1427

11298

1.02

0.31

4.7

6.9

119.27

118.34

g/l

1.05

1397

11025

Photocontact dermatitis [berloque dermatitis]

1.28

0.31

2.1

9.9

126.57

119.70

g/l

—

Tic and related disorders

259

1.17

0.30

10.0

12.1

120.27

123.42

g/l

0.43

250

Acrodermatitis chronica atrophicans

1.31

0.29

7.9

8.2

108.88

121.22

g/l

—

Allergic contact dermatitis

439

4534

0.97

0.28

8.1

8.5

121.94

121.46

g/l

0.20

431

4420

Benign neoplasm: Skin, unspecified

153

1448

1.06

0.28

7.9

9.0

119.48

121.22

g/l

0.48

147

1420

Cervical polyps

354

3418

1.04

0.27

7.6

8.5

119.28

117.82

g/l

0.85

344

3345

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

243

1.16

0.27

2.6

13.7

126.29

123.21

g/l

0.36

236

Other disorders of breast and lactation associated with childbirth

279

0.86

0.27

8.0

7.2

118.96

120.43

g/l

0.14

274

Disorders of parathyroid gland, other and/or unspecified

254

1.16

0.26

7.3

7.8

118.34

119.00

g/l

0.06

248

Foreign body on external eye

591

6059

0.97

0.25

8.4

10.5

127.20

124.81

g/l

1.93

576

5925

Dysplasia of cervi uteri

764

5252

1.02

0.25

7.5

8.6

118.17

118.48

g/l

0.17

749

5128

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

199

1.17

0.24

15.9

8.3

115.30

121.25

g/l

0.67

193

Other specified disorders of external ear

153

1606

0.95

0.24

7.7

9.4

121.87

121.84

g/l

0.01

146

1569

Other disorders of breast

427

4393

0.97

0.24

7.7

7.9

118.89

118.70

g/l

0.08

421

4286

Enteritis due to Yersinia enterocolitica

162

1.19

0.24

7.9

8.9

121.89

122.27

g/l

0.02

157

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

247

1.15

0.23

6.0

8.9

126.61

120.09

g/l

1.16

242

Visual disturbances in diseases classified elsewhere

0.00

0.23

0.0

7.2

—

134.78

—

Transient global amnesia

413

4018

1.03

0.23

6.2

8.2

122.10

119.60

g/l

1.86

404

3928

Anthrax

0.00

0.23

0.0

8.7

—

116.30

—

Ethmoidectomy

480

4924

0.97

0.23

7.2

9.7

126.83

122.46

g/l

4.55

460

4812

Anthrax, including avohilmo

0.00

0.22

0.0

8.3

—

119.09

—

Injury of nerves at ankle and foot level

210

1.16

0.22

15.7

9.0

125.87

122.67

g/l

0.29

204

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.22

0.0

4.3

—

128.40

—

Sudden idiopathic hearing loss

443

4317

1.03

0.22

9.7

8.7

121.87

120.67

g/l

0.56

435

4214

Pustulosis subcornealis

0.00

0.22

0.0

10.8

—

113.25

—

Blastomycosis, including avohilmo

0.00

0.21

0.0

2.8

—

133.38

—

Enophthalmos

0.00

0.21

0.0

13.4

—

121.00

—

Thyrotoxicosis with toxic single thyroid nodule

249

1.14

0.21

4.7

7.6

122.43

120.76

g/l

0.19

244

Pregnancy, childbirth and the puerperium

1176

6236

0.98

0.21

6.1

7.1

117.77

117.57

g/l

0.13

1161

6077

Other specified and unspecified disorders of choroid

146

1.19

0.20

10.2

8.7

116.24

119.71

g/l

0.42

140

Other and unspecified disorders of vitreous body

2131

21048

0.99

0.20

8.2

8.5

121.37

120.27

g/l

1.84

2084

20589

Benign neoplasm: Short bones of upper limb

472

1.09

0.19

5.4

9.0

121.65

121.37

g/l

0.04

464

Vascular dementia (sudden onset)

122

0.81

0.19

2.7

5.6

113.00

115.63

g/l

—

117

Intentional self-harm by hanging, strangulation and suffocation

213

1.14

0.19

10.3

11.2

128.29

125.16

g/l

0.30

206

Tic disorders

251

1.12

0.19

10.6

11.5

121.61

123.48

g/l

0.22

243

Puerperal sepsis

413

4033

1.03

0.19

8.9

8.3

120.81

119.30

g/l

0.90

406

3940

Contact with lifting and transmission devices, not elsewhere classified

639

1.07

0.18

10.1

12.1

124.34

123.94

g/l

0.05

622

Abrasion of teeth

1583

16013

0.99

0.18

8.1

8.9

121.42

121.13

g/l

0.24

1543

15649

Contact with venomous snakes and lizards

329

1.10

0.18

5.4

11.3

127.72

121.34

g/l

0.92

322

Contraceptive management

1561

11034

0.99

0.18

9.0

10.4

123.35

123.86

g/l

0.44

1517

10815

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

198

2048

0.96

0.18

11.3

8.3

119.08

120.52

g/l

0.52

190

2002

Anogenital herpesviral [herpes simplex] infection, including avohilmo

304

2960

1.03

0.17

11.2

9.5

121.89

122.83

g/l

0.37

296

2895

Conjunctivitis (acute, non atopic), including avohilmo

5436

32995

0.99

0.17

8.7

8.9

122.63

121.63

g/l

2.96

5353

32209

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

196

1.14

0.17

8.7

14.5

127.82

125.34

g/l

0.17

191

Abnormal findings on diagnostic imaging of breast

437

1.08

0.17

10.9

7.0

119.11

118.41

g/l

0.10

431

Gilbert syndrome

196

1.13

0.17

12.7

10.0

131.91

123.99

g/l

0.75

191

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

147

1415

1.04

0.16

11.8

8.4

121.54

121.05

g/l

0.12

140

1378

Triptan medication for migraine, min. 3 purchases

2106

15583

1.01

0.16

7.9

9.1

123.65

121.45

g/l

5.85

2065

15218

Enterobiasis, including avohilmo

442

0.92

0.16

8.0

10.8

121.29

122.06

g/l

0.09

432

Hereditary motor and sensory neuropathy

275

1.10

0.15

9.2

8.8

122.43

122.79

g/l

0.03

268

Leiomyoma of uterus

2599

14462

1.01

0.14

7.4

7.6

119.20

118.58

g/l

0.92

2537

14131

Gender identity disorders

202

0.89

0.14

7.1

14.1

126.17

124.54

g/l

0.11

193

Deep bite

357

3072

1.02

0.13

8.4

10.5

125.25

122.90

g/l

1.42

349

3009

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

198

2033

0.97

0.13

11.3

8.0

119.08

120.59

g/l

0.55

190

1984

Undefined dementia

540

5052

0.98

0.12

4.9

6.0

119.57

118.02

g/l

1.05

525

4930

Complications predominantly related to the puerperium

758

7493

1.01

0.11

8.8

8.0

119.90

119.65

g/l

0.14

748

7304

Intrahepatic Cholestasis of Pregnancy (ICP)

147

1430

1.03

0.11

11.8

8.5

121.54

121.06

g/l

0.12

140

1399

Pemphigus foliaceus

1.15

0.10

5.0

5.1

102.60

121.48

g/l

—

Benign neoplasm: Parathyroid gland

398

1.06

0.10

3.5

7.5

123.48

120.19

g/l

0.53

392

Cholera

1.12

0.10

23.6

10.8

124.40

116.11

g/l

—

Benign neoplasm: Vagina

379

1.06

0.10

6.1

6.3

114.62

118.11

g/l

0.58

371

Multiple gestation

210

2058

1.02

0.09

8.7

8.9

119.61

120.78

g/l

0.42

203

2014

Pediculosis and phthiriasis, including avohilmo

174

1.10

0.09

6.7

9.7

123.74

121.31

g/l

0.18

169

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1715

12533

1.01

0.09

7.4

8.1

119.84

119.55

g/l

0.26

1671

12246

Other congenital malformations of male genital organs

155

0.90

0.09

9.8

17.1

133.21

126.79

g/l

0.47

150

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

1.14

0.09

6.2

6.9

109.67

119.42

g/l

—

Overjet

485

1.05

0.09

10.9

12.2

117.04

122.49

g/l

1.61

476

Twin gestation

201

1972

1.02

0.09

9.0

8.9

119.60

120.84

g/l

0.45

194

1929

Rheumatic heart disease, other

1.10

0.08

4.6

6.6

124.43

120.14

g/l

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

200

1.08

0.08

25.6

19.9

121.05

120.68

g/l

0.02

195

Pollen allergy

535

5219

1.01

0.08

8.4

10.0

124.67

123.33

g/l

0.79

526

5105

Other congenital malformations of skin, including avohilmo

268

2640

1.02

0.08

9.4

121.32

122.05

g/l

0.24

263

2582

Familial erythrocytosis

166

1.09

0.08

14.1

11.5

132.78

121.98

g/l

1.27

161

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

1.06

0.07

10.1

17.8

139.11

128.08

g/l

—

Hypertrophy of (infrapatellar) fat pad

265

1.06

0.07

7.6

10.9

123.18

122.12

g/l

0.10

259

Other abnormal products of conception

849

5530

1.01

0.06

6.6

8.6

121.14

120.47

g/l

0.44

820

5389

Reduction defects of lower limb, including avohilmo

1.12

0.06

17.8

6.9

120.18

123.23

g/l

0.16

Postpartum haemorrhage due to retained placenta

271

2744

0.99

0.06

7.7

113.95

121.52

g/l

7.62

266

2671

Impacted teeth

504

4287

1.01

0.06

8.8

9.8

123.83

124.06

g/l

0.09

495

4190

Defect, injury or illness of neck

178

1.07

0.06

10.6

8.5

130.42

122.53

g/l

1.04

173

Benign neoplasm: Eye, unspecified

149

1.08

0.05

5.2

5.8

118.44

119.84

g/l

0.12

149

Colour vision deficiencies

110

1.10

0.05

7.6

16.4

116.42

126.43

g/l

0.77

105

Other puerperal infections

149

1468

1.02

0.05

8.3

8.4

120.73

120.48

g/l

0.05

149

1430

Maternal care for known or suspected abnormality of pelvic organs

646

4378

1.00

0.03

6.9

8.8

120.00

120.68

g/l

0.41

635

4281

Obstructed labour due to maternal pelvic abnormality

491

4887

1.01

0.03

8.1

119.75

119.15

g/l

0.30

480

4773

Lichenoid drug reaction

112

1.08

0.03

20.3

7.0

120.75

115.36

g/l

0.43

112

Early syphilis

409

0.98

0.02

10.4

11.9

124.77

124.99

g/l

0.02

399

Bus occupant injured in other and unspecified transport accidents

212

1.04

0.02

12.6

8.2

113.64

121.28

g/l

1.21

205

Eccrine sweat disorders

1.08

0.02

2.3

8.9

129.90

123.15

g/l

—

Single delivery by caesarean section

468

2676

1.00

0.01

7.7

10.4

118.01

120.15

g/l

1.54

459

2627

Early syphilis, including avohilmo

433

1.02

0.01

10.1

11.6

124.80

125.14

g/l

0.04

422

Maternal care for other known or suspected fetal problems

530

3317

1.00

0.01

7.2

9.1

119.38

121.49

g/l

1.78

513

3247

Testicular dysfunction, other/unspecified

184

1.04

0.00

8.2

16.7

130.95

125.71

g/l

0.42

178

Enterobiasis

1.04

0.00

5.1

9.0

123.50

123.25

g/l

—

Retained placenta and membranes, without haemorrhage

357

3566

1.00

0.00

6.9

8.0

117.38

119.74

g/l

1.64

352

3485

Hydatidiform mole

299

1.00

0.00

2.0

9.3

127.27

119.05

g/l

2.24

290

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

197

0.99

0.00

28.0

20.2

120.00

120.35

g/l

0.02

192

Heberden's nodes [with arthropathy]

307

1.01

0.00

6.5

7.9

121.00

118.66

g/l

0.25

301

Mesial bite

194

0.98

0.00

11.8

14.5

117.84

121.37

g/l

0.29

189

Idiopathic hypercalciuria

195

1.03

0.00

9.9

9.7

127.10

123.61

g/l

0.31

189

Miliaria, unspecified

0.00

0.0

34.6

—

114.00

—

Accident to nonpowered aircraft causing injury to occupant

0.00

0.0

10.2

—

129.67

—

Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons

0.00

0.0

7.4

—

131.20

—

Other inflammatory disorders of orbit (ICD-8 only)

0.00

0.0

15.8

—

113.20

—

Androgen resistance syndrome

0.00

-0.00

0.0

17.2

—

112.00

—

Pneumoconiosis associated with tuberculosis

0.00

-0.00

0.0

6.8

—

122.00

—

Fetal blood loss

0.00

-0.00

0.0

19.6

—

120.25

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

10.0

—

107.20

—

Granuloma inguinale

0.00

-0.00

0.0

4.6

—

103.50

—

Reduction defects of lower limb

0.87

-0.00

29.7

7.3

132.33

125.03

g/l

—

Beau lines

0.00

-0.00

0.0

24.6

—

111.11

—

Congenital retinoschisis

0.87

-0.00

4.3

10.6

117.86

120.43

g/l

—

Dietary selenium deficiency

0.00

-0.00

0.0

14.8

—

117.50

—

Chlamydia psittaci infection

0.00

-0.00

0.0

2.4

—

115.43

—

Dermato(poly)myositis in neoplastic disease

0.00

-0.00

0.0

9.4

—

112.43

—

Toxic effect of soaps and detergents

0.00

-0.00

0.0

7.7

—

120.43

—

Neuropathic heredofamilial amyloidosis

0.00

-0.00

0.0

6.6

—

128.00

—

Disorders of zinc metabolism

0.00

-0.00

0.0

14.1

—

114.57

—

Toxic effect of noxious substances eaten as seafood

0.00

-0.00

0.0

14.4

—

118.00

—

Blastomycosis

0.00

-0.00

0.0

2.8

—

139.00

—

Monkeypox, including avohilmo

0.00

-0.00

0.0

7.7

—

121.33

—

Toxic liver disease with acute hepatitis, drug-induced

0.00

-0.00

0.0

18.3

—

126.57

—

Congenital malformation of vitreous humour

0.00

-0.00

0.0

3.2

—

132.50

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

-0.00

0.0

86.1

—

119.33

—

Other specified types of T/NK-cell lymphoma, hilmo

0.00

-0.00

0.0

3.4

—

124.80

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hemoglobin [Mass/volume] in Arterial blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS